"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtAU_IN","meanArtPer_AU_IN_FIRST","meanArtPer_AU_IN_LAST","meanArtPer_AU_IN_CORR","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","InternCoauthorship","AffCoauthorship","meanCitationTrend","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","medianAltmetricScore","altmetric_score_mean_top25AltmScore","altmetric_score_min_top25AltmScore","altmetric_score_max_top25AltmScore","cited_by_accounts_count_mean_top25AltmScore","cited_by_accounts_count_min_top25AltmScore","cited_by_accounts_count_max_top25AltmScore","cited_by_fbwalls_count_mean_top25AltmScore","cited_by_fbwalls_count_min_top25AltmScore","cited_by_fbwalls_count_max_top25AltmScore","cited_by_feeds_count_mean_top25AltmScore","cited_by_feeds_count_min_top25AltmScore","cited_by_feeds_count_max_top25AltmScore","cited_by_gplus_count_mean_top25AltmScore","cited_by_gplus_count_min_top25AltmScore","cited_by_gplus_count_max_top25AltmScore","cited_by_msm_count_mean_top25AltmScore","cited_by_msm_count_min_top25AltmScore","cited_by_msm_count_max_top25AltmScore","cited_by_patents_count_mean_top25AltmScore","cited_by_patents_count_min_top25AltmScore","cited_by_patents_count_max_top25AltmScore","cited_by_peer_review_sites_count_mean_top25AltmScore","cited_by_peer_review_sites_count_min_top25AltmScore","cited_by_peer_review_sites_count_max_top25AltmScore","cited_by_policies_count_mean_top25AltmScore","cited_by_policies_count_min_top25AltmScore","cited_by_policies_count_max_top25AltmScore","cited_by_posts_count_mean_top25AltmScore","cited_by_posts_count_min_top25AltmScore","cited_by_posts_count_max_top25AltmScore","cited_by_rdts_count_mean_top25AltmScore","cited_by_rdts_count_min_top25AltmScore","cited_by_rdts_count_max_top25AltmScore","cited_by_rh_count_mean_top25AltmScore","cited_by_rh_count_min_top25AltmScore","cited_by_rh_count_max_top25AltmScore","cited_by_tweeters_count_mean_top25AltmScore","cited_by_tweeters_count_min_top25AltmScore","cited_by_tweeters_count_max_top25AltmScore","cited_by_videos_count_mean_top25AltmScore","cited_by_videos_count_min_top25AltmScore","cited_by_videos_count_max_top25AltmScore","cited_by_wikipedia_count_mean_top25AltmScore","cited_by_wikipedia_count_min_top25AltmScore","cited_by_wikipedia_count_max_top25AltmScore","cohorts.com_mean_top25AltmScore","cohorts.com_min_top25AltmScore","cohorts.com_max_top25AltmScore","cohorts.doc_mean_top25AltmScore","cohorts.doc_min_top25AltmScore","cohorts.doc_max_top25AltmScore","cohorts.pub_mean_top25AltmScore","cohorts.pub_min_top25AltmScore","cohorts.pub_max_top25AltmScore","cohorts.sci_mean_top25AltmScore","cohorts.sci_min_top25AltmScore","cohorts.sci_max_top25AltmScore","readers.citeulike_mean_top25AltmScore","readers.citeulike_min_top25AltmScore","readers.citeulike_max_top25AltmScore","readers.connotea_mean_top25AltmScore","readers.connotea_min_top25AltmScore","readers.connotea_max_top25AltmScore","readers.mendeley_mean_top25AltmScore","readers.mendeley_min_top25AltmScore","readers.mendeley_max_top25AltmScore","readers_count_mean_top25AltmScore","readers_count_min_top25AltmScore","readers_count_max_top25AltmScore","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internazionali","avg_ResultingPublications_per_grant","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","nClTrial_w_AltmScore","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n"
"AOU_SANGIOVANNIDIDIO",2000,5,4.8,4,0.25,1,0.6,0.2,0.2,0,0,1,2,2,0,0.2,0.4,0.4,27.2,0.600031180169412,0,0.2,0,0.367647058823529,0.133333333333333,0.166666666666667,0,"GIUSEPPE DI BENEDETTO;PAOLO MASIELLO;M. CRISTOFARI;GAETANA PALUMBO;FRANCESCO ITRI;EMILIA QUATTROCCHI;A. CAPRA;FAUSTO AVANZINI;C ALLI;MARIA CARLA RONCAGLIONI;CARLO COSTANTINI;FILIPPO CASTORINO;E RONCHI;ROSA NAPOLETANO;L. NOSOTTI;GIUSEPPE SANTORO;GENEROSO MASTROGIOVANNI;GABRIELE CAPO;ANDREA ESPOSITO;PATRÍCIA R. M. ROCCO","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GIUSEPPE DI BENEDETTO;GIUSEPPE SANTORO;PAOLO MASIELLO;PATRÍCIA R. M. ROCCO;ROSA NAPOLETANO;GABRIELE CAPO;ANDREA ESPOSITO;FRANCESCO ITRI;EMILIA QUATTROCCHI;FILIPPO CASTORINO;GENEROSO MASTROGIOVANNI;M. CRISTOFARI;GAETANA PALUMBO;A. CAPRA;FAUSTO AVANZINI;C ALLI;MARIA CARLA RONCAGLIONI;CARLO COSTANTINI;E RONCHI;L. NOSOTTI","0.5;0.5;0.5;0.5;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.09;0.09;0.09;0.09;0.09;0.09;0.09;0.09;0.09","GIUSEPPE DI BENEDETTO;PAOLO MASIELLO;M. CRISTOFARI;GAETANA PALUMBO;FRANCESCO ITRI;A. CAPRA;FAUSTO AVANZINI;C ALLI;MARIA CARLA RONCAGLIONI;CARLO COSTANTINI;FILIPPO CASTORINO;E RONCHI;ROSA NAPOLETANO;L. NOSOTTI;GIUSEPPE SANTORO;GENEROSO MASTROGIOVANNI;GABRIELE CAPO;ANDREA ESPOSITO;R. PIETROFESO;STEFANO ROSSI","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GIUSEPPE DI BENEDETTO;GIUSEPPE SANTORO;PAOLO MASIELLO;ROSA NAPOLETANO;GABRIELE CAPO;ANDREA ESPOSITO;FRANCESCO ITRI;FILIPPO CASTORINO;GENEROSO MASTROGIOVANNI;M. CRISTOFARI;GAETANA PALUMBO;A. CAPRA;FAUSTO AVANZINI;C ALLI;MARIA CARLA RONCAGLIONI;CARLO COSTANTINI;E RONCHI;L. NOSOTTI;R. PIETROFESO;STEFANO ROSSI","0.5;0.5;0.5;0.33;0.33;0.33;0.25;0.25;0.25;0.09;0.09;0.09;0.09;0.09;0.09;0.09;0.09;0.09;0.09;0.09","A. CAPRA;C ALLI;CARLO COSTANTINI;E RONCHI;FAUSTO AVANZINI;GAETANA PALUMBO;L. NOSOTTI;M. CRISTOFARI;MARIA CARLA RONCAGLIONI;R. PIETROFESO;STEFANO ROSSI;GIUSEPPE DI BENEDETTO;PAOLO MASIELLO;EMILIA QUATTROCCHI;FILIPPO CASTORINO;FRANCESCO ITRI;GENEROSO MASTROGIOVANNI;ANDREA ESPOSITO;GABRIELE CAPO;GIUSEPPE SANTORO","99;99;99;99;99;99;99;99;99;99;99;37;37;35;35;2;2;0;0;0","A. CAPRA;C ALLI;CARLO COSTANTINI;E RONCHI;FAUSTO AVANZINI;GAETANA PALUMBO;L. NOSOTTI;M. CRISTOFARI;MARIA CARLA RONCAGLIONI;R. PIETROFESO;STEFANO ROSSI;FILIPPO CASTORINO;FRANCESCO ITRI;GENEROSO MASTROGIOVANNI;GIUSEPPE DI BENEDETTO;PAOLO MASIELLO;ANDREA ESPOSITO;GABRIELE CAPO;GIUSEPPE SANTORO;ROSA NAPOLETANO","99;99;99;99;99;99;99;99;99;99;99;35;2;2;2;2;0;0;0;0","A. CAPRA;C ALLI;CARLO COSTANTINI;E RONCHI;FAUSTO AVANZINI;FILIPPO CASTORINO;FRANCESCO ITRI;GAETANA PALUMBO;GENEROSO MASTROGIOVANNI;GIUSEPPE DI BENEDETTO;L. NOSOTTI;M. CRISTOFARI;MARIA CARLA RONCAGLIONI;PAOLO MASIELLO;R. PIETROFESO;STEFANO ROSSI;ANDREA ESPOSITO;GABRIELE CAPO;GIUSEPPE SANTORO;ROSA NAPOLETANO","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;0;0;0;0","MEDICINE;PHILOSOPHY;PSYCHOLOGY","5;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;RADIOLOGY;ANESTHESIA;EPISTEMOLOGY;GENERAL SURGERY;PATHOLOGY;PHYSICAL MEDICINE AND REHABILITATION;SOCIAL PSYCHOLOGY","4;4;3;2;1;1;1;1;1;1","MITRAL VALVE;AMBULATORY;ASPIRIN;ATRIAL FIBRILLATION;BIOPSY;BLOOD PRESSURE;CANCER;CARDIAC TUMORS;COMPLICATION;DEHISCENCE;DISSECTION (MEDICAL);ELBOW;ENDOCARDITIS;EXPECTANCY THEORY;HISTOPATHOLOGY;LESION;LYMPH NODE;NORMATIVE;PRESENTATION (OBSTETRICS);SARCOMA;STENOSIS;VENTRICLE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMBULATORY BLOOD PRESSURE;ATRIOVENTRICULAR VALVE;ATRIUM (ARCHITECTURE);BREAST CANCER;LYMPHADENECTOMY;MITRAL VALVE REPLACEMENT;RHABDOMYOSARCOMA;SEROMA;ULNAR NERVE","1;1;1;1;1;1;1;1;1","AXILLA;LYMPHEDEMA;SENTINEL LYMPH NODE;SENTINEL NODE","1;1;1;1","HEART NEOPLASMS;HUMANS;RHABDOMYOSARCOMA;AGED;BLOOD PRESSURE;FEMALE;HYPERTENSION;MITRAL VALVE;MITRAL VALVE INSUFFICIENCY;MITRAL VALVE STENOSIS;POSTOPERATIVE COMPLICATIONS;ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;ASPIRIN;BREAST NEOPLASMS;CIRCADIAN RHYTHM;ECHOCARDIOGRAPHY, TRANSESOPHAGEAL;HEART ATRIA;LYMPH NODE EXCISION;MALE;VITAMIN E","4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF CARPAL TUNNEL SYNDROME;EPIDEMIOLOGY AND MANAGEMENT OF FUNGAL SKIN INFECTIONS;MANAGEMENT AND EPIDEMIOLOGY OF INFECTIVE ENDOCARDITIS;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS","1;1;1;1;1","ATRIOVENTRICULAR VALVE;ATRIUM (ARCHITECTURE);AXILLA;AXILLARY DISSECTION;CARDIAC IMAGING;CARDIAC MYXOMAS;CARDIAC TUMORS;CLINICAL PRACTICE GUIDELINES;ECHOCARDIOGRAPHY;HISTOPATHOLOGY;HYPERTENSION;LYMPHADENECTOMY;MITRAL REGURGITATION;MITRAL VALVE REPLACEMENT;NEUROPHYSIOLOGICAL GRADING SCALE;PRESENTATION (OBSTETRICS);PRIMARY CARDIAC NEOPLASMS;RHABDOMYOSARCOMA;SEROMA;TRANSCATHETER AORTIC-VALVE REPLACEMENT","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMBULATORY BLOOD;AXILLARY LYMPHADENECTOMY;BLOOD PRESSURE;CARDIAC RHABDOMYOSARCOMA;CARPENTIER MITRAL;COMMON ELECTRONEUROGRAPHIC;DEHISCED CARPENTIER;ECHOCARDIOGRAPHIC DIAGNOSIS;ELECTRONEUROGRAPHIC PARAMETERS;HYPERTENSIVE PATIENTS;LEFT ATRIUM;LOW-DOSE ASPIRIN;MITRAL RING;NORMATIVE VALUES;PEOPLE AGED;PRIMARY CARDIAC;TRANSESOPHAGEAL ECHOCARDIOGRAPHIC;TREATED HYPERTENSIVE;UNUSUAL PRESENTATION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MM HG;ASPIRIN TREATMENT;BP CONTROL;HYPERTENSIVE PATIENTS;LOW-DOSE ASPIRIN;AFFECT BLOOD;AMBULATORY BP;AMBULATORY SBP;AMBULATORY SYSTOLIC;ANGIOTENSIN CONVERTING;ANTIHYPERTENSIVE DRUG;ANTIHYPERTENSIVE DRUGS;ANTIHYPERTENSIVE THERAPY;ANTIINFLAMMATORY DRUGS;ASPIRIN MGDAY;AUTOMATIC SPHYGMOMANOMETER;BASELINE DELTASBP;BLOOD PRESSURE;BP EVALUATION;BP MONITORING;CALCIUM ANTAGONISTS;CARDIOVASCULAR RISK;CHRONIC STABLE;CHRONIC TREATMENT;CLASSES ANGIOTENSIN;CLINIC BP;CLINIC SBP;CONFIDENCE INTERVALS;CONTROLLED FACTORIAL;CONVERTING ENZYME","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2001,4,6,1.25,0.8,0.75,0.25,0,0,0,0,1,0,3,0,0.25,0,0.75,4.75,0.103955952915185,0,0.25,0,0.247076023391813,0.166666666666667,0,0,"FRANCESCO ORIO;A FASOLINO;FASOLINO MC;ANNAMARIA COLAO;MICHELE MANZO;DI LEO L;DI BENEDETTO G;STEFANO PALOMBA;C. DENTICO;CARMINE NAPPI;V LONGO;DI FILIPPO;F FRANCO;MARIO PETRETTA;GAETANA MELCHIORRE;GIACOMO CAPECE;SALVATORE CASSESE;M C FASOLINO;R TROTTA;MARTA TENUTA","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","A FASOLINO;FASOLINO MC;DI FILIPPO;SALVATORE CASSESE;FRANCESCO ORIO;MICHELE MANZO;DI LEO L;DI BENEDETTO G;GAETANA MELCHIORRE;ANDREA CAMPANA;V LONGO;F FRANCO;GIACOMO CAPECE;M C FASOLINO;R TROTTA;ANNAMARIA COLAO;STEFANO PALOMBA;C. DENTICO;CARMINE NAPPI;MARIO PETRETTA","0.42;0.25;0.25;0.25;0.22;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.11;0.11;0.11;0.11;0.11","FRANCESCO ORIO;A FASOLINO;MARTA TENUTA;ANDREA CAMPANA","2;2;1;1","A FASOLINO;FRANCESCO ORIO;ANDREA CAMPANA;MARTA TENUTA","0.42;0.22;0.2;0.11","FRANCESCO ORIO;ANNAMARIA COLAO;C. DENTICO;CARMINE NAPPI;GAETANO LOMBARDI;MARIO PETRETTA;MARTA TENUTA;STEFANO PALOMBA;A FASOLINO;F FRANCO;GIACOMO CAPECE;M C FASOLINO;R TROTTA;V LONGO;DI FILIPPO;FASOLINO MC;SALVATORE CASSESE;ANDREA CAMPANA;DI BENEDETTO G;DI LEO L","32;16;16;16;16;16;16;16;3;2;2;2;2;2;1;1;1;0;0;0","FRANCESCO ORIO;MARTA TENUTA;A FASOLINO;ANDREA CAMPANA","16;16;3;0","A FASOLINO;FRANCESCO ORIO;MARTA TENUTA;ANDREA CAMPANA","2;1;1;0","MEDICINE;BIOLOGY;CHEMISTRY;ENGINEERING","4;1;1;1","INTERNAL MEDICINE;ANDROLOGY;ANESTHESIA;CARDIOLOGY;ENDOCRINOLOGY;GENETICS;MECHANICAL ENGINEERING;ORGANIC CHEMISTRY;PEDIATRICS;PHARMACOLOGY;PHYSIOLOGY;SURGERY","3;1;1;1;1;1;1;1;1;1;1;1","ADHESION;ASYSTOLE;ATRIAL FIBRILLATION;BLOOD PRESSURE;DIAGNOSTIC TEST;EMBRYO;HORMONE;INSERT (COMPOSITES);LAPAROSCOPY;PREGNANCY;RECEPTOR;SECRETION;SYNCOPE (PHONOLOGY)","1;1;1;1;1;1;1;1;1;1;1;1;1","AGONIST;EMBRYOGENESIS;GROWTH HORMONE;HEART RATE;IMPLANTABLE LOOP RECORDER;IN VITRO FERTILISATION;LAPAROSCOPIC SURGERY;MENSTRUAL CYCLE;OOCYTE;PREGNANCY RATE","1;1;1;1;1;1;1;1;1;1","BACLOFEN;BLASTOMERE;BRADYCARDIA;EMBRYO QUALITY;INTRACYTOPLASMIC SPERM INJECTION;TILT TABLE TEST;VERESS NEEDLE;ZONA PELLUCIDA","1;1;1;1;1;1;1;1","HUMANS;ADULT;BACLOFEN;FEMALE;GABA AGONISTS;GROWTH HORMONE;MENSTRUAL CYCLE;OOCYTES;SYNCOPE;EMBRYO, MAMMALIAN;FOLLICLE STIMULATING HORMONE;FOLLICULAR PHASE;HEART FUNCTION TESTS;LAPAROSCOPY;LUTEAL PHASE;OVULATION;TISSUE ADHESIONS;ABDOMEN;ADMINISTRATION, ORAL;EMBRYO TRANSFER","4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1","DIAGNOSIS AND MANAGEMENT OF SYNCOPE;FERTILITY PRESERVATION IN CANCER PATIENTS;INNOVATIONS IN TRANSGASTRIC SURGICAL TECHNIQUES;MENSTRUAL HEALTH AND DISORDERS","1;1;1;1","ASYSTOLE;BACLOFEN;BLASTOMERE;CRYOPRESERVED OOCYTES;EMBRYO QUALITY;HORMONAL TREATMENTS;HORMONE THERAPY;IMPLANTABLE LOOP RECORDER;INSERT (COMPOSITES);MENSTRUAL HYGIENE MANAGEMENT;NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY;NEURALLY MEDIATED SYNCOPE;OOCYTE MATURATION;OOCYTE QUALITY;PERIVITELLINE SPACE;PERORAL TRANSGASTRIC ENDOSCOPY;SYNCOPE;TILT TABLE TEST;VERESS NEEDLE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABDOMINAL ADHESION;BACLOFEN ADMINISTRATION;EXTRAUMBILICAL INSERTION;GROWTH HORMONE;HEALTHY WOMEN;HORMONE SECRETION;IMPLANTABLE LOOP;LOOP RECORDER;MENSTRUAL CYCLE;OOCYTE MATURITY;PATIENTS UNDERGOING;R-FSH TREATMENT;SYNCOPE REPORT;UNDERGOING ICSI;UNDETERMINED SYNCOPE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2002,9,4.77777777777778,2,0.5,0.777777777777778,0.222222222222222,0.222222222222222,0,1,0,4,0,3,0,0.44,0,0.33,16.33,0.296061538876053,0,0.444444444444444,0,0.337278106508876,0.107142857142857,0.166666666666667,0,"GIOVANNI D’ARENA;ANGELO MICHELE CARELLA;NICOLA CASCAVILLA;ROSELLA MATERA;A FASOLINO;PAOLO MASIELLO;GIUSEPPE NUNZIATA;G. R. PISTOLESE;FASOLINO MC;CHRISTIAN CURCIO;MARIA CARMEN FASOLINO;ENRICO COSCIONI;ALESSANDRA SPLENDIANI;RENATO GALZIO;GIUSEPPE DI BENEDETTO;O. DELLA GATTA;MASSIMO CAULO;GIUSEPPE PREZIOSI;LUCIA SAVINO;F. TRIUMBARI","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","PAOLO MASIELLO;A FASOLINO;GIOVANNI D’ARENA;ANGELO MICHELE CARELLA;NICOLA CASCAVILLA;ROSELLA MATERA;GIUSEPPE NUNZIATA;G. R. PISTOLESE;FASOLINO MC;CHRISTIAN CURCIO;MARIA CARMEN FASOLINO;O. DELLA GATTA;ELENA PASTORE;MICHELE VALENTE;GIUSEPPE SANTORO;SALVATORE CASSESE;E. PASTORE;ROSA RUSSO;D. PALADINI;PASQUALE MARTINELLI","1.17;0.5;0.29;0.29;0.29;0.29;0.29;0.29;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25","GIOVANNI D’ARENA;A FASOLINO;PAOLO MASIELLO;GIUSEPPE NUNZIATA;G. R. PISTOLESE;ENRICO COSCIONI;GIUSEPPE DI BENEDETTO;GIUSEPPE PREZIOSI;F. TRIUMBARI;GIUSEPPE SANTORO;ROSA RUSSO;R RUSSO;ANTONIO PANZA","2;2;2;2;2;1;1;1;1;1;1;1;1","PAOLO MASIELLO;A FASOLINO;GIOVANNI D’ARENA;GIUSEPPE NUNZIATA;G. R. PISTOLESE;GIUSEPPE SANTORO;ROSA RUSSO;ENRICO COSCIONI;GIUSEPPE DI BENEDETTO;GIUSEPPE PREZIOSI;F. TRIUMBARI;R RUSSO;ANTONIO PANZA","1.17;0.5;0.29;0.29;0.29;0.25;0.25;0.17;0.17;0.17;0.17;0.17;0.17","PAOLO MASIELLO;A. AGANGI;D. PALADINI;PASQUALE MARTINELLI;ROSA RUSSO;ANTONIO PANZA;ENRICO COSCIONI;F. TRIUMBARI;GIUSEPPE DI BENEDETTO;GIUSEPPE PREZIOSI;ANGELO MICHELE CARELLA;G. R. PISTOLESE;GIOVANNI D’ARENA;GIUSEPPE NUNZIATA;NICOLA CASCAVILLA;ROSELLA MATERA;ALESSANDRA SPLENDIANI;ALESSANDRO RICCI;MASSIMO CAULO;MICHELE GALLUCCI","70;33;33;33;33;22;22;22;22;22;20;20;20;20;20;20;18;18;18;18","PAOLO MASIELLO;ROSA RUSSO;ANTONIO PANZA;ENRICO COSCIONI;F. TRIUMBARI;GIUSEPPE DI BENEDETTO;GIUSEPPE PREZIOSI;G. R. PISTOLESE;GIOVANNI D’ARENA;GIUSEPPE NUNZIATA;R RUSSO;A FASOLINO;GIUSEPPE SANTORO","70;33;22;22;22;22;22;20;20;20;18;6;0","A FASOLINO;G. R. PISTOLESE;GIOVANNI D’ARENA;GIUSEPPE NUNZIATA;PAOLO MASIELLO;ANTONIO PANZA;ENRICO COSCIONI;F. TRIUMBARI;GIUSEPPE DI BENEDETTO;GIUSEPPE PREZIOSI;R RUSSO;ROSA RUSSO;GIUSEPPE SANTORO","2;2;2;2;2;1;1;1;1;1;1;1;0","MEDICINE;BIOLOGY","8;3","SURGERY;INTERNAL MEDICINE;ANESTHESIA;PATHOLOGY;CARDIOLOGY;GENETICS;IMMUNOLOGY;PSYCHIATRY;RADIOLOGY;ANATOMY;CANCER RESEARCH;CELL BIOLOGY;ENDOCRINOLOGY","5;4;3;3;2;2;2;2;2;1;1;1;1","ANTIGEN;BONE MARROW;INTENSIVE CARE UNIT;INTUBATION;MAGNETIC RESONANCE IMAGING;MECHANICAL VENTILATION;MEDIAN STERNOTOMY;STENOSIS;ABDOMEN;ABDOMINAL WALL;AGENESIS;AMYLOIDOSIS;CANCER;CATHETER;CELL CULTURE;CENTRAL NERVOUS SYSTEM;CORD BLOOD;CORPUS CALLOSUM;CRANIOFACIAL;DYSPLASIA;EDEMA;ENDOSCOPY;FLOW CYTOMETRY;FOLEY;GENE;HYPERTELORISM;HYSTERECTOMY;LAPAROSCOPY;LEUKEMIA;NEUROLOGY;NEUROSURGERY;OSTEOCHONDRODYSPLASIA;PREGNANCY;STEM CELL;UMBILICAL CORD;URINARY SYSTEM;VAGINA","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AORTIC VALVE REPLACEMENT;AGENESIS OF THE CORPUS CALLOSUM;BREAST CANCER;CD19;CD34;CORTICAL DYSPLASIA;CYSTOSCOPY;FETUS;FOLEY CATHETER;GENE ISOFORM;HAEMATOPOIESIS;LAPAROSCOPIC HYSTERECTOMY;NEURORADIOLOGY;PROGENITOR CELL;PROMYELOCYTE;RETINOIC ACID;WHITE MATTER","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE PROMYELOCYTIC LEUKEMIA;HEMIMEGALENCEPHALY;HOLOPROSENCEPHALY;IN UTERO;MASTECTOMY;PRENATAL DIAGNOSIS;SENTINEL LYMPH NODE","1;1;1;1;1;1;1","HUMANS;BRAIN;FEMALE;AMYLOIDOSIS;BONE MARROW CELLS;BRAIN DISEASES;LEUKEMIA, PROMYELOCYTIC, ACUTE;MALE;ADULT;ANTIGENS, CD34;AORTIC VALVE;AORTIC VALVE INSUFFICIENCY;AORTIC VALVE STENOSIS;BREAST NEOPLASMS;CRANIOFACIAL DYSOSTOSIS;FETAL BLOOD;FRONTAL BONE;GLYCOPROTEINS;GRANULOCYTE PRECURSOR CELLS;HEART VALVE PROSTHESIS IMPLANTATION","8;5;5;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2","CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;EVOLUTION AND USAGE OF ANATOMICAL NOMENCLATURE;GENETICS AND DEVELOPMENT OF CRANIOFACIAL ABNORMALITIES;HEMATOPOIETIC STEM CELL BIOLOGY;MOLECULAR MECHANISMS OF AMYLOIDOSIS;OBSTETRIC VESICOVAGINAL FISTULA AND URETERAL INJURIES;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;ROLE OF RETINOIC ACID IN BIOLOGICAL PROCESSES","2;1;1;1;1;1;1;1","HEART VALVE SURGERY;MEDIAN STERNOTOMY;MINIMALLY INVASIVE SURGERY;SURGICAL AORTIC-VALVE REPLACEMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;ACUTE PROMYELOCYTIC LEUKEMIA;AGENESIS;AORTIC ROOT REPLACEMENT;CORD BLOOD;CRANIOFACIAL ANOMALIES;DAMAGE CONTROL SURGERY;FETAL DEVELOPMENT;FOLEY;FOLEY CATHETER;HEMIMEGALENCEPHALY;HYPERTELORISM;LAPAROSCOPIC HYSTERECTOMY;MEDICAL TERMINOLOGY;NEUROINFLAMMATION;NEURORADIOLOGY","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AORTIC VALVE;MEDIAN STERNOTOMY;PARTIAL UPPER;STERNOTOMY COMPARISON;SURGICAL RESULTS;UPPER STERNOTOMY;VALVE REPLACEMENT;ABDOMINAL WALL;ABNORMAL PROMYELOCYTES;AC-POSITIVE CELLS;ANTIGEN CD;BONE MARROW;CENTRAL NERVOUS;COMMON LEUKOCYTE;COMPARATIVE STUDY;CONTROL ABDOMINAL;CORD BLOOD;FOLEYS CATHETER;FRONTONASAL DYSPLASIA;HAEMORRHAGE PROVOKED;IMMUNOPHENOTYPIC PROFILE;ISOLATED AMYLOIDOMA;LAPAROSCOPIC HYSTERECTOMY;LEUKOCYTE ANTIGEN;LYMPH NODE;MARROW MOBILIZED;MOBILIZED PERIPHERAL;NERVOUS SYSTEM;NEURORADIOLOGICAL FINDINGS;PERIPHERAL BLOOD","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2003,7,7,2,0.5,0.428571428571429,0.285714285714286,0,0.142857142857143,0,2,0,1,2,0.29,0,0.14,0.29,14.71,0.27800621671952,0.142857142857143,0.571428571428571,0,0.12997287522604,0,0,0,"FASOLINO MC;G. SIRABELLA;GIOVANNI CAVALIERE;FEDERICA FERRO;A. PAPPACODA;ALFREDO SIANI;MICHELE MANZO;MARIO COLUCCI;ANTONELLA NAPOLI;E. TIERNO;A. D'ARCA SIMONETTI;ALESSANDRA SPLENDIANI;ELVIRA BIANCO;A. BERRA;A FASOLINO;P D’ARGENIO;PELLEGRINO MASIELLO;ROSSANA BERNACCHIA;F. PETROSINO;M PUNZI","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FASOLINO MC;A FASOLINO;SALVATORE CASSESE;E. PASTORE;MICHELE MANZO;ALESSANDRA SPLENDIANI;NATALE MARRAZZO;GAETANA MELCHIORRE;M BRIGANTE;F. IANNESSI;EDOARDO PUGLIELLI;ROSA RUSSO;MICHELE GALLUCCI;ANDREA CAMPANA;G. SIRABELLA;ALFREDO SIANI;ANTONELLA NAPOLI;FELICE ESPOSITO;RENATO SAPONIERO;GIUSEPPE LOCATELLI","0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17","G. SIRABELLA;ALFREDO SIANI;MARIO COLUCCI;ANTONELLA NAPOLI;A FASOLINO;VALENTINA SICA;VINCENZO VILLARI;FELICE ESPOSITO;RENATO SAPONIERO;ELENA DE STEFANI;ROSA RUSSO;GIUSEPPE LOCATELLI;ANDREA CAMPANA;D DONADIO","1;1;1;1;1;1;1;1;1;1;1;1;1;1","A FASOLINO;ROSA RUSSO;ANDREA CAMPANA;G. SIRABELLA;ALFREDO SIANI;ANTONELLA NAPOLI;FELICE ESPOSITO;RENATO SAPONIERO;GIUSEPPE LOCATELLI;VALENTINA SICA;VINCENZO VILLARI;ELENA DE STEFANI;D DONADIO;MARIO COLUCCI","0.25;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.12;0.12;0.07","A. D'ARCA SIMONETTI;ALFONSO MELE;ANDRÉ SALEM SZKLO;ANTONINO PARLATO;CARLA MARIA ZOTTI;CRESCENZO BOVE;ELVIRA BIANCO;MARIO COLUCCI;P D’ARGENIO;PIER LUIGI LOPALCO;PIETRO RAGNI;ROSA COPPOLA;ROSSANA BERNACCHIA;TOMMASO STROFFOLINI;A. BERRA;A. PAPPACODA;D DONADIO;E. TIERNO;ELENA DE STEFANI;ENZO MADONINI","52;52;52;52;52;52;52;52;52;52;52;52;52;52;34;34;34;34;34;34","MARIO COLUCCI;D DONADIO;ELENA DE STEFANI;VALENTINA SICA;VINCENZO VILLARI;ANDREA CAMPANA;ALFREDO SIANI;ANTONELLA NAPOLI;FELICE ESPOSITO;G. SIRABELLA;GIUSEPPE LOCATELLI;RENATO SAPONIERO;A FASOLINO;ROSA RUSSO","52;34;34;11;11;5;1;1;1;1;1;1;0;0","ALFREDO SIANI;ANDREA CAMPANA;ANTONELLA NAPOLI;D DONADIO;ELENA DE STEFANI;FELICE ESPOSITO;G. SIRABELLA;GIUSEPPE LOCATELLI;MARIO COLUCCI;RENATO SAPONIERO;VALENTINA SICA;VINCENZO VILLARI;A FASOLINO;ROSA RUSSO","1;1;1;1;1;1;1;1;1;1;1;1;0;0","MEDICINE;BIOLOGY;PHYSICS;SOCIOLOGY","6;2;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;GENETICS;IMMUNOLOGY;ANATOMY;DEMOGRAPHY;DERMATOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;NURSING;OBSTETRICS;PEDIATRICS;QUANTUM MECHANICS;RADIOLOGY","5;3;2;2;2;1;1;1;1;1;1;1;1;1;1","PREGNANCY;ALLERGY;ANEURYSM;CATHETER;CENTRAL NERVOUS SYSTEM;CEREBELLUM;DERMOID CYST;DISSECTION (MEDICAL);FOURTH VENTRICLE;HEMODIALYSIS;HEPATITIS B;HYPOKALEMIA;LAPAROSCOPY;LOGISTIC REGRESSION;OCCLUSION;OVARY;PONS;PUBLIC HEALTH;QT INTERVAL;RETROSPECTIVE COHORT STUDY;TERM (TIME);VIRUS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLERGEN;CEREBELLAR VERMIS;ENDOVASCULAR TREATMENT;FETUS;FLOW DIVERTER;HEPATITIS B VIRUS;LONG QT SYNDROME;MEDULLA OBLONGATA;VASCULAR ACCESS","1;1;1;1;1;1;1;1;1","ALLERGEN IMMUNOTHERAPY;HBSAG;PLACENTA;SUBLINGUAL IMMUNOTHERAPY","1;1;1;1","HUMANS;DESENSITIZATION, IMMUNOLOGIC;FEMALE;HEART ARREST;HEPATITIS B;HYPERSENSITIVITY;ADOLESCENT;ADULT;ARTERIOVENOUS SHUNT, SURGICAL;DIABETIC NEPHROPATHIES;HEPATITIS B VACCINES;HYPOKALEMIA;LONG QT SYNDROME;MASS SCREENING;PREGNANCY COMPLICATIONS, INFECTIOUS;RENAL DIALYSIS;TORSADES DE POINTES;;AFRICA;AGED","5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2","ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;GENETICS AND DEVELOPMENT OF CRANIOFACIAL ABNORMALITIES;HEPATITIS B INFECTION AND TREATMENT;MANAGEMENT OF PRIMARY ALDOSTERONISM;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS","1;1;1;1;1;1;1","ALLERGEN IMMUNOTHERAPY;ALLERGEN-SPECIFIC IMMUNOTHERAPY;CENTRAL VENOUS CATHETERIZATION;CEREBELLAR VERMIS;CEREBRAL DEVELOPMENT;DERMOID CYST;ENDOVASCULAR TREATMENT;FLOW DIVERTER;FOURTH VENTRICLE;HEMODIALYSIS VASCULAR ACCESS;HEPATITIS B;HYPERTENSION;INTRAOPERATIVE FLUID MANAGEMENT;OVARIAN RESERVE;PERIPHERALLY INSERTED CENTRAL CATHETERS;PONS;PREGNANCY;SUBLINGUAL IMMUNOTHERAPY;TREATMENT;VASCULAR ACCESS GUIDELINES","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLERGEN-SPECIFIC IMMUNOTHERAPY;ANEURISMI GIGANTI;ANTENATAL HEPATITIS;CARDIAC ARREST;CONSERVATIVE TREATMENT;DEGLI ANEURISMI;DELLO SVILUPPO;DERMOID CYSTS;ENDOVASCOLARE DEGLI;FACTORS AFFECTING;GENETICA DELLO;IL TRATTAMENTO;INTRA-AORTIC TESIO;LAPAROSCOPIC CONSERVATIVE;MULTICENTRIC STUDY;OVARIAN DERMOID;PREVENTIVE EFFECTS;RETROSPECTIVE MULTICENTRIC;SCREENING PROGRAMME;SUBLINGUAL ALLERGEN-SPECIFIC;SVILUPPO CEREBELLARE;TESIO CATHETER;TRATTAMENTO ENDOVASCOLARE;VASCULAR ACCESS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2004,4,8.75,1.75,0.571428571428571,0,0,0,0.5,0,2,1,1,0,0.5,0.25,0.25,0,1.75,0.0371916179530367,0.5,1,0,0.384057971014493,0,0,0,"E. VARVARIGOS;S. IACCARINO;RICARDO LAURINI;M. IACCARINO;ROSA RUSSO;GIOVANNI D’ARENA;A. MARVASO;GERMANICO PATRELLI;SILVANA NOVIELLO;LUIGI IMPERATO;PATRIZIA MAIO;VINCENZO CALLEA;ELIANA PIA ESPOSITO;ROSARIO GIUSTOLISI;MAURA BRUGIATELLI;G. ROMANO;SEBASTIANO LEONE;CATERINA MUSOLINO;SILVANA CAPALBO;TED ALOISIO","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","E. VARVARIGOS;S. IACCARINO;RICARDO LAURINI;M. IACCARINO;ROSA RUSSO;GIOVANNI D’ARENA;VINCENZO CALLEA;ROSARIO GIUSTOLISI;MAURA BRUGIATELLI;CATERINA MUSOLINO;SILVANA CAPALBO;ALBERTO FRAGASSO;PATRIZIA GUGLIELMO;VINCENZO LISO;COSIMA BATTISTA;A. MARVASO;GERMANICO PATRELLI;SILVANA NOVIELLO;LUIGI IMPERATO;PATRIZIA MAIO","0.4;0.4;0.4;0.4;0.4;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.07;0.07;0.07;0.07;0.07","ROSA RUSSO;GIOVANNI D’ARENA;LUIGI IMPERATO;ELIANA PIA ESPOSITO;D AIELLO;C. COPPOLA","2;1;1;1;1;1","ROSA RUSSO;GIOVANNI D’ARENA;LUIGI IMPERATO;ELIANA PIA ESPOSITO;D AIELLO;C. COPPOLA","0.4;0.1;0.07;0.07;0.07;0.07","ALBERTO FRAGASSO;CATERINA MUSOLINO;COSIMA BATTISTA;GIOVANNI D’ARENA;MAURA BRUGIATELLI;PATRIZIA GUGLIELMO;ROSARIO GIUSTOLISI;SILVANA CAPALBO;VINCENZO CALLEA;VINCENZO LISO;A. MARVASO;C. COPPOLA;D AIELLO;D. ACIERNOG;ELIANA PIA ESPOSITO;F. IANNIELLO;G. ROMANO;GERMANICO PATRELLI;LUIGI IMPERATO;NICOLA IANNANTUONI","6;6;6;6;6;6;6;6;6;6;1;1;1;1;1;1;1;1;1;1","GIOVANNI D’ARENA;C. COPPOLA;D AIELLO;ELIANA PIA ESPOSITO;LUIGI IMPERATO;ROSA RUSSO","6;1;1;1;1;0","C. COPPOLA;D AIELLO;ELIANA PIA ESPOSITO;GIOVANNI D’ARENA;LUIGI IMPERATO;ROSA RUSSO","1;1;1;1;1;0","MEDICINE;BIOLOGY;PHYSICS;SOCIOLOGY","4;2;1;1","INTERNAL MEDICINE;ANATOMY;GENETICS;DEMOGRAPHY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;MICROBIOLOGY;NUCLEAR MEDICINE;OPTICS;SURGERY","3;2;2;1;1;1;1;1;1;1","CEREBELLUM;AMBULATORY;ANTIBIOTICS;DEMOGRAPHICS;DISEASE;FOURTH VENTRICLE;GENE;HEMATOLOGY;HYPOPLASIA;INCIDENCE (GEOMETRY);LEUKEMIA;LYMPHOMA;POPULATION;PREGNANCY;SAGITTAL PLANE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CEREBELLAR VERMIS;ANTIBIOTIC PROPHYLAXIS;CHRONIC LYMPHOCYTIC LEUKEMIA;MUTATION;OBSTETRICS AND GYNAECOLOGY","2;1;1;1;1","PROBAND","1","CROSS INFECTION;ITALY;SURGICAL WOUND INFECTION;HEMATOLOGIC NEOPLASMS;LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;;ADULT;AGED;ANTI-BACTERIAL AGENTS;FEMALE;HUMANS;MALE;MIDDLE AGED;SURVEYS AND QUESTIONNAIRES;ADOLESCENT;AGED, 80 AND OVER;ANTIBIOTIC PROPHYLAXIS;ANTICIPATION, GENETIC;FAMILY HEALTH;INFECTION CONTROL","4;4;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","DEVELOPMENT AND DISORDERS OF FETAL BRAIN;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;PREVENTION AND MANAGEMENT OF SURGICAL SITE INFECTIONS","2;1;1","CEREBELLAR MALFORMATIONS;CEREBELLAR VERMIS;AXONAL TRACKING;DEMOGRAPHICS;FETAL MRI;FOURTH VENTRICLE;HEMATOLOGY;MANTLE CELL LYMPHOMA;NEUROSONOGRAPHY;PROBAND;SURGICAL SITE INFECTION","2;2;1;1;1;1;1;1;1;1;1","CEREBELLAR VERMIS;DIFFERENTIAL DIAGNOSIS;ANTIBIOTIC SURGICAL;B-CELL CHRONIC;CHRONIC LYMPHOCYTIC;DANDY WALKER;FAMILIAL B-CELL;ITALIAN REGION;LYMPHOCYTIC LEUKEMIA;OC VMODE;POST-OPERATIVE INFECTIONS;SECONDARY FISSURES;SOUTHERN ITALY;SURGICAL PROPHYLAXIS;VERMIS ANOMALIES;VERMIS PRIMARY;VERMIS ROTATION;WALKER COMPLEX","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CEREBELLAR VERMIS;SF ABSENT;BDC ABSENT;DW VARIANT;LH ABSENT;SECONDARY FISSURES;ABSENT BDC;ABSENT EPCF;ABSENT EV;ABSENT LH;ABSENT MCM;ABSENT PF;DANDY WALKER;DIFFERENTIAL DIAGNOSIS;DWV PF;EPCF ABSENT;FISSURES PF;HT ABSENT;MAGNA MCM;MALFORMATION DWM;NM MCM;PATIENTS GA;SAGITTAL SCAN;VARIANT DWV;VERMIS PRIMARY;VERMIS ROTATION;VH ABSENT;WALKER MALFORMATION;ABNORMAL VERMIS;ABSENT CVR","6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2005,4,9,3,0.333333333333333,0.5,0.25,0,0.5,0,2,1,0,0,0.5,0.25,0,0,19.25,0.363593583153293,0.25,0.5,0,0.0303030303030304,0,0,0,"P VICINANZA;MARIELLA VICINANZA;VINCENZA CARAFA;MICHELE MANZO;BRUNO ROTOLI;GUIDO SAUTER;LUIGI TERRACCIANO;LUIGI INSABATO;ALESSANDRO DE FRANCISCIS;LUIGI TORNILLO;GIACOMO DUCHINI;GIUSEPPE POLLIO;MARIA TERESA PETRUCCI;ANTONIO CORRERA;NATALE MARRAZZO;DOLORES DI VIZIO;ALESSANDRO LUGLI;GAETANA MELCHIORRE;AMEDEO BOSCAINO;SEBASTIANO MANGANI","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MICHELE MANZO;MARIA TERESA PETRUCCI;NATALE MARRAZZO;GAETANA MELCHIORRE;M BRIGANTE;ANDREA CAMPANA;F. SILVESTRI;P VICINANZA;MARIELLA VICINANZA;BRUNO ROTOLI;ALESSANDRO DE FRANCISCIS;GIUSEPPE POLLIO;ANTONIO CORRERA;SEBASTIANO MANGANI;LUIGI TARALLO;STEFANIA DI;LUCIO CATALANO;M. BUONANNO;ALFREDO GUARINO;AMALIA DE RENZO","0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12","P VICINANZA;MARIELLA VICINANZA;MICHELE MANZO;MARIA TERESA PETRUCCI;NATALE MARRAZZO;GAETANA MELCHIORRE;LUIGI TARALLO;M BRIGANTE;PIGHI CHIARA;ANDREA CAMPANA;F. SILVESTRI","1;1;1;1;1;1;1;1;1;1;1","MICHELE MANZO;MARIA TERESA PETRUCCI;NATALE MARRAZZO;GAETANA MELCHIORRE;M BRIGANTE;ANDREA CAMPANA;F. SILVESTRI;P VICINANZA;MARIELLA VICINANZA;LUIGI TARALLO;PIGHI CHIARA","0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.12;0.12;0.12;0.12","ALESSANDRO LUGLI;AMEDEO BOSCAINO;COYA TAPIA;DOLORES DI VIZIO;GIACOMO DUCHINI;GUIDO SAUTER;LUIGI INSABATO;LUIGI TERRACCIANO;LUIGI TORNILLO;REGINE SCHNEIDER‐STOCK;ROSANNA RUSSO;STEFAN DIRNHOFER;VINCENZA CARAFA;ALESSANDRO DE FRANCISCIS;ALFREDO GUARINO;ANTONIO CORRERA;G. DE MARCO;LUIGI TARALLO;SEBASTIANO MANGANI;STEFANIA DI","61;61;61;61;61;61;61;61;61;61;61;61;61;13;13;13;13;13;13;13","LUIGI TARALLO;MARIELLA VICINANZA;P VICINANZA;PIGHI CHIARA;ANDREA CAMPANA;F. SILVESTRI;GAETANA MELCHIORRE;M BRIGANTE;MARIA TERESA PETRUCCI;MICHELE MANZO;NATALE MARRAZZO","13;3;3;3;0;0;0;0;0;0;0","LUIGI TARALLO;MARIELLA VICINANZA;P VICINANZA;PIGHI CHIARA;ANDREA CAMPANA;F. SILVESTRI;GAETANA MELCHIORRE;M BRIGANTE;MARIA TERESA PETRUCCI;MICHELE MANZO;NATALE MARRAZZO","1;1;1;1;0;0;0;0;0;0;0","MEDICINE;BIOLOGY;ENGINEERING;PHILOSOPHY","4;2;1;1","INTERNAL MEDICINE;GENETICS;ANESTHESIA;BIOCHEMISTRY;CANCER RESEARCH;CARDIOLOGY;EMERGENCY MEDICINE;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;MECHANICAL ENGINEERING;NURSING;PATHOLOGY;PEDIATRICS;THEOLOGY","3;2;1;1;1;1;1;1;1;1;1;1;1;1","GENE;ANEMIA;APNEA;CANCER;CHRISTIAN MINISTRY;EMERGENCY DEPARTMENT;GASTROINTESTINAL TRACT;HEART FAILURE;HEMOGLOBIN;HOSPITAL ADMISSION;PEDIATRIC HOSPITAL;POPULATION;SLEEP APNEA;STROMAL CELL;VENTILATION (ARCHITECTURE)","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CDKN2A;CHROMOSOME;EJECTION FRACTION;ERYTHROPOIESIS;GENE DUPLICATION;GIST;HEMOGLOBIN A2;MACROCYTOSIS;MESSENGER RNA;POLYSOMNOGRAPHY;STROMAL TUMOR","1;1;1;1;1;1;1;1;1;1;1","CENTRAL SLEEP APNEA;FLUORESCENCE IN SITU HYBRIDIZATION;HYPOPNEA;PDGFRA;RETICULOCYTE","1;1;1;1;1","GASTROINTESTINAL STROMAL TUMORS;NEOPLASMS, CONNECTIVE TISSUE;ANEMIA, IRON-DEFICIENCY;FEMALE;HEMOGLOBINS;HUMANS;MALE;STROMAL CELLS;ADULT;HOSPITALIZATION;INFLUENZA, HUMAN;ONCOGENES;PATIENT ADMISSION;RETICULOCYTES;;ADOLESCENT;AGED;AGED, 80 AND OVER;CASE-CONTROL STUDIES;CHILD","4;4;3;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1","DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;INFLUENZA VIRUS RESEARCH AND EPIDEMIOLOGY;REGULATION OF IRON METABOLISM AND ANEMIA;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES","1;1;1;1","CENTRAL SLEEP APNEA;CHRISTIAN MINISTRY;GASTRIC CANCER;GIST CONSENSUS CONFERENCE;HEMOGLOBIN A2;HOSPITAL ADMISSION;HOSPITAL OVERCROWDING;HYPERTENSION;HYPOPNEA;IRON DEFICIENCY;MACROCYTOSIS;METASTATIC GASTRIC CANCER;OBSTRUCTIVE SLEEP APNEA;PDGFRA;PEDIATRIC HOSPITAL;PEDIATRIC SLEEP APNEA;RETICULOCYTE;SLEEP-DISORDERED BREATHING;STROMAL TUMOR","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANEMIC SYNDROMES;CASE-CONTROLLED STUDY;DELTA-CHR IMPROVES;GASTROINTESTINAL STROMAL;GENE AMPLIFICATION;HEMOGLOBIN SYNTHESIS;HOSPITAL ADMISSIONS;INAPPROPRIATE HOSPITAL;INFLUENZA-LIKE ILLNESS;SLEEP APNEA;SPECIFIC GUIDELINES;STROMAL TUMORS;TUMORS GIST;VENTRICULAR ARRHYTHMIAS","1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEART DISEASE;INAPPROPRIATE HOSPITAL;APNEA INDEX;DR PM;HOSPITAL ADMISSION;HOSPITAL ADMISSIONS;HOURS HOLTER;ISCHEMIC ORIGIN;LOW EF;PTS IMPLANTED;TALENT DR;ACCIDENTS SA;ADMISSION RATE;ADMISSIONS TRAINING;AGED POPULATION;AH EPISODES;AH HISTOGRAMS;AH INDEXES;AH PERIODS;AH PHASES;ANALYSIS CARRIED;APNEA SA;APNEAHYPOPNEA AH;ARRHYTHMIAS PVCS;ARRHYTHMIAS SOCIAL;ARTERIAL BLOOD;ATRIAL OVERDRIVE;AUTOMATIC ANALYSIS;BREATHING APNEA;BREATHING DEPTH","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,0.25,1.5,1.5,1.5,1.5,3,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,3,0,0,0,0,0,0,3,3,3,0,0,0,0,0,0,0,0,0,1,1,1,2,2,2,0,0,0,0,0,0,0,0,0,20,20,20,20,20,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2006,2,1,1,1,1,0,1,0,2,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"M PUNZI;FRANCESCO FERRO","1;1","M PUNZI;FRANCESCO FERRO","1;1","M PUNZI;FRANCESCO FERRO","1;1","M PUNZI;FRANCESCO FERRO","1;1","FRANCESCO FERRO;M PUNZI","0;0","FRANCESCO FERRO;M PUNZI","0;0","FRANCESCO FERRO;M PUNZI","0;0","MEDICINE","2","RADIOLOGY;SURGERY","1;1","ARTERIOVENOUS FISTULA;CATHETER;DIALYSIS;HEMODIALYSIS","1;1;1;1","CENTRAL VENOUS CATHETER;VASCULAR ACCESS","1;1","","","","2","MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE","2","ARTERIOVENOUS FISTULAS;CATHETER-RELATED BLOODSTREAM INFECTIONS;CENTRAL VENOUS CATHETER;CENTRAL VENOUS CATHETERIZATION;DIALYSIS;ENDOVENOUS TREATMENT;HEMODIALYSIS VASCULAR ACCESS;PERIPHERALLY INSERTED CENTRAL CATHETERS;PULMONARY ARTERY CATHETERIZATION;VASCULAR ACCESS COMPLICATIONS;VASCULAR ACCESS GUIDELINES","1;1;1;1;1;1;1;1;1;1;1","ARTERIOVENOUS FISTULA;CENTRAL VENOUS;CONTROVERSY VASCULAR;DIALYSIS PATIENT;ELDERLY DIALYSIS;PATIENT ARTERIOVENOUS;VASCULAR ACCESS;VENOUS CATHETER","1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2007,5,7.6,1.6,0.625,0.4,0.2,0,0.2,0,2,1,2,0,0.4,0.2,0.4,0,30,0.568440297674739,0.4,0.8,0,0.299573560767591,0,0,0,"PARIDE DE ROSA;MICHELE SANTANGELO;ANDREA RENDA;M ZUCCARO;GIUSEPPINA SPINOSA;MAURIZIO IEMMA;PAOLO RIGHINI;SAVERIO REGA;SILVIA CIRRI;A. DISTANTE;VINCENZO TAMMARO;SANTI TRIMARCHI;GIUSEPPE DI BENEDETTO;C. LA TESSA;ANTONELLA CIOTOLA;EDUARDO BOSSONE;KIM A. EAGLE;STEFANO FEDERICO;MARCO CLEMENTE;RODOLFO CITRO","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ROSA RUSSO;CATHERINE FALLET‐BIANCO;MAURIZIO IEMMA;MATTEO CAVALIERE;GIAMPIERO MOTTOLA;PARIDE DE ROSA;MICHELE SANTANGELO;ANDREA RENDA;M ZUCCARO;C. LA TESSA;MARCO CLEMENTE;L. CAGGIANO;L PELOSIO;GIUSEPPINA SPINOSA;VINCENZO TAMMARO;ANTONELLA CIOTOLA;STEFANO FEDERICO;SEBASTIANO GRASSIA;PAOLO RIGHINI;SAVERIO REGA","0.5;0.5;0.33;0.33;0.33;0.24;0.24;0.24;0.24;0.12;0.12;0.12;0.12;0.11;0.11;0.11;0.11;0.11;0.06;0.06","PARIDE DE ROSA;MAURIZIO IEMMA;GIUSEPPE DI BENEDETTO;ROSA RUSSO;MATTEO CAVALIERE;GIAMPIERO MOTTOLA;ANTONELLO PANZA","2;1;1;1;1;1;1","ROSA RUSSO;MAURIZIO IEMMA;MATTEO CAVALIERE;GIAMPIERO MOTTOLA;PARIDE DE ROSA;GIUSEPPE DI BENEDETTO;ANTONELLO PANZA","0.5;0.33;0.33;0.33;0.24;0.06;0.06","GIAMPIERO MOTTOLA;MATTEO CAVALIERE;MAURIZIO IEMMA;A. DISTANTE;ALESSANDRO FRIGIOLA;ANDREA BALLOTTA;ANTONELLO PANZA;EDUARDO BOSSONE;GIANNIGNAZIO CARBONE;GIUSEPPE DI BENEDETTO;JIANMING FANG;KIM A. EAGLE;PAOLO RIGHINI;RAJENDRA H. MEHTA;RODOLFO CITRO;SANTI TRIMARCHI;SAVERIO REGA;SILVIA CIRRI;STEFANO MESSINA;ANDREA RENDA","67;67;67;36;36;36;36;36;36;36;36;36;36;36;36;36;36;36;36;31","GIAMPIERO MOTTOLA;MATTEO CAVALIERE;MAURIZIO IEMMA;ANTONELLO PANZA;GIUSEPPE DI BENEDETTO;PARIDE DE ROSA;ROSA RUSSO","67;67;67;36;36;31;16","PARIDE DE ROSA;ANTONELLO PANZA;GIAMPIERO MOTTOLA;GIUSEPPE DI BENEDETTO;MATTEO CAVALIERE;MAURIZIO IEMMA;ROSA RUSSO","2;1;1;1;1;1;1","MEDICINE;BIOLOGY;ENGINEERING;PHYSICS","5;2;1;1","INTERNAL MEDICINE;SURGERY;ANATOMY;RADIOLOGY;UROLOGY;ANESTHESIA;CARDIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;MECHANICAL ENGINEERING;NEUROSCIENCE;OPTICS;PATHOLOGY","4;4;2;2;2;1;1;1;1;1;1;1;1","KIDNEY;TRANSPLANTATION;ABLATION;AGENESIS;BIOPSY;BRAINSTEM;CEREBELLUM;DIABETES MELLITUS;EDEMA;ENDOSCOPY;ETIOLOGY;FOURTH VENTRICLE;GOLD STANDARD (TEST);HEART FAILURE;HYDROCEPHALUS;HYPOPLASIA;INCIDENCE (GEOMETRY);NASAL CAVITY;NOSE;POPULATION;SINGLE CENTER;STROKE (ENGINE);URINARY SYSTEM;VALVULAR HEART DISEASE;VISUAL ANALOGUE SCALE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","KIDNEY TRANSPLANTATION;ACOUSTIC RHINOMETRY;CEREBELLAR VERMIS;DANDY–WALKER SYNDROME;EJECTION FRACTION;RENAL BIOPSY;RHINOMANOMETRY;TURBINATES","2;1;1;1;1;1;1;1","","","KIDNEY TRANSPLANTATION;HUMANS;KIDNEY;CEREBELLUM;DANDY-WALKER SYNDROME;FEMALE;FOLLOW-UP STUDIES;HEART VALVE DISEASES;HEART VALVE PROSTHESIS IMPLANTATION;MALE;POSTOPERATIVE COMPLICATIONS;TISSUE DONORS;TREATMENT OUTCOME;TURBINATES;AORTIC VALVE;CATHETER ABLATION;FETUS;GLIAL FIBRILLARY ACIDIC PROTEIN;HYPERTROPHY;ITALY","7;5;5;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","ETHICAL AND MEDICAL ASPECTS OF ORGAN DONATION;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;MANAGEMENT OF VALVULAR HEART DISEASE;NASAL SURGERY TECHNIQUES AND OUTCOMES","2;1;1;1","KIDNEY TRANSPLANTATION;TRANSPLANTATION;ACOUSTIC RHINOMETRY;AGENESIS;CEREBELLAR MALFORMATIONS;CEREBELLAR VERMIS;CEREBRAL DEVELOPMENT;DANDY–WALKER SYNDROME;ETIOLOGY;FETAL MRI;FOURTH VENTRICLE;GOLD STANDARD (TEST);HEART VALVE SURGERY;LIVING DONOR LIVER TRANSPLANTATION;LIVING KIDNEY DONORS;ORGAN DONATION;PONTOCEREBELLAR HYPOPLASIA;PRENATAL DIAGNOSIS;PROSTHETIC VALVES EVALUATION;RENAL TRANSPLANTATION","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANATOMY EVALUATION;BIPOLAR RADIOFREQUENCY;CEREBELLAR VERMAL;CEREBELLAR VERMIS;CLINICAL LABORATORY;DANDY-WALKER CONTINUUM;DONOR TRANSPLANTATION;FETUSESEARLY STAGE;HARVESTED KIDNEY;INFERIOR TURBINATES;ISOLATED POSTERIOR;KIDNEYS DONOR;LONG-TERM OUTCOMES;MACROSCOPIC ANATOMY;MIDSAGITTAL CEREBELLAR;MONTH FOLLOWUP;MORPHOLOGICAL STUDY;OCTOGENARIANS IN-HOSPITAL;POSTERIOR CEREBELLAR;RADIOFREQUENCY THERMAL;THERMAL ABLATION;TURBINATES MONTH;URINARY ANOMALIES;VALVE SURGERY;VERMAL DEFECT;VERMAL DYSGENESIS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","VALVE SURGERY;FUNCTIONAL CLASS;ASSOCIATION FUNCTIONAL;HEART ASSOCIATION;RENAL INSUFFICIENCY;SURGERY ISOLATED;VALVE DISEASE;YORK HEART;AGE-RELATED INCIDENCE;AORTIC VALVE;ATRIAL ARRHYTHMIAS;CALCIFIC VALVE;CARDIAC CENTRES;CLASS IV;CLASS OPERATIVE;CLINICAL STATUS;CLINICAL VARIABLES;CONGESTIVE HEART;CONSECUTIVE PATIENTS;DIABETES HYPERTENSION;EFFECTIVE THERAPEUTIC;EJECTION FRACTION;ELDERLY PATIENTS;EVALUATED SEVENTY-NINE;FAILURE RESPIRATORY;FREQUENT IN-HOSPITAL;GLOBAL POPULATION;HEART FAILURE;HYPERTENSION RENAL;IMPROVED FUNCTIONAL","8;6;4;4;4;4;4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.2,6,6,6,6,2,2,2,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,1,1,1,2,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,18,18,18,18,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2008,9,14.4444444444444,2.66666666666667,0.375,0.444444444444444,0.444444444444444,0.111111111111111,0.333333333333333,0,2,1,2,2,0.22,0.11,0.22,0.22,8.11,0.147819110400612,0.333333333333333,0.666666666666667,0,0.289553886575068,0.133333333333333,0.15,0,"ALFREDO SANTINELLI;FABRIZIO ZANCONATI;ROSA RUSSO;ANNA SAPINO;RICCARDO ARISIO;ANTONELLA TORIELLO;GERARDO BOTTI;MONICA IURLARO;ALESSANDRA BERSIGA;MASSIMO RONCALLI;FABIA COSIMI;LUIGI GIUSTO SPAGNOLI;CLAUDIO DOGLIONI;PAOLO TRICOMI;LUIGI FASOLINO;RENATO SAPONIERO;ISABELLA CASTELLANO;ROBERTO BANDELLONI;CESARE BORDI;GIUSEPPE VIALE","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LUIGI FASOLINO;LUCIO CIPULLO;ANTONELLA TORIELLO;RENATO SAPONIERO;GIUSEPPE LOCATELLI;A FASOLINO;MARIACARMEN FASOLINO;EDOARDO PASTORE;SALVATORE CASSESE;ALFREDO SIANI;FRANCESCA IZZI;NICOLA PUGLIESE;MAURIZIO IEMMA;G. PARENTE;GABRIELLA FIORILLO;F. VOLINO;ANNA MARIA CASCONE;BASILIO ANGRISANI;MATTEO CAVALIERE;GIAMPIERO MOTTOLA","0.5;0.5;0.26;0.26;0.26;0.25;0.25;0.25;0.25;0.17;0.17;0.17;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12","ROSA RUSSO;ANTONELLA TORIELLO;LUIGI FASOLINO;RENATO SAPONIERO;LUCIO CIPULLO;GIUSEPPE LOCATELLI;MAURIZIO IEMMA;ALFREDO SIANI;FRANCESCA IZZI;G. PARENTE;NICOLA PUGLIESE;GIUSEPPE DI BENEDETTO;F. VOLINO;N NARCISO;MARIACARMEN FASOLINO;ANNA MARIA CASCONE;EDOARDO PASTORE;L. POSTERARO;SEVERINO IESU;MATTEO CAVALIERE","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LUIGI FASOLINO;LUCIO CIPULLO;ANTONELLA TORIELLO;RENATO SAPONIERO;GIUSEPPE LOCATELLI;MARIACARMEN FASOLINO;EDOARDO PASTORE;ALFREDO SIANI;FRANCESCA IZZI;NICOLA PUGLIESE;MAURIZIO IEMMA;G. PARENTE;F. VOLINO;ANNA MARIA CASCONE;MATTEO CAVALIERE;GIAMPIERO MOTTOLA;GIUSEPPE DI BENEDETTO;SEVERINO IESU;ROSA RUSSO;N NARCISO","0.5;0.5;0.26;0.26;0.26;0.25;0.25;0.17;0.17;0.17;0.12;0.12;0.12;0.12;0.12;0.12;0.11;0.11;0.11;0.09","ALFREDO SANTINELLI;ANNA SAPINO;FABRIZIO ZANCONATI;ROSA RUSSO;A LABRIOLA;A LANZA;A. DE MATTEIS;A. MOLINO;ANDREA BALSARI;ANNUNZIATA GLOGHINI;CLAUDIA BIGHIN;ELDA TAGLIABUE;EMILIA MONTAGNA;F.A. ZITO;FABIO CASTIGLIONI;FERDINANDO MARANDINO;FRANCO PERRONE;G. CARRILLO;GIORGIO MUSTACCHI;GIUSEPPE CANCELLO","35;35;35;35;33;33;33;33;33;33;33;33;33;33;33;33;33;33;33;33","ROSA RUSSO;GIUSEPPE DI BENEDETTO;SEVERINO IESU;ANNA MARIA CASCONE;F. VOLINO;G. PARENTE;GIAMPIERO MOTTOLA;MATTEO CAVALIERE;MAURIZIO IEMMA;L. POSTERARO;N NARCISO;LUCIO CIPULLO;ALFREDO SIANI;ANTONELLA TORIELLO;EDOARDO PASTORE;FRANCESCA IZZI;GIUSEPPE LOCATELLI;LUIGI FASOLINO;MARIACARMEN FASOLINO;NICOLA PUGLIESE","35;16;16;8;8;8;8;8;8;7;7;6;1;1;1;1;1;1;1;1","ROSA RUSSO;LUCIO CIPULLO;ALFREDO SIANI;ANNA MARIA CASCONE;ANTONELLA TORIELLO;EDOARDO PASTORE;F. VOLINO;FRANCESCA IZZI;G. PARENTE;GIAMPIERO MOTTOLA;GIUSEPPE DI BENEDETTO;GIUSEPPE LOCATELLI;L. POSTERARO;LUIGI FASOLINO;MARIACARMEN FASOLINO;MATTEO CAVALIERE;MAURIZIO IEMMA;N NARCISO;NICOLA PUGLIESE;RENATO SAPONIERO","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHILOSOPHY;PHYSICS;PSYCHOLOGY","9;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;ONCOLOGY;RADIOLOGY;BIOCHEMISTRY;CARDIOLOGY;FISHERY;CANCER RESEARCH;GENERAL SURGERY;LINGUISTICS;METEOROLOGY;ORGANIC CHEMISTRY;PSYCHIATRY;UROLOGY","5;4;4;3;3;2;2;2;1;1;1;1;1;1;1","CANCER;FISH <ACTINOPTERYGII>;GENE;IN SITU;ANEURYSM;ANGIOGRAPHY;APHASIA;BLADDER INJURY;CEREBRAL ARTERIES;CHEMOTHERAPY;CLIPPING (MORPHOLOGY);COGNITION;CONCOMITANT;CORPUS CALLOSUM;DISEASE;EXTRACORPOREAL;EXTRACORPOREAL CIRCULATION;HYSTERECTOMY;IMMUNOHISTOCHEMISTRY;INTERVENTIONAL RADIOLOGY;ISCHEMIA;LAPAROSCOPY;LARYNX;LESION;MAGNETIC RESONANCE IMAGING;MONOCYTE;MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;OSTEOID;OSTEOSARCOMA;SUBARACHNOID HEMORRHAGE;TUMOR NECROSIS FACTOR ALPHA;URINARY INCONTINENCE","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;CHROMOSOME;METASTASIS;ABDOMINAL HYSTERECTOMY;ANTERIOR COMMUNICATING ARTERY;APRAXIA;CELL CYCLE;CEREBRAL ANGIOGRAPHY;DIFFUSION MRI;LAPAROSCOPIC HYSTERECTOMY;LARYNGECTOMY;MIDDLE CEREBRAL ARTERY;NEUROPSYCHOLOGY;RARE DISEASE;REVASCULARIZATION","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","DUCTAL CARCINOMA;FLUORESCENCE IN SITU HYBRIDIZATION;HORMONE RECEPTOR;LYMPHOVASCULAR INVASION;ANTERIOR CEREBRAL ARTERY;BREAST CARCINOMA;ESTROGEN RECEPTOR;INVASIVE DUCTAL CARCINOMA;ONCOGENE;SPLENIUM","2;2;2;2;1;1;1;1;1;1",";BREAST NEOPLASMS;FEMALE;HUMANS;HYSTERECTOMY;INFLAMMATION;RECEPTOR, ERBB-2;CORONARY ARTERY BYPASS, OFF-PUMP;CORONARY DISEASE;CYTOKINES;EXTRACORPOREAL MEMBRANE OXYGENATION;INTERLEUKIN-6;LAPAROSCOPY;MYOCARDIAL REVASCULARIZATION;POSTOPERATIVE COMPLICATIONS;TUMOR NECROSIS FACTOR-ALPHA;ANTINEOPLASTIC AGENTS, HORMONAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;C-REACTIVE PROTEIN;GENES, ERBB-2","5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2","HER2 SIGNALING IN BREAST CANCER TREATMENT;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS;PELVIC FLOOR DISORDERS;SARCOMA RESEARCH AND TREATMENT","3;1;1;1;1;1;1","HER2;BREAST CANCER;LYMPHOVASCULAR INVASION;ABDOMINAL HYSTERECTOMY;ANTERIOR CEREBRAL ARTERY;ANTERIOR COMMUNICATING ARTERY;APRAXIA;BLADDER INJURY;BREAST CARCINOMA;CARDIAC SURGERY RISK MODELS;CLIPPING (MORPHOLOGY);CONCOMITANT;CORPUS CALLOSUM AGENESIS;CORPUS CALLOSUM LESIONS;EXTRACORPOREAL;EXTRACORPOREAL CIRCULATION;HEART VALVE SURGERY;INTERVENTIONAL RADIOLOGY;INTRACRANIAL ANEURYSMS;INVASIVE LOBULAR CARCINOMA","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCERS;DUCTAL HISTOTYPE;SCREENING TEST;SITU HYBRIDIZATION;ANALYSIS BASED;ANEURYSMS ENDOVASCULAR;ANTERIOR CEREBRAL;ARTERY ANEURYSMS;ASSISTED BEATING;BEATING HEART;BIOLOGY PROGNOSIS;BREAST CARCINOMAS;CALLOSAL INFARCT;CEREBRAL ARTERY;CURRENT LITERATURE;DISTAL ANTERIOR;INFLAMMATORY RESPONSE;LAPAROSCOPIC HYSTERECTOMY;LEFT VENTRICULAR;LESIONS RISK;MESH EROSIONS;MYOCARDIAL REVASCULARIZATION;NEUROPSYCHOLOGICAL STUDY;PREVENTIVE STRATEGIES;REDUCED SYSTEMIC;RISK ANALYSIS;SUBURETHRAL TAPE;SURGICAL TREATMENT;SYSTEMIC INFLAMMATORY;TRANSOBTURATOR SUBURETHRAL","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DISTANT METASTASES;ILC HISTOTYPES;RECEPTOR EXPRESSION;SCREENING TEST;AGGRESSIVE SURGERY;AGGRESSIVE TUMOUR;AMPLIFICATION INCREASED;BREAST CANCER;BREAST CANCERS;BREAST CARCINOMAA;BREAST CARCINOMAS;CANCER METASTASES;CARCINOMAA MULTICENTER;CARCINOMAS DIAGNOSED;CONDUCTEDDUCTAL HISTOTYPE;DEVELOPED REGIONAL;DIAGNOSED BREAST;DIFFERED SIGNIFICANTLY;DIFFERENCES DEPENDING;DIFFERENTIATED BREAST;DIRECTLY PRODUCED;DISTINCT DISEASES;DUCTAL IDC;EFFECTIVE SCREENING;EXPRESSION DIFFERED;EXPRESSION LEVEL;FISH ANALYSIS;GHORMONE RECEPTOR-NEGATIVE;GRADE MIB;HER-POSITIVE TUMORS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2009,11,8,2.09090909090909,0.478260869565217,0.454545454545455,0.0909090909090909,0.0909090909090909,0.272727272727273,0,3,3,1,3,0.27,0.27,0.09,0.27,24.64,0.532594964695657,0.0909090909090909,0.818181818181818,0,0.300982447486332,0.222222222222222,0,0,"CLEMENTINA SAVASTANO;AMEDEO BOSCAINO;ANTONIO D′ANTONIO;ALESSIA CALEO;VINCENZO MONTESARCHIO;MARIA ADDESSO;SALVATORE DEL PRETE;GIANFRANCO DE DOMINICIS;M. BIANCO;BRUNO VINCENZI;RAFFAELE ADDEO;MICHELE CICCARELLI;LIVIO LEO;MAURIZIO IEMMA;LUIGI MAIORINO;SAVERIO CINIERI;A. ANTICO;VINCENZO ALTIERI;ALBERTO D’AGOSTINO;GIUSEPPE SERRAVEZZA","3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","AMEDEO BOSCAINO;ANTONIO D′ANTONIO;ALESSIA CALEO;GIANFRANCO DE DOMINICIS;MARIA ADDESSO;MICHELE CICCARELLI;MAURIZIO IEMMA;MARCIO CURI RONDINELLI;GAETANO MOTTOLA;LUIGI LOMBARDI;VALERIA VISCONTI;MATTEO CAVALIERE;RAFFAELE RUSSO;CLEMENTINA SAVASTANO;OLIVIERO CALEO;VINCENZO ALTIERI;GAETANO DE ROSA;LUIGI INSABATO;S. SIMONETTI;ROSA RUSSO","0.54;0.54;0.54;0.4;0.34;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.23;0.2;0.17;0.17;0.17;0.17;0.17","CLEMENTINA SAVASTANO;ANTONIO D′ANTONIO;ALESSIA CALEO;VINCENZO MONTESARCHIO;SALVATORE DEL PRETE;M. BIANCO;BRUNO VINCENZI;RAFFAELE ADDEO;LIVIO LEO;SAVERIO CINIERI;S POTO;ROSA RUSSO;GENEROSO MASTROGIOVANNI;VALERIA VISCONTI;VITO LORUSSO;MATTEO CAVALIERE;G. FILIPPELLI","3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1","ANTONIO D′ANTONIO;ALESSIA CALEO;VALERIA VISCONTI;MATTEO CAVALIERE;CLEMENTINA SAVASTANO;ROSA RUSSO;VINCENZO MONTESARCHIO;SALVATORE DEL PRETE;M. BIANCO;BRUNO VINCENZI;RAFFAELE ADDEO;S POTO;GENEROSO MASTROGIOVANNI;LIVIO LEO;SAVERIO CINIERI;VITO LORUSSO;G. FILIPPELLI","0.54;0.54;0.25;0.25;0.23;0.17;0.15;0.15;0.15;0.15;0.15;0.14;0.14;0.1;0.1;0.1;0.1","CLEMENTINA SAVASTANO;AGATA PISANO;ALBERTO D’AGOSTINO;ANTONIETTA SABIA;ANTONIO FEBBRARO;BRUNO VINCENZI;ELENA CAPASSO;G. PIAI;GIOVANNELLA PALMIERI;GREGORIO CENNAMO;LILIANA MONTELLA;LUCIANO TARANTINO;LUIGI MAIORINO;M. BIANCO;MICHELE CARAGLIA;RAFFAELE ADDEO;ROSANNA MAMONE;ROSARIO GUARRASI;SALVATORE DEL PRETE;VINCENZO FAIOLA","88;73;73;73;73;73;73;73;73;73;73;73;73;73;73;73;73;73;73;73","CLEMENTINA SAVASTANO;MATTEO CAVALIERE;ALESSIA CALEO;ANTONIO D′ANTONIO;ROSA RUSSO;S POTO;GENEROSO MASTROGIOVANNI;BRUNO VINCENZI;G. FILIPPELLI;LIVIO LEO;M. BIANCO;RAFFAELE ADDEO;SALVATORE DEL PRETE;SAVERIO CINIERI;VALERIA VISCONTI;VINCENZO MONTESARCHIO;VITO LORUSSO","88;68;49;49;46;15;5;0;0;0;0;0;0;0;0;0;0","ALESSIA CALEO;ANTONIO D′ANTONIO;CLEMENTINA SAVASTANO;GENEROSO MASTROGIOVANNI;MATTEO CAVALIERE;ROSA RUSSO;S POTO;BRUNO VINCENZI;G. FILIPPELLI;LIVIO LEO;M. BIANCO;RAFFAELE ADDEO;SALVATORE DEL PRETE;SAVERIO CINIERI;VALERIA VISCONTI;VINCENZO MONTESARCHIO;VITO LORUSSO","3;3;3;1;1;1;1;0;0;0;0;0;0;0;0;0;0","MEDICINE;BIOLOGY;CHEMISTRY;MATHEMATICS","11;5;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;BIOCHEMISTRY;ONCOLOGY;ENVIRONMENTAL HEALTH;GENETICS;GYNECOLOGY;IMMUNOLOGY;OBSTETRICS;ANATOMY;ANESTHESIA;BOTANY;CANCER RESEARCH;CARDIOLOGY;CLINICAL PSYCHOLOGY;DENTISTRY;FISHERY;GASTROENTEROLOGY;GEOMETRY;NURSING;PHYSICAL THERAPY","8;5;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENE;CARCINOMA;CHEMOTHERAPY;IMMUNOHISTOCHEMISTRY;POPULATION;ADRENAL GLAND;ALLERGY;ALTERNATIVE MEDICINE;ANEMIA;APOPTOSIS;CARDIAC SURGERY;CARDIOPULMONARY BYPASS;CARTILAGE;CYTOKINE;DIFFERENTIAL DIAGNOSIS;DISEASE;DISTRESS;EOSINOPHILIC;ERYTHROPOIETIN;EXTRACORPOREAL;EXTRACORPOREAL CIRCULATION;FISH <ACTINOPTERYGII>;FLOW CYTOMETRY;GRANULOCYTE;HEPATOCELLULAR CARCINOMA;HUMERUS;IN VITRO;INFLAMMATION;INTERNAL FIXATION;KIDNEY;LYMPHOMA;MIDDLE EAR;MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;OSTEOSYNTHESIS;OTOLOGY;OVARY;PATIENT SATISFACTION;PHLEUM;QUALITY OF LIFE (HEALTHCARE);REDUCTION (MATHEMATICS);RENAL CELL CARCINOMA;RESORPTION;SOMATOSTATIN;STROMAL CELL;THYROID;TUBEROUS SCLEROSIS;TUMOR NECROSIS FACTOR ALPHA;TYMPANOPLASTY","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLERGEN;ANGIOMYOLIPOMA;ANNEXIN;BLADDER CANCER;BREAST CANCER;CHROMOSOME;CLEAR CELL;CYTOKERATIN;EPITHELIOID CELL;EPOETIN ALFA;FIXATION (POPULATION GENETICS);GENE DUPLICATION;GENE EXPRESSION;HMB-45;HUMAN GENETICS;INTERLEUKIN;INTERLEUKIN 8;OCTREOTIDE;PHASES OF CLINICAL RESEARCH;POTENCY;REVASCULARIZATION;SERIAL DILUTION;SORAFENIB;THYROIDITIS;VIMENTIN","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FLUORESCENCE IN SITU HYBRIDIZATION;HASHIMOTO DISEASE;LASER CAPTURE MICRODISSECTION;MAMMOGRAPHY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;THYROID LYMPHOMA;TRANSITIONAL CELL CARCINOMA","1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;MALE;MIDDLE AGED;AGED;ADRENAL GLAND NEOPLASMS;ANGIOMYOLIPOMA;BREAST NEOPLASMS;MYOCARDIAL ISCHEMIA;;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CARCINOMA, HEPATOCELLULAR;CARCINOMA, TRANSITIONAL CELL;EPITHELIOID CELLS;HEMORRHAGE;HISTAMINE;HYPERSENSITIVITY;LIVER NEOPLASMS;RECEPTOR, ERBB-2","8;7;6;6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3","ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;DIAGNOSIS AND MANAGEMENT OF OTITIS MEDIA;GLOBAL CANCER INCIDENCE AND MORTALITY PATTERNS;HEPATOCELLULAR CARCINOMA;LYMPHOID NEOPLASMS;ROLE OF ERYTHROPOIETIN IN DISEASE TREATMENT AND MANAGEMENT;ROLE OF FIBROBLAST ACTIVATION IN CANCER PROGRESSION;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;TESTICULAR GERM CELL TUMORS AND TREATMENT;TUBEROUS SCLEROSIS COMPLEX AND RELATED DISORDERS","1;1;1;1;1;1;1;1;1;1;1","ACOUSTIC RHINOMETRY;ALLERGEN IMMUNOTHERAPY;ANEMIA;ANGIOMYOLIPOMA;BREAST CANCER;BREAST CANCER SCREENING;CANCER RISK;CANCER SUSCEPTIBILITY;CANCER TREATMENT;CARDIOPULMONARY BYPASS;CONTACT ALLERGY;DISTAL RADIUS FRACTURES;EPITHELIOID HEMANGIOENDOTHELIOMA;EPOETIN ALFA;EXTRACORPOREAL;EXTRACORPOREAL CIRCULATION;HASHIMOTO DISEASE;HMB-45;HUMAN GENETICS;INTERLEUKIN 8","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADRENAL GLAND;ADVANCED HEPATOCELLULAR;AFFECTS NEUTROPHIL;B-CELL LYMPHOMA;BETA TREATMENT;BLADDER IMMUNOHISTOCHEMICAL;BREAST CANCER;C-ERBB- GENE;CANCER DETECTION;CANCER EFFICACY;CAPTURE MICRODISSECTION;CARCINOMA MULTICENTER;CELL CARCINOMA;CON IL;CORD STROMAL;DA VINCI;DELLA TESTA;DIAGNOSIS DELAY;DIAGNOSTIC PRODUCTS;EFFICACY PATIENT;EPITHELIOID ANGIOMYOLIPOMA;ERYTHROPOIETIN BETA;EXTRANODAL MARGINAL;EXTRARENAL TUMOR;FAVORABLY AFFECTS;FISH ANALYSIS;FRATTURE DELLA;FUNCTIONAL RESULTS;HASHIMOTO THYROIDITIS;HEART PUMPASSISTED","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MYOCARDIAL REVASCULARIZATION;NEUTROPHIL APOPTOSIS;BEATING HEART;BREAST CANCER;CPB PATIENTS;DETECTED BCA;DIAGNOSIS DELAY;HEART MYOCARDIAL;HISTOLOGICALLY CONFIRMED;LYMPHOID INFILTRATE;MAMMOGRAPHY MG;MINUTE FOCUS;ABSTRACT OBJECTIVES;ANCILLARY TECHNIQUES;ANNEXINV ASSAYS;APOPTOSIS COMPARED;ASSAYS REVEALED;AUTOIMMUNE THYROIDITIS;B-CELL LYMPHOMA;BALLS IMMUNOISTOCHEMISTRY;BCA DETECTED;BCA DETECTION;BCA PATIENTS;BCA WOMEN;BLOOD SAMPLES;BREAST HEALTH;BYPASS CPB;CANCER BCA;CANCER DIAGNOSIS;CAPTURE MICRODISSECTION","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,0.09,7,7,7,7,1,1,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,20,20,20,20,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2010,18,8.38888888888889,2.72222222222222,0.36734693877551,0.555555555555556,0.333333333333333,0.166666666666667,0.166666666666667,0,5,5,5,3,0.28,0.28,0.28,0.17,23.83,0.527395889771983,0.111111111111111,0.555555555555556,0,0.382732155296426,0.267857142857143,0.25,0.25,"RODOLFO CITRO;PARIDE DE ROSA;DONATO SCIANO;VINCENZO CERBONE;GIUSEPPE VALERIANI;ANTONIO D′ANTONIO;ELISA MARIA DE SOUSA RUSSO;GEMMA SALERNO;RAFFAELLA SCARAFILE;MARIA ADDESSO;RITA GRAVINO;OLGA VRIZ;ROSANGELA COCCHIA;EDUARDO BOSSONE;GIUSEPPE LIMONGELLI;AMEDEO BOSCAINO;ALESSIA CALEO;ANTONELLO D’ANDREA;RAFFAELE CALABRÒ;MARIA GIOVANNA RUSSO","4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","PARIDE DE ROSA;DONATO SCIANO;VINCENZO CERBONE;GIUSEPPE VALERIANI;ANTONIO D′ANTONIO;ELISA MARIA DE SOUSA RUSSO;RODOLFO CITRO;AMEDEO BOSCAINO;ALESSIA CALEO;MARIA ADDESSO;CESARE BALDI;PIETRO GIUDICE;TIZIANA ATTISANO;LAURENT PIAZZA;M. POLICHETTI;DARIO PIAZZA;DANIELE TORELLI;MICHELE CICCARELLI;OLIVIERO CALEO;LUIGI LOMBARDI","0.57;0.57;0.57;0.57;0.57;0.57;0.42;0.4;0.4;0.37;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.2;0.2;0.2","RODOLFO CITRO;PARIDE DE ROSA;DONATO SCIANO;VINCENZO CERBONE;GIUSEPPE VALERIANI;ANTONIO D′ANTONIO;ELISA MARIA DE SOUSA RUSSO;ALESSIA CALEO;P PREDOTTI;GIUSEPPE BARBATO;P ANGRISANI;ANTONELLA NAPOLI;ANTONELLA TORIELLO;NICOLA PUGLIESE;R LEONE;CONCETTA MELI;GIUSEPPE DI BENEDETTO;G. DE GREGORIO;M. POLICHETTI;N NARCISO","4;3;3;3;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1","PARIDE DE ROSA;DONATO SCIANO;VINCENZO CERBONE;GIUSEPPE VALERIANI;ANTONIO D′ANTONIO;ELISA MARIA DE SOUSA RUSSO;RODOLFO CITRO;ALESSIA CALEO;TIZIANA ATTISANO;M. POLICHETTI;VALERIA VISCONTI;P PREDOTTI;GIUSEPPE BARBATO;P ANGRISANI;SABINO CASSESE;R LEONE;GIUSEPPE DI BENEDETTO;G. DE GREGORIO;G BOTTIGLIERI;EDUARDO BOSSONE","0.57;0.57;0.57;0.57;0.57;0.57;0.42;0.4;0.33;0.25;0.2;0.17;0.17;0.17;0.17;0.12;0.12;0.12;0.12;0.12","RODOLFO CITRO;EDUARDO BOSSONE;ANTONELLO D’ANDREA;GEMMA SALERNO;GIOVANNI DI SALVO;GIUSEPPE LIMONGELLI;LUCIA RIEGLER;MARIA GIOVANNA RUSSO;OLGA VRIZ;PIO CASO;RAFFAELE CALABRÒ;RAFFAELLA SCARAFILE;RITA GRAVINO;ROSANGELA COCCHIA;ENRICA GOLIA;PAOLO CALABRÒ;SERGIO CUOMO;ALBERTO ABBRUZZESE;BRUNO VINCENZI;CIRO PARLATO","279;256;251;251;251;251;251;251;251;251;251;251;251;251;162;162;89;68;68;68","RODOLFO CITRO;VINCENZO FAIOLA;ANTONIO D′ANTONIO;DONATO SCIANO;ELISA MARIA DE SOUSA RUSSO;GIUSEPPE VALERIANI;PARIDE DE ROSA;VINCENZO CERBONE;A. SERAFINO;ALESSIA CALEO;VALERIA VISCONTI;GIUSEPPE BARBATO;ANTONELLO PANZA;EDUARDO BOSSONE;G BOTTIGLIERI;G. DE GREGORIO;GENNARO PROVENZA;GIUSEPPE DI BENEDETTO;R LEONE;P ANGRISANI","279;68;33;23;23;23;23;23;14;11;10;7;5;5;5;5;5;5;5;3","RODOLFO CITRO;ANTONIO D′ANTONIO;DONATO SCIANO;ELISA MARIA DE SOUSA RUSSO;GIUSEPPE VALERIANI;PARIDE DE ROSA;VINCENZO CERBONE;A. SERAFINO;ALESSIA CALEO;ANTONELLO PANZA;CONCETTA MELI;EDUARDO BOSSONE;G BOTTIGLIERI;G. DE GREGORIO;GENNARO PROVENZA;GIUSEPPE BARBATO;GIUSEPPE DI BENEDETTO;P ANGRISANI;R LEONE;SABINO CASSESE","4;3;3;3;3;3;3;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;COMPUTER SCIENCE;BIOLOGY;CHEMISTRY;PHYSICS","17;3;2;1;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;PATHOLOGY;PHYSICAL THERAPY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;PSYCHIATRY;RADIOLOGY;ANATOMY;ASTRONOMY;CANCER RESEARCH;CELL BIOLOGY;COMPUTATIONAL BIOLOGY;COMPUTER SECURITY;ECOLOGY;ENDOCRINOLOGY;GENERAL SURGERY;GENETICS;GYNECOLOGY;ONCOLOGY;OPERATING SYSTEM;PROGRAMMING LANGUAGE;UROLOGY","12;7;7;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","KIDNEY;TRANSPLANTATION;GENE;HEART FAILURE;ATHLETES;BODY SURFACE AREA;HEMODYNAMICS;POPULATION;ABSCESS;AMINO ACID;ANASTOMOSIS;AORTA;ARTERY;BLOOD FLOW;BLOOD PRESSURE;CANCER;CHOLESTEROL;COMPLICATION;CONTRACTILITY;CORONARY ARTERY DISEASE;DECOMPRESSION;DERMIS;DIALYSIS;DIFFERENTIAL DIAGNOSIS;DISSECTION (MEDICAL);DOPPLER EFFECT;EMBOLIZATION;EMBRYO;EPIDURAL SPACE;EXTERNAL ILIAC ARTERY;FEMORAL ARTERY;GLIOBLASTOMA;GOLD STANDARD (TEST);HEMODIALYSIS;HEPATOCELLULAR CARCINOMA;HUMERUS;IMMUNOHISTOCHEMISTRY;INTERNAL ILIAC ARTERY;INTERVENTION (COUNSELING);INTRAVASCULAR ULTRASOUND;LUMEN (ANATOMY);LYMPHATIC SYSTEM;MITRAL REGURGITATION;MYOCARDIAL INFARCTION;OBESITY;ORTHOPEDIC SURGERY;OVARY;PERCUTANEOUS;PROXIMAL HUMERUS;PULMONARY EMBOLISM;QRS COMPLEX;RENAL CELL CARCINOMA;SAFER;SCHEDULE;SLING (WEAPON);SOFT TISSUE;SPINAL CORD;STENOSIS;STENT;STRESS TESTING (SOFTWARE);THROMBUS;ULTRASONOGRAPHY;ULTRASOUND;URETHRA;URINARY INCONTINENCE;VULVA;YOLK","4;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EJECTION FRACTION;KIDNEY TRANSPLANTATION;RENAL ARTERY;AGGRESSIVE ANGIOMYXOMA;AORTIC ROOT;ASCENDING AORTA;COMPETITIVE ATHLETES;CONVENTIONAL PCI;DIASTOLE;DOBUTAMINE;DUPLEX ULTRASONOGRAPHY;EMBOLECTOMY;EPIDURAL ABSCESS;ESCHERICHIA COLI;EXON;GERM CELL;HEART RATE;LIPID PROFILE;LIVER TRANSPLANTATION;METABOLIC SYNDROME;METASTASIS;NEPHRECTOMY;ONCOCYTOMA;PARAPLEGIA;PATENT FORAMEN OVALE;PERCUTANEOUS CORONARY INTERVENTION;RENAL BLOOD FLOW;SPINAL CORD COMPRESSION;SPINAL EPIDURAL ABSCESS;STRESS ECHOCARDIOGRAPHY;STROMA;TEMOZOLOMIDE;VULVAR NEOPLASM;YOLK SAC","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","STROKE VOLUME;BRUCE PROTOCOL;CARDIAC RESYNCHRONIZATION THERAPY;CARDIAC SKELETON;HFR CELL;PARADOXICAL EMBOLISM;RENAL ARTERY STENOSIS;RENAL CIRCULATION;RENAL ONCOCYTOMA","3;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;RENAL ARTERY;AGED;MIDDLE AGED;ADULT;KIDNEY;;ACTIVATED PROTEIN C RESISTANCE;CARDIAC VOLUME;EMBOLISM, PARADOXICAL;HEART FAILURE;KIDNEY TRANSPLANTATION;PULMONARY EMBOLISM;RENAL VEINS;THROMBOSIS;ADOLESCENT;ANGINA PECTORIS;AORTA","14;10;8;8;7;7;6;5;4;4;4;4;4;4;4;4;4;3;3;3","DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;BIOLOGICAL ACTIVITIES OF TRITERPENOIDS AND SAPONINS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND TREATMENT OF RENAL ARTERY STENOSIS;DIAGNOSIS AND TREATMENT OF SPINAL INFECTIONS;EXERCISE PHYSIOLOGY AND CARDIOVASCULAR HEALTH;GENITOURINARY SOFT TISSUE TUMORS AND ANOMALIES;GLIOMAS;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;MANAGEMENT OF VASCULAR GRAFT INFECTIONS AND ANEURYSMS;PELVIC FLOOR DISORDERS;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;RENAL CELL CARCINOMA;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;TESTICULAR GERM CELL TUMORS AND TREATMENT","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BODY SURFACE AREA;AGGRESSIVE ANGIOMYXOMA;ANGIOMYXOMA;APOPTOSIS;BRUCE PROTOCOL;CARDIAC IMAGING;CARDIAC REMODELING;CARDIAC RESYNCHRONIZATION THERAPY;CARDIAC SKELETON;CARDIOPULMONARY EXERCISE TESTING;CARDIORESPIRATORY FITNESS;COMPETITIVE ATHLETES;CONTRACTILITY;DISTAL RADIUS FRACTURES;DOBUTAMINE;DOPPLER ULTRASONOGRAPHY;DUPLEX ULTRASONOGRAPHY;ECHOCARDIOGRAPHY;EMBOLECTOMY;END-SYSTOLIC VOLUME","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACETATE-FREE BIOFILTRATION;ACID LEVELS;AGGRESSIVE ANGIOMYXOMA;ALLOGRAFT RESCUE;AMINO ACID;ANGIOMYXOMA REPORT;AORTIC ROOT;ARTERY DISSECTION;ASSIST LEFT;ATRIAL VOLUME;B-FLOW ULTRASONOGRAPHY;BENCH SURGERY;BENEFICIAL EFFECTS;CARCINOMA METASTATIC;CARDIAC RESYNCHRONIZATION;CARDIOVASCULAR RISK;CLINICAL EXPERIENCE;COMBINED DIET;COMPLEX PROXIMAL;DA VINCI;ELDERLY WOMAN;ELITE ATHLETES;ENDOGENOUS REINFUSION;ENDOMETRIOID-LIKE PATTERN;EPIDURAL ABSCESS;ESSENTIAL TOOL;EXERCISE TRAINING;EXON DELETIONS;EXTERNAL ILIAC;EXTRAOVARIAN YOLK","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR RISK;EXERCISE TRAINING;COMBINED DIET;EXERCISE STRESS;HR ACHIEVED;INDUCTION PHASE;LIPID PROFILE;MS PATIENTS;PATIENTS UNDERWENT;PROGRESSION-FREE SURVIVAL;RISK PROFILE;SECOND-LINE CHEMOTHERAPY;STUDY PROTOCOL;TRAINING PROGRAM;ADMINISTRATIONS INDUCTION;ATTITUDES CYCLETTE;BEHAVIOURAL RECOMMENDATIONS;BENEFICIAL EFFECTS;BIWEEKLY INDUCTION;BIWEEKLY SCHEDULE;BLOOD PRESSURE;BMI LIPID;CHOLESTEROL EDUCATION;CI MONTHS;CI PARTIAL;CLINICAL RESPONSE;COMPLETE RESPONSE;CONCOMITANT TEMOZOLOMIDE;CONFIDENCE INTERVAL;CONSECUTIVE ADMINISTRATIONS","3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",3,0.17,3,3,3,3,1.5,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,1,2,0,0,0,0,0,0,0,0,0,0,0,0,1.5,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62.5,3,122,62.5,3,122,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2011,19,9.57894736842105,3.68421052631579,0.271428571428571,0.631578947368421,0.368421052631579,0.0526315789473684,0.368421052631579,1,6,3,5,2,0.32,0.16,0.26,0.11,25.84,0.607559385592349,0.210526315789474,0.578947368421053,0,0.357408569934006,0.336134453781513,0.166666666666667,0,"RODOLFO CITRO;ANTONIO D′ANTONIO;PARIDE DE ROSA;DOMENICO MEMOLI;ROBERTO CUOMO;CHIARA PAOLILLO;MARIA ADDESSO;CESARE BALDI;P ANGRISANI;ROSA PAOLILLO;ROSARIO FARINA;M. MIRRA;ANNA BATTIMELLI;VINCENZO CERBONE;ROBERTA GIUDICE;GERARDO IULIANO;GIUSEPPE VALERIANI;ELISA MARIA DE SOUSA RUSSO;ALESSIA CALEO;AMELIA RAVERA","4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GERARDO IULIANO;ANTONIO D′ANTONIO;PARIDE DE ROSA;ROBERTO CUOMO;DOMENICO MEMOLI;RODOLFO CITRO;MARIA ADDESSO;CARMINE SELLERI;JAROSLAW P. MACIEJEWSKI;BIANCA SERIO;P ANGRISANI;BASILIO ANGRISANI;ALESSIA CALEO;CARLO BALDI;VINCENZO CERBONE;GIUSEPPE VALERIANI;ELISA MARIA DE SOUSA RUSSO;CHIARA PAOLILLO;A. MARCOS;CESARE BALDI","1.03;0.54;0.49;0.47;0.43;0.43;0.34;0.33;0.33;0.33;0.32;0.32;0.29;0.29;0.29;0.29;0.29;0.2;0.2;0.2","RODOLFO CITRO;ANTONIO D′ANTONIO;PARIDE DE ROSA;DOMENICO MEMOLI;CHIARA PAOLILLO;CESARE BALDI;P ANGRISANI;ROSA PAOLILLO;ROSARIO FARINA;M. MIRRA;ANNA BATTIMELLI;VINCENZO CERBONE;ROBERTA GIUDICE;GERARDO IULIANO;GIUSEPPE VALERIANI;ELISA MARIA DE SOUSA RUSSO;ALESSIA CALEO;AMELIA RAVERA;CARLO BALDI;GENNARO PROVENZA","4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GERARDO IULIANO;ANTONIO D′ANTONIO;PARIDE DE ROSA;DOMENICO MEMOLI;RODOLFO CITRO;CARMINE SELLERI;BIANCA SERIO;P ANGRISANI;ALESSIA CALEO;CARLO BALDI;VINCENZO CERBONE;GIUSEPPE VALERIANI;ELISA MARIA DE SOUSA RUSSO;CHIARA PAOLILLO;CESARE BALDI;ROSA PAOLILLO;ROSARIO FARINA;M. MIRRA;ANNA BATTIMELLI;ROBERTA GIUDICE","1.03;0.54;0.49;0.43;0.43;0.33;0.33;0.32;0.29;0.29;0.29;0.29;0.29;0.2;0.2;0.2;0.2;0.2;0.2;0.2","RODOLFO CITRO;ANTONELLO D’ANDREA;ANTONIO CITTADINI;EDUARDO BOSSONE;ENRICA GOLIA;ENRICA PEZZULLO;GEMMA SALERNO;GIOVANNI DI SALVO;LUCIA RIEGLER;LUIGI NUNZIATA;MARIA GIOVANNA RUSSO;PIO CASO;RAFFAELE CALABRÒ;RAFFAELLA SCARAFILE;ROSANGELA COCCHIA;SERGIO CUOMO;AGNESE ROSSI;ANDREA SALICA;CORRADO FONDACONE;ENRICO COSCIONI","180;169;169;169;169;169;169;169;169;169;169;169;169;169;169;169;100;100;100;100","RODOLFO CITRO;ENRICO COSCIONI;GIUSEPPE DI BENEDETTO;ANTONIO D′ANTONIO;GERARDO IULIANO;DOMENICO MEMOLI;GIAMPIERO VOLPE;BIANCA SERIO;CARMINE SELLERI;ALESSIA CALEO;CARLO BALDI;ANTONIO D’ANTONIO;PIO ZEPPA;R ROSAMILIO;PARIDE DE ROSA;ELISA MARIA DE SOUSA RUSSO;GIUSEPPE VALERIANI;VINCENZO CERBONE;D VICEDOMINI;GIUSEPPE BARBATO","180;100;100;74;49;46;27;25;25;20;20;16;16;16;13;11;11;11;6;6","ANTONIO D′ANTONIO;RODOLFO CITRO;PARIDE DE ROSA;DOMENICO MEMOLI;ALESSIA CALEO;AMELIA RAVERA;ANNA BATTIMELLI;CARLO BALDI;CESARE BALDI;CHIARA PAOLILLO;ELISA MARIA DE SOUSA RUSSO;GENNARO PROVENZA;GERARDO IULIANO;GIUSEPPE VALERIANI;M. MIRRA;ROBERTA GIUDICE;ROSA PAOLILLO;ROSARIO FARINA;VINCENZO CERBONE;A M D'ALESSANDRO","4.11;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY","18;7;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;GENETICS;SURGERY;IMMUNOLOGY;PATHOLOGY;PEDIATRICS;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;ANATOMY;CANCER RESEARCH;GEOMETRY;MICROBIOLOGY;MOLECULAR BIOLOGY;NEUROSCIENCE;PROGRAMMING LANGUAGE;PSYCHIATRY;RADIOLOGY;STATISTICS;VIROLOGY","11;6;6;5;4;4;3;3;2;1;1;1;1;1;1;1;1;1;1;1","DISEASE;IMMUNOHISTOCHEMISTRY;HEART FAILURE;AORTA;BLOOD PRESSURE;ETIOLOGY;GENE;KIDNEY;MULTIPLE SCLEROSIS;PREGNANCY;STEM CELL;TRANSPLANTATION;ABSCESS;ANEURYSM;ANGIOGENESIS;ANTIBIOTICS;ANTIGEN;ARTERY;ATHLETES;ATYPIA;BIOPSY;BODY SURFACE AREA;BONE MARROW;CARCINOMA;CELL CULTURE;CELL GROWTH;COHORT;COHORT STUDY;CORRELATION;CYTOKINE;CYTOLOGY;DIFFERENTIAL DIAGNOSIS;ENDOCARDITIS;FIBROSIS;FLOW CYTOMETRY;HEART DISEASE;HEMATOLOGY;HEMOSTASIS;HORSESHOE (SYMBOL);HUMAN IMMUNODEFICIENCY VIRUS (HIV);HYPERBARIC OXYGEN;LESION;LIPOMA;LYMPH NODE;LYMPHOMA;MELANOMA;NEUROENDOCRINE TUMORS;NEUROLOGY;NEUROSURGERY;PAROTID GLAND;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;PATHOGEN;PERITONITIS;PROSPECTIVE COHORT STUDY;PULMONARY ARTERY;RANDOMIZED CONTROLLED TRIAL;RANK CORRELATION;REHABILITATION;SALIVARY GLAND;SARCOMA;SUPERIOR MESENTERIC ARTERY","4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOMYOPATHY;DIASTOLE;KIDNEY TRANSPLANTATION;RENAL ARTERY;ABDOMINAL AORTA;ALLELE;ANTIBIOTIC THERAPY;AORTIC ANEURYSM;APLASTIC ANEMIA;BYPASS GRAFTING;CD34;CD68;CHOP;CORONARY ARTERY BYPASS SURGERY;CYTOKINE RECEPTOR;CYTOPATHOLOGY;EJECTION FRACTION;EPITHELIOID CELL;EPITHELIOID SARCOMA;EXPANDED DISABILITY STATUS SCALE;FINE-NEEDLE ASPIRATION;GENOTYPE;HAEMATOPOIESIS;HEART RATE;HORSESHOE KIDNEY;HUMAN LEUKOCYTE ANTIGEN;IMMUNOSTAINING;LIPOSARCOMA;MATRIGEL;METASTATIC CARCINOMA;MUTATION;MYELODYSPLASTIC SYNDROMES;MYOFIBROBLAST;NEURORADIOLOGY;PARKINSON'S DISEASE;PLEOMORPHISM (CYTOLOGY);SACCULAR ANEURYSM;STREPTOCOCCACEAE;STROMA","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PERIPARTUM CARDIOMYOPATHY;ALLELE FREQUENCY;BONE MARROW FAILURE;CARDIAC RESYNCHRONIZATION THERAPY;DOPPLER ECHOCARDIOGRAPHY;HAPLOTYPE;LRRK2;OFF-PUMP CORONARY ARTERY BYPASS;SINGLE-NUCLEOTIDE POLYMORPHISM;STREPTOCOCCUS GORDONII;STROKE VOLUME","2;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;SKIN NEOPLASMS;ADULT;KIDNEY;AGED;POSTOPERATIVE HEMORRHAGE;TREATMENT OUTCOME;ABSCESS;HERPESVIRIDAE INFECTIONS;ITALY;MIDDLE AGED;STREPTOCOCCAL INFECTIONS;TIME FACTORS;;ACTINS;GPI-LINKED PROTEINS;LIPOMA;LYMPHOMA, LARGE B-CELL, DIFFUSE","15;10;9;8;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF RENAL ARTERY STENOSIS;MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY;CANCER STEM CELLS AND TUMOR METASTASIS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;GENITOURINARY SOFT TISSUE TUMORS AND ANOMALIES;HEMOSTATIC AGENTS AND TECHNIQUES;MANAGEMENT AND EPIDEMIOLOGY OF INFECTIVE ENDOCARDITIS;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;NATURAL KILLER CELLS IN IMMUNITY;NEUROBLASTOMA RESEARCH AND TREATMENT;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;SARCOMA RESEARCH AND TREATMENT;VIRAL-RELATED CANCERS IN IMMUNOCOMPROMISED PATIENTS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","DILATED CARDIOMYOPATHY;ETIOLOGY;PERIPARTUM CARDIOMYOPATHY;POSTINFARCTION VENTRICULAR SEPTAL DEFECT;ABDOMINAL AORTA;ANEURYSM RUPTURE;ANEURYSM SCREENING;ANTIBIOTIC THERAPY;AORTIC ANEURYSMS;AORTIC DISSECTION;APLASTIC ANEMIA;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;ATYPIA;BODY SURFACE AREA;BONE MARROW FAILURE;CANCER;CARDIAC ELECTROPHYSIOLOGY;CARDIAC RESYNCHRONIZATION THERAPY;CARDIAC SURGERY RISK MODELS;CARDIOPULMONARY BYPASS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MULTIPLE SCLEROSIS;PERIPARTUM CARDIOMYOPATHY;AORTIC ANEURYSMS;ARTERY BYPASS;ASPIRATION BIOPSY;BONE MARROW;BYPASS SURGERY;CARDIAC RESYNCHRONIZATION;CAVITY HEMOSTASIS;CELL LIPOMA;CELLULAR NEUROTHEKEOMA;CLINICAL ATTACKS;CONTRACTILE RESERVE;CORONARY ARTERY;CUTANEOUS MELANOMA;DIASTOLIC DYSFUNCTION;DISEASE PATIENTS;EDSS RANK;ELDERLY PATIENTS;EPITHELIOID VARIANT;EXTENSIVE MULTIPLE;FAILURE SYNDROMES;FINE NEEDLE;FUNCTIONAL ROLE;GORDONII EXTENSIVE;GRAFT RENAL;HEART MEASUREMENTS;HHV-KSHV INFECTION;HIGH-RISK PATIENTS;HIV SERONEGATIVE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEART FAILURE;MELANOMA CELLS;DIASTOLIC DYSFUNCTION;SEVERE DIASTOLIC;ARTERY BYPASS;BYPASS GRAFTING;CORONARY ARTERY;CR- PROTEIN;AETIOPATHOGENETIC HYPOTHESES;AGENTS AUTOIMMUNE;APPEARS PROMISING;AUTOIMMUNE PROCESSES;BROMOCRIPTINE APPEARS;CARDIOMYOCITE METABOLIC;CELL LINES;COMPLETELY UNDERSTOOD;COMPLICATIONS INCLUDING;COMPOSITE PRIMARY;CONFIDENCE INTERVAL;CONGESTIVE HEART;CONTRACTILE RESERVE;CR- DIAST;CURRENT LITERATURE;CURRENT TREATMENT;CUTANEOUS MELANOMA;DRUG STOPS;EVIDENCES AROUSED;FAILURE OCCURRING;FORMULATED INFLAMMATION;INADEQUATE MANAGEMENT","5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",3,0.16,3,3,3,3,2,1,3,0,0,0,0,0,0,0,0,0,0,0,0,3,3,3,0,0,0,1,1,1,2,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,33,63,48,33,63,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2012,31,10.4516129032258,1.70967741935484,0.584905660377358,0.290322580645161,0.451612903225806,0.290322580645161,0.483870967741935,1,15,8,3,1,0.48,0.26,0.1,0.03,18.45,0.441760797499825,0.258064516129032,0.806451612903226,3.30357142857143,0.474104856354133,0.2625,0.291304347826087,0.2,"ALESSANDRO WEISZ;CONCITA CANTARELLA;GIORGIO GIURATO;PARIDE DE ROSA;GERARDO SARNO;ALESSANDRA LUGARESI;EDUARDO BOSSONE;CAVIT BOZ;GERARDO IULIANO;DARIO CAPUTO;GIOVANNA MUSCOGIURI;PIO ZEPPA;CELIA OREJA‐GUEVARA;VINCENT VAN PESCH;MR DE FILIPPO;GIULIA PAOLELLA;ERIC M. ISSELBACHER;ROBERTO BERGAMASCHI;ROBERTA TARALLO;JEANNETTE LECHNER‐SCOTT","5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","ALESSANDRO WEISZ;PARIDE DE ROSA;GERARDO SARNO;GIOVANNA MUSCOGIURI;GIULIA PAOLELLA;PIO ZEPPA;CONCITA CANTARELLA;GIORGIO GIURATO;MAURIZIO IEMMA;DARIO CAPUTO;MATTEO CAVALIERE;MR DE FILIPPO;ANTONIO D′ANTONIO;MARCELLO DELLA CORTE;MARIO AVOSSA;LILIA M. JIMÉNEZ-CEJA;GIUSEPPE SANTORO;NICOLA MARIA VITOLA;RUCHA MEHTA;RODOLFO GUARDADO‐MENDOZA","1.54;0.67;0.67;0.67;0.59;0.58;0.54;0.54;0.5;0.5;0.5;0.48;0.4;0.33;0.33;0.33;0.33;0.33;0.33;0.33","ALESSANDRO WEISZ;PARIDE DE ROSA;GERARDO SARNO;EDUARDO BOSSONE;GERARDO IULIANO;DARIO CAPUTO;GIOVANNA MUSCOGIURI;PIO ZEPPA;RODOLFO CITRO;ANTONIO D′ANTONIO;PIETRO VAJRO;RAFFAELE ALBANO;PASQUALE PISANO;CHIARA PAOLILLO;MAURIZIO IEMMA;MARCELLO DELLA CORTE;ARIANNA BIANCHI;CAROLINA SAORI ISHII MAURO;LUCIA TEDESCO;VIRGINIA SCAFARTO","5;3;3;3;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1","ALESSANDRO WEISZ;PARIDE DE ROSA;GERARDO SARNO;GIOVANNA MUSCOGIURI;PIO ZEPPA;MAURIZIO IEMMA;DARIO CAPUTO;MATTEO CAVALIERE;ANTONIO D′ANTONIO;MARCELLO DELLA CORTE;MARIO AVOSSA;GIUSEPPE SANTORO;PIETRO VAJRO;EDUARDO BOSSONE;GERARDO IULIANO;RODOLFO CITRO;RAFFAELE ALBANO;PASQUALE PISANO;CAROLINA SAORI ISHII MAURO;LUCIO CANNAVIELLO","1.54;0.67;0.67;0.67;0.58;0.5;0.5;0.5;0.4;0.33;0.33;0.33;0.25;0.23;0.21;0.19;0.14;0.14;0.14;0.14","ALESSANDRA LUGARESI;CAVIT BOZ;CELIA OREJA‐GUEVARA;GERARDO IULIANO;VINCENT VAN PESCH;FRANÇOIS GRAND’MAISON;GIORGIO GIULIANI;GUILLERMO IZQUIERDO;HELMUT BUTZKUEVEN;JEANNETTE LECHNER‐SCOTT;JOSEPH HERBERT;MARCELA FIOL;MARIA TROJANO;MARK SLEE;PIERRE GRAMMOND;ROBERTO BERGAMASCHI;VILIJA JOKUBAITIS;ALESSANDRO WEISZ;CONCITA CANTARELLA;FRANCESCA RIZZO","116;116;116;116;116;106;106;106;106;106;106;106;106;106;106;106;106;93;93;93","GERARDO IULIANO;ALESSANDRO WEISZ;TIZIANA ATTISANO;VINCENZO BELLIZZI;DAVIDE DI GENNARO;PIO ZEPPA;ANTONIO D′ANTONIO;ALESSIA CALEO;GERARDO SARNO;GIOVANNA MUSCOGIURI;MATTEO CAVALIERE;MAURIZIO IEMMA;S. CIGOLARI;DARIO CAPUTO;CAROLINA SAORI ISHII MAURO;LUCIO CANNAVIELLO;PASQUALE PISANO;PIETRO VAJRO;RAFFAELE ALBANO;GIUSEPPE SANTORO","116;93;69;54;49;36;33;30;28;28;26;26;20;15;14;14;14;14;14;5","ALESSANDRO WEISZ;GERARDO IULIANO;DARIO CAPUTO;EDUARDO BOSSONE;ANTONIO D′ANTONIO;GERARDO SARNO;GIOVANNA MUSCOGIURI;PIO ZEPPA;RODOLFO CITRO;ALESSIA CALEO;ARIANNA BIANCHI;CAROLINA SAORI ISHII MAURO;DAVIDE DI GENNARO;GIUSEPPE SANTORO;LUCA PEZZULLO;LUCIO CANNAVIELLO;MARCELLO DELLA CORTE;MARIO AVOSSA;MATTEO CAVALIERE;MAURIZIO IEMMA","5;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;SOCIOLOGY;ECONOMICS;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY","28;10;4;3;2;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;CARDIOLOGY;ENDOCRINOLOGY;PEDIATRICS;BIOCHEMISTRY;CANCER RESEARCH;PALEONTOLOGY;PATHOLOGY;SURGERY;COMPUTATIONAL BIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;ONCOLOGY;RADIOLOGY;DEMOGRAPHY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;PROGRAMMING LANGUAGE;PSYCHIATRY","22;6;5;5;5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2","CANCER;GENE;DIABETES MELLITUS;DISEASE;CLINICAL TRIAL;TRANSPLANTATION;ADVERSE EFFECT;AORTA;BLOOD PRESSURE;CONCOMITANT;CORONARY ARTERY DISEASE;HEART FAILURE;IMMUNOHISTOCHEMISTRY;MULTIPLE SCLEROSIS;OBSERVATIONAL STUDY;POPULATION;RANDOMIZED CONTROLLED TRIAL;TOXICITY;AMINO ACID;ANTIBODY;ANTIOXIDANT;ARCH;ASSOCIATION (PSYCHOLOGY);BIOPSY;CATALYSIS;CHRONIC DISEASE;CIRRHOSIS;CLINICAL NEUROLOGY;CONFIDENCE INTERVAL;CONTEXT (ARCHAEOLOGY);CONTRAST (VISION);DEMOGRAPHICS;DISCONTINUATION;DISSECTION (MEDICAL);DUCHENNE MUSCULAR DYSTROPHY;EMERGENCY DEPARTMENT;ENDOSCOPE;ESTROGEN;EXPRESSION (COMPUTER SCIENCE);FASCIA;FRUCTOSE;HEPATOCELLULAR CARCINOMA;HISTOPATHOLOGICAL EXAMINATION;HORMONE;INSULIN;KIDNEY;KIDNEY DISEASE;LESION;LOGISTIC REGRESSION;LUNG CANCER;LYMPHOMA;METRIC (UNIT);MITRAL REGURGITATION;MUSCULAR DYSTROPHY;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;NODULE (GEOLOGY);NOSE;ODDS RATIO;OUTPATIENT CLINIC;PAROTID GLAND;PATHOGENESIS;PHARMACOTHERAPY;PIPELINE (SOFTWARE);PLEURAL EFFUSION;RADIATION THERAPY;RETROSPECTIVE COHORT STUDY;SALIVARY GLAND;SEASONALITY;SERIES (STRATIGRAPHY);STAGE (STRATIGRAPHY);STROKE (ENGINE);THROAT;THROMBUS;THYROID;TISSUE PLASMINOGEN ACTIVATOR;WORKFLOW","6;6;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;MICRORNA;ADENOCARCINOMA;AORTIC DISSECTION;CARCINOGENESIS;FATTY LIVER;LIVER TRANSPLANTATION;RENIN–ANGIOTENSIN SYSTEM;RNA;TOLERABILITY;ACUTE STROKE;ACUTE TOXICITY;AORTIC ARCH;B CELL;BCL10;CARDIOMYOPATHY;CHROMOSOMAL TRANSLOCATION;CLINICALLY ISOLATED SYNDROME;CO POISONING;CYTOKERATIN;DNA SEQUENCING;EAR NOSE AND THROAT;EJECTION FRACTION;ELECTROCARDIOGRAPHY IN MYOCARDIAL INFARCTION;EXPANDED DISABILITY STATUS SCALE;FINE-NEEDLE ASPIRATION;GENE REARRANGEMENT;GENE SILENCING;GENOME;GENOTYPE;GLATIRAMER ACETATE;HAZARD RATIO;IMATINIB;INSULIN RESISTANCE;LEFT VENTRICULAR THROMBUS;LYCOPENE;MALT LYMPHOMA;METABOLIC SYNDROME;MUTATION;NATALIZUMAB;NODULAR FASCIITIS;ODDS;PANCREATIC CANCER;PARKINSON'S DISEASE;PERFORMANCE STATUS;PHENOTYPE;QUALITY SCORE;SOCIOECONOMIC STATUS;THYROID CARCINOMA;TRANSCRIPTION FACTOR;TYPE 2 DIABETES;VALSARTAN","4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALISKIREN;ESTROGEN RECEPTOR;RNA INTERFERENCE;DASATINIB;DEEP SEQUENCING;DISEASE MANAGEMENT;EXOME SEQUENCING;IMATINIB MESYLATE;MASTECTOMY;MILAN CRITERIA;MIRBASE;MUCOSA-ASSOCIATED LYMPHOID TISSUE;NILOTINIB;NONALCOHOLIC FATTY LIVER DISEASE;PANCREATIC DUCTAL ADENOCARCINOMA;REFERENCE GENOME;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL INTERFERING RNA;SMALL RNA;STEATOHEPATITIS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;BREAST NEOPLASMS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;MULTIPLE SCLEROSIS, RELAPSING-REMITTING;CARCINOMA;CARCINOMA, HEPATOCELLULAR;CARCINOMA, NON-SMALL-CELL LUNG;CARDIOVASCULAR DISEASES;CYTOPLASM;DIABETES MELLITUS, TYPE 2;LIVER CIRRHOSIS;LIVER NEOPLASMS;LUNG NEOPLASMS;RISK FACTORS;THYROID NEOPLASMS","18;13;13;13;10;9;7;5;5;4;4;4;4;4;4;4;4;4;4;4","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;ADVANCEMENTS IN LUNG CANCER RESEARCH;ANALYSIS OF GENE INTERACTION NETWORKS;BIOLOGICAL AND CLINICAL EFFECTS OF IONIZING RADIATION;CHALLENGES AND SOLUTIONS IN RURAL HEALTH WORKFORCE;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;EFFECTS OF KETOGENIC DIET ON HEALTH;EFFICACY AND RESISTANCE IN CML TREATMENT;GENOME EVOLUTION AND POLYPLOIDY IN PLANTS;INFECTIONS RELATED TO ENDOSCOPIC PROCEDURES;KIDNEY TRANSPLANTATION;LYMPHOID NEOPLASMS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF POISONING AND TOXIC EXPOSURES;MEDICAL APPLICATIONS OF INFRARED THERMOGRAPHY;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MICRORNA REGULATION IN CANCER AND DEVELOPMENT","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALISKIREN;AORTIC DISSECTION;CONCOMITANT;DIAGNOSTIC CRITERIA;ECHOCARDIOGRAPHY;HYPERTENSION;KIDNEY TRANSPLANTATION;TOLERABILITY;TYPE 2 DIABETES;TYPE B AORTIC DISSECTION;1000 GENOMES PROJECT;ACUTE STROKE;AORTIC ROOT REPLACEMENT;ARGONAUTE;ASSOCIATION (PSYCHOLOGY);BCL10;BRAF MUTATIONS;BREAST CANCER DETECTION;CANCER EPIGENETICS;CANCER TREATMENT","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;CLINICAL TRIALS;DIABETES MELLITUS;HORMONE-RESPONSIVE BREAST;LIVER TRANSPLANTATION;MELLITUS PREDICTIVE;MULTICENTRE EVALUATION;MULTIPLE SCLEROSIS;NEW-ONSET DIABETES;OBSERVATIONAL PROSPECTIVE;OPEN-LABEL MULTICENTRE;PATIENTS UNDERGOING;PREDICTIVE FACTORS;PROSPECTIVE OPEN-LABEL;TREATED UNCONTROLLED;UNCONTROLLED PATIENTS;UNDERGOING LIVER;ABSTRACT AORTIC;ABSTRACT STROKE;ACCURATE PIPELINE;ACID THERAPY;ACUTE POISONING;ACUTE TYPE;ADENOCARCINOMA DIAGNOSED;ADVANCED BREAST;ADVANCED NON-SMALL;ANDOR NECESSITY;ANTERIOR MYOCARDIAL;ANTHOCIANIN IXOR;ANTIDIABETIC THERAPY","5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;SKIN TOXICITY;BC CELLS;GENE EXPRESSION;MALT LYMPHOMAS;PRIMARY BREAST;ACUTE POISONING;BREAST MALT;PATIENTS TREATED;ANTIDIABETIC DRUGS;IDENTIFY PIRNAS;LEFT VENTRICULAR;PRESCRIBED DOSE;CAMPANIA REGION;CANCER CELLS;CANCER RESEARCH;CLINICAL PRACTICE;CON IL;CORE LABORATORY;CORONARY ARTERIES;CORONARY ARTERY;CRITICAL CAD;DATA OBTAINED;DIFFERENTIALLY EXPRESSED;ECHOCARDIOGRAPHY CORE;FONDAZIONE CON;HUMAN CANCER;IL SUD;IMD CESSATION;ITALIAN ASSOCIATION","8;7;6;6;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",8,0.26,2.35,8.62,3.25,14,2,2,2,0,0,0,0,0,0,0,0,0,2,2,2,0,0,0,0,0,0,1,1,1,4,2,6,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,56,52,60,56,52,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2013,39,12.6923076923077,1.8974358974359,0.527027027027027,0.333333333333333,0.282051282051282,0.0769230769230769,0.461538461538462,1,11,11,12,2,0.28,0.28,0.31,0.05,39.31,1.12653491242018,0.358974358974359,0.82051282051282,2.97435897435897,0.416633528623795,0.30622009569378,0.3,0.380952380952381,"EDUARDO BOSSONE;GERARDO IULIANO;RODOLFO CITRO;ROBERTO BERGAMASCHI;MARIA ADDESSO;DIETER POEHLAU;JEANNETTE LECHNER‐SCOTT;TATJANA PETKOVSKA‐BOSKOVA;MARIA TROJANO;EDGARDO CRISTIANO;HELMUT BUTZKUEVEN;ALESSANDRA LUGARESI;MARIA PIA AMATO;CAVIT BOZ;PIERRE DUQUETTE;CAMERON SHAW;FRANÇOIS GRAND’MAISON;MARK SLEE;GIORGIO GIULIANI;PIERRE GRAMMOND","5;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","NICOLA MAFFULLI;MARIA ADDESSO;ALESSIA CALEO;GERARDO IULIANO;ANTONIO D’ANTONIO;EDUARDO BOSSONE;ANTONIO D′ANTONIO;RODOLFO CITRO;PARIDE DE ROSA;GIOVANNA MUSCOGIURI;MAURIZIO IEMMA;GERARDO SARNO;FEDERICO RUSSO;ROSA NAPOLETANO;M. CIANFRANI;MATTEO CAVALIERE;FA ALIBERTI;VINCENZO BELLIZZI;FEDERICO PISCIONE;FRANCESCO DI BLASIO","1.25;0.7;0.7;0.64;0.5;0.49;0.45;0.43;0.42;0.42;0.33;0.33;0.33;0.33;0.33;0.33;0.31;0.29;0.27;0.25","EDUARDO BOSSONE;GERARDO IULIANO;RODOLFO CITRO;ALESSIA CALEO;PARIDE DE ROSA;FEDERICO PISCIONE;PIETRO SIANO;VINCENZO BELLIZZI;NICOLA MAFFULLI;FA ALIBERTI;ANTONIO D’ANTONIO;ANTONIO D′ANTONIO;NESTOR CIOCIANO;LUCILLA GRISI;FRANCESCO ORIO;ERICA PIRONTI;MAURIZIO IEMMA;GM LOMBARDI;DOMENICO CAGGIANO;GERARDO SARNO","5;5;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","NICOLA MAFFULLI;ALESSIA CALEO;GERARDO IULIANO;ANTONIO D’ANTONIO;EDUARDO BOSSONE;ANTONIO D′ANTONIO;RODOLFO CITRO;PARIDE DE ROSA;MAURIZIO IEMMA;GERARDO SARNO;FEDERICO RUSSO;ROSA NAPOLETANO;M. CIANFRANI;MATTEO CAVALIERE;FA ALIBERTI;VINCENZO BELLIZZI;FEDERICO PISCIONE;LUCA VALVANO;VINCENZA DI STASI;PIETRO SIANO","1.25;0.7;0.64;0.5;0.49;0.45;0.43;0.42;0.33;0.33;0.33;0.33;0.33;0.33;0.31;0.29;0.27;0.25;0.25;0.22","GERARDO IULIANO;ALESSANDRA LUGARESI;CAMERON SHAW;CAVIT BOZ;CELIA OREJA‐GUEVARA;DIETER POEHLAU;EDGARDO CRISTIANO;ELI SKROMNE;FRANÇOIS GRAND’MAISON;FRASER MOORE;FREEK VERHEUL;GIORGIO GIULIANI;GUILLERMO IZQUIERDO;HELMUT BUTZKUEVEN;JEANNETTE LECHNER‐SCOTT;JOSEPH HERBERT;JOSÉ ANTONIO CABRERA-GÓMEZ;MARCELA FIOL;MARIA EDITE RIO;MARIA PIA AMATO","473;461;461;461;461;461;461;461;461;461;461;461;461;461;461;461;461;461;461;461","GERARDO IULIANO;EDUARDO BOSSONE;VINCENZO BELLIZZI;RODOLFO CITRO;NICOLA MAFFULLI;FEDERICO RUSSO;MATTEO CAVALIERE;MAURIZIO IEMMA;PIETRO SIANO;ALESSANDRO WEISZ;ERICA PIRONTI;GIANGENNARO COPPOLA;ALESSIA CALEO;ALFONSO MASULLO;ANGELO SILVERIO;ANTONIO D′ANTONIO;COSTANTINA PROTA;FEDERICO PISCIONE;LUIGI GRECO;M. MIRRA","473;361;215;131;87;81;81;81;58;42;42;42;35;34;34;34;34;34;34;34","EDUARDO BOSSONE;RODOLFO CITRO;GERARDO IULIANO;ANTONIO D′ANTONIO;ALESSIA CALEO;PARIDE DE ROSA;PIETRO SIANO;VINCENZO BELLIZZI;ALESSANDRO WEISZ;ALFONSO MASULLO;ANGELO SILVERIO;ANTONIO LONGOBARDI;ANTONIO PANZA;CARMINE SELLERI;CLEMENTINA SAVASTANO;COSTANTINA PROTA;DOMENICO CAGGIANO;ERICA PIRONTI;FABIO FIMIANI;FEDERICO PISCIONE","4;4;4;2.83;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;ECONOMICS;SOCIOLOGY;BUSINESS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHILOSOPHY","38;9;3;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;SURGERY;GENETICS;IMMUNOLOGY;PEDIATRICS;ANATOMY;CARDIOLOGY;CLINICAL PSYCHOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;INTENSIVE CARE MEDICINE;OPTICS;PHARMACOLOGY;RADIOLOGY;CANCER RESEARCH;DERMATOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;MACROECONOMICS;NEUROSCIENCE;PALEONTOLOGY;PHYSICAL THERAPY;UROLOGY","30;9;8;8;5;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","DISEASE;CANCER;MULTIPLE SCLEROSIS;OBSERVATIONAL STUDY;AIRWAY;GENE;HEMODIALYSIS;INCIDENCE (GEOMETRY);POPULATION;TRANSPLANTATION;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANXIETY;AORTA;BODY MASS INDEX;CARCINOMA;CHEMOTHERAPY;CLINICAL TRIAL;COGNITION;COHORT;CORONARY ARTERY DISEASE;DEPRESSION (ECONOMICS);DISTRESS;DRUG;EPIDEMIOLOGY;HEART FAILURE;HORMONE;LARYNX;LIPOMA;MALIGNANCY;MELANOMA;NODULE (GEOLOGY);PHARMACY;RENAL FUNCTION;SEPSIS;STEM CELL;TENDON;TONGUE;URINE;VIRUS","8;6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","KIDNEY TRANSPLANTATION;ADVERSE DRUG REACTION;APATHY;CARDIOMYOPATHY;CD34;DEMENTIA;EXECUTIVE FUNCTIONS;NEUROPSYCHOLOGY;PARKINSON'S DISEASE;PHARMACIST;PHARMACOVIGILANCE;STRIDOR;ADENOCARCINOMA;AGE OF ONSET;AIRWAY OBSTRUCTION;ALZHEIMER'S DISEASE;AMOXICILLIN;ANDROGEN;ANOREXIA NERVOSA;AORTIC DISSECTION;AORTOGRAPHY;ASCENDING AORTA;BREAST CANCER;CANCER-RELATED FATIGUE;CAUSE OF DEATH;CELL CYCLE;CHELATION THERAPY;CHROMOSOME;CHRONIC LYMPHOCYTIC LEUKEMIA;COELIAC DISEASE;CUMULATIVE INCIDENCE;DEFERASIROX;DEFERIPRONE;DIASTOLE;DNA SEQUENCING;END STAGE RENAL DISEASE;ENDOCRINE SYSTEM;EPIGLOTTIS;EXPANDED DISABILITY STATUS SCALE;GENETIC PREDISPOSITION;GLOTTIS;HAZARD RATIO;HEART RATE;HEPATITIS C VIRUS;HOSPITAL ANXIETY AND DEPRESSION SCALE;HUMAN LEUKOCYTE ANTIGEN;HYPERPHOSPHATEMIA;IN SITU HYBRIDISATION;INSULIN RESISTANCE;INTERFERON BETA;LARYNGOSCOPY;LIPOSARCOMA;METALLOPROTEINASE;METASTATIC CARCINOMA;MUTATION;NEPHRECTOMY;NEPHROPATHY;NEVUS;OPEN LABEL;OVERWEIGHT;PANACEA (MEDICINE);PHENOTYPE;POSTPARTUM PERIOD;PROTEASES;PROTEOLYTIC ENZYMES;PSYCHOLOGICAL DISTRESS;REAL-TIME POLYMERASE CHAIN REACTION;RITUXIMAB;SEROLOGY;SLEEP DISORDER;SLEEP QUALITY;TACROLIMUS;TENDINOPATHY;VASCULAR ACCESS;VASCULAR RESISTANCE;VIRAL LOAD;VIREMIA;WAIST","3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EXECUTIVE DYSFUNCTION;ANDROSTENEDIONE;BK VIRUS;CENTROMERE;CLAVULANIC ACID;CYCLIN D1;DISINTEGRIN;DOPPLER ECHOCARDIOGRAPHY;FLUORESCENCE IN SITU HYBRIDIZATION;HEMODIALYSIS ACCESS;INTERFERON BETA-1A;PHOSPHATE BINDER;PITTSBURGH SLEEP QUALITY INDEX;POLYCYSTIC OVARY;SANGER SEQUENCING;SEVELAMER;SEX HORMONE-BINDING GLOBULIN;SPITZ NEVUS;STROKE VOLUME;SUBGLOTTIS;THROMBOSPONDIN;UNDERWEIGHT","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;AGED;FEMALE;MIDDLE AGED;;ADULT;NEOPLASMS;MELANOMA;TAKOTSUBO CARDIOMYOPATHY;AGED, 80 AND OVER;ANTINEOPLASTIC AGENTS;ITALY;CORONARY ARTERY DISEASE;RENAL INSUFFICIENCY, CHRONIC;STRESS, PSYCHOLOGICAL;TIME FACTORS;TREATMENT OUTCOME;ADRENAL GLAND NEOPLASMS;CORONARY STENOSIS","26;22;19;19;16;13;12;9;8;8;7;7;7;6;6;6;6;6;5;5","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;MELANOMA;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;CANCER SURVIVORSHIP AND QUALITY OF LIFE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CORYNEBACTERIUM INFECTIONS AND TETANUS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENE THERAPY TECHNIQUES AND APPLICATIONS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GRANULAR CELL TUMOR: CLINICAL AND PATHOLOGICAL CHARACTERISTICS;HEPATITIS C INFECTION AND TREATMENT;HERBAL MEDICINE USE AND SAFETY MONITORING;KIDNEY TRANSPLANTATION;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER","5;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADVERSE DRUG REACTION;APATHY;COGNITIVE DECLINE;DEMENTIA;DEPRESSION (ECONOMICS);DIAGNOSTIC CRITERIA;EXECUTIVE DYSFUNCTION;MELANOMA;MULTIPLE SCLEROSIS;NODULE (GEOLOGY);SKIN CANCERS;STRESS-INDUCED CARDIOMYOPATHY;ADAMTS;ADHD;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ADRENOCORTICAL CARCINOMA;ADVERSE DRUG EVENTS;ADVERSE DRUG REACTIONS;AIRWAY OBSTRUCTION;ALTERNATIVE MEDICINE","2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","MULTIPLE SCLEROSIS;ALZHEIMERS DISEASE;CANCER PATIENTS;EXECUTIVE SYNDROMES;HEMODIALYSIS PATIENTS;KIDNEY TRANSPLANTATION;PARKINSONS DISEASE;PATIENTS RESULTS;RELATED EXECUTIVE;ADRENAL APOPLEXY;ADRENAL GLAND;ADVERSE EVENTS;AIRWAY OBSTRUCTION;ALTERNATIVE MEDICINE;ANEMIA MANAGEMENT;ANOREXIA NERVOSA;ANTIGEN CLASS;AORTA TUBULAR;AORTIC DISSECTION;APNEAHYPOPNOEA SYNDROME;ARTERY DISEASE;ARTERY THROMBOSIS;ASCENDING AORTA;ASSOCIATIONS IN-;AUTOGENOUS RADIAL;AWAITING KIDNEY;AWAKE VERSUS;BERBERINE IMPROVES;CALCIUM CARBONATE;CAMPOBASSO MOLISE","5;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MULTIPLE SCLEROSIS;URINE CREATININE;ANOREXIA NERVOSA;PRIMARY PROGRESSIVE;SLEEP DISTURBANCES;DISEASE DURATION;PROGRESSIVE MULTIPLE;ADRENAL GLAND;CLINICAL OUTCOMES;EXAMINATION REVEALED;FRONTAL TASKS;INTERFERON Β-A;CONFIDENCE INTERVAL;CREATININE EXCRETION;DIAGNOSTIC SCORE;HISTOLOGICAL EXAMINATION;KIDNEY FAILURE;PATIENT AGE;PROPENSITY SCORE;ABDOMINAL PAIN;ADJUSTED HAZARD;ADVERSE DRUG;BEHAVIORAL RATING;BODY MASS;CANCER PATIENTS;CELIAC DISEASE;CHOKING SPELLS;CKD STAGES;COPIES ML;DIAGNOSTIC CRITERIA","9;8;6;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2",10,0.26,4.8,21.82,10.304,32.504,12.33,6,19,1,1,1,1.33,1,2,0,0,0,2,2,2,0,0,0,0,0,0,2,2,2,14,7,21,0,0,0,1,1,1,9,4,16,0,0,0,0,0,0,1,1,1,2,2,2,6.67,3,14,1.33,1,2,0,0,0,0,0,0,128.33,110,164,128.33,110,164,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2014,46,12.1521739130435,2.23913043478261,0.446601941747573,0.326086956521739,0.260869565217391,0.152173913043478,0.608695652173913,1,18,10,11,2,0.39,0.22,0.24,0.04,42.78,1.13206358751762,0.304347826086957,0.956521739130435,4.1747572815534,0.402288656981228,0.263736263736264,0.263636363636364,0.263736263736264,"FEDERICO PISCIONE;PAOLO BARONE;CESARE BALDI;NICOLA MAFFULLI;M. MIRRA;MARCO DI MAIO;PIETRO GIUDICE;TIZIANA ATTISANO;FRANCESCO VIGORITO;RODOLFO CITRO;ANTONIO D′ANTONIO;ALESSANDRO PUZZIELLO;CARMINE VITALE;PASQUALE PISANO;KATIA LONGO;MARK PAINE;MAURIZIO IEMMA;ROBERTO BERGAMASCHI;MARIA ADDESSO;MARINA PICILLO","4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","CAMPANA;NICOLA MAFFULLI;MARCO DI MAIO;FRANCESCO VIGORITO;ANTONIO D′ANTONIO;M. MIRRA;MAURIZIO IEMMA;MARIA ADDESSO;ALESSANDRO PUZZIELLO;PIETRO GIUDICE;TIZIANA ATTISANO;GIUSEPPE DI BENEDETTO;MARIA PANETTI;MATTEO CAVALIERE;FEDERICO PISCIONE;CESARE BALDI;SALVATORE D. TOMASELLO;ALFREDO R. GALASSI;MARIO VITALE;ELISABETTA ANGRISANI","1;0.64;0.52;0.52;0.52;0.5;0.46;0.45;0.39;0.39;0.39;0.38;0.33;0.33;0.32;0.29;0.29;0.29;0.27;0.27","FEDERICO PISCIONE;CESARE BALDI;NICOLA MAFFULLI;MARCO DI MAIO;PIETRO GIUDICE;TIZIANA ATTISANO;FRANCESCO VIGORITO;RODOLFO CITRO;ANTONIO D′ANTONIO;ALESSANDRO PUZZIELLO;PASQUALE PISANO;MAURIZIO IEMMA;GERARDO BOTTI;ROSARIO FARINA;CARMINE SELLERI;GIUSEPPE DI BENEDETTO;M BUDETTA;EDUARDO BOSSONE;GERARDO IULIANO;ELISABETTA ANGRISANI","4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","CAMPANA;NICOLA MAFFULLI;MARCO DI MAIO;FRANCESCO VIGORITO;ANTONIO D′ANTONIO;MAURIZIO IEMMA;ALESSANDRO PUZZIELLO;PIETRO GIUDICE;TIZIANA ATTISANO;GIUSEPPE DI BENEDETTO;MATTEO CAVALIERE;FEDERICO PISCIONE;CESARE BALDI;ELISABETTA ANGRISANI;MARIO CARRANO;SERGIO BRONGO;DOMENICO PAGLIARA;CORRADO RUBINO;ANDREA CAMPANA;PIO ZEPPA","1;0.64;0.52;0.52;0.52;0.46;0.39;0.39;0.39;0.38;0.33;0.32;0.29;0.27;0.27;0.25;0.25;0.25;0.25;0.24","CARMINE VITALE;PAOLO BARONE;GABRIELLA SANTANGELO;DARIO GROSSI;F SANTANGELO;FABRIZIA FALCO;LUIGI TROJANO;MATTIA SICILIANO;PIETRO SIANO;ROBERTO PEDONE;ROSSELLA BISOGNO;RODOLFO CITRO;ANTONELLO D’ANDREA;EDUARDO BOSSONE;FEDERICO PISCIONE;CONCETTA ZITO;FAUSTO RIGO;FRANCESCO ANTONINI‐CANTERIN;GENNARO PROVENZA;GUIDO PARODI","404;404;363;309;309;309;309;309;309;309;309;268;259;259;228;220;220;220;220;220","PIETRO SIANO;RODOLFO CITRO;EDUARDO BOSSONE;ALESSANDRO WEISZ;ALESSANDRO PUZZIELLO;CARMINE NAPOLITANO;MARCO CLEMENTE;GERARDO IULIANO;ANTONELLA TORIELLO;ELISA DE MICHELE;CARMINE SELLERI;FRANCESCO ORIO;NICOLA MAFFULLI;GABRIELE CAPO;GIOVANNA CANTATORE;M BUDETTA;ROSARIO FARINA;VINCENZO BELLIZZI;GIUSEPPE CAPO;MAURIZIO IEMMA","309;268;259;154;150;139;139;128;95;71;68;65;65;54;53;44;44;44;41;39","ANTONIO D′ANTONIO;CESARE BALDI;FRANCESCO VIGORITO;NICOLA MAFFULLI;PIETRO GIUDICE;RODOLFO CITRO;TIZIANA ATTISANO;CARMINE SELLERI;EDUARDO BOSSONE;ELISABETTA ANGRISANI;ELISABETTA BELLINO;FEDERICO PISCIONE;GERARDO IULIANO;M BUDETTA;MARIO CARRANO;MAURIZIO IEMMA;PASQUALE PISANO;ROSARIO FARINA;ALESSANDRO PUZZIELLO;ALESSANDRO WEISZ","3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;PHYSICS;PSYCHOLOGY;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY","42;17;3;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PATHOLOGY;GENETICS;RADIOLOGY;BIOCHEMISTRY;CANCER RESEARCH;ENDOCRINOLOGY;IMMUNOLOGY;PALEONTOLOGY;ANESTHESIA;PEDIATRICS;ANATOMY;ENVIRONMENTAL HEALTH;ONCOLOGY;PSYCHIATRY;BOTANY;CELL BIOLOGY;GASTROENTEROLOGY;PHYSICAL THERAPY","35;18;13;11;9;6;5;5;5;5;5;4;4;3;3;3;3;2;2;2;2","CANCER;MYOCARDIAL INFARCTION;GENE;CONFIDENCE INTERVAL;DISEASE;THYROID;ADVERSE EFFECT;DIABETES MELLITUS;HEART FAILURE;IMMUNOHISTOCHEMISTRY;NODULE (GEOLOGY);POPULATION;PROPORTIONAL HAZARDS MODEL;PROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;ANGIOGRAPHY;ARTERY;BODY MASS INDEX;CELL CULTURE;COHORT;CORONARY ARTERY DISEASE;DIFFERENTIAL DIAGNOSIS;ELECTROPHYSIOLOGY;EVEROLIMUS;HYPOPARATHYROIDISM;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;MAGNETIC RESONANCE IMAGING;MALNUTRITION;MULTIPLE SCLEROSIS;OBESITY;PERCUTANEOUS;SALINE;SHOCK (CIRCULATORY);STENT;SUDDEN CARDIAC DEATH;TENDON","8;7;6;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HAZARD RATIO;METASTASIS;COLORECTAL CANCER;DOWNREGULATION AND UPREGULATION;EJECTION FRACTION;EPIGENETICS;GENE EXPRESSION;PARKINSON'S DISEASE;PERCUTANEOUS CORONARY INTERVENTION;REGULATION OF GENE EXPRESSION;REPOLARIZATION;THYROID NODULES;TOLERABILITY;TYROSINE-KINASE INHIBITOR;A549 CELL;ACHILLES TENDON;ACINETOBACTER;ADENOCARCINOMA;AGE OF ONSET;AMOXICILLIN;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;ANTIBIOTIC RESISTANCE;AORTIC VALVE REPLACEMENT;AORTIC VALVE STENOSIS;ATYPICAL FIBROXANTHOMA;BENIGNITY;BETA OXIDATION;BREAST CANCER;BYPASS GRAFTING;C-REACTIVE PROTEIN;CARBAMAZEPINE;CARDIOGENIC SHOCK;CARDIOMYOPATHY;CD34;CELL CYCLE;CHELATION THERAPY;CLEAR-CELL SARCOMA;COGNITIVE FLEXIBILITY;COGNITIVE IMPAIRMENT;COLISTIN;COMMON ILIAC ARTERY;CONVENTIONAL PCI;COPOLYMER;CORONARY ANGIOGRAPHY;CORONARY ARTERY BYPASS SURGERY;CORONARY OCCLUSION;DEFERASIROX;DEMENTIA;DOPAMINERGIC;DRUG-NAÏVE;END STAGE RENAL DISEASE;ENDOCRINE SURGERY;EPITOPE;ESCHERICHIA COLI;EUROSCORE;FATTY ACID METABOLISM;FORESKIN;FUNCTIONAL ENDOSCOPIC SINUS SURGERY;GENE SILENCING;GESTATION;GESTATIONAL AGE;GLATIRAMER ACETATE;GOITER;HERPES SIMPLEX VIRUS;HYPOCALCAEMIA;ICTAL;INSULIN RESISTANCE;INTERFERON BETA;J WAVE;LEVOFLOXACIN;LEVOTHYROXINE;LIFE EXPECTANCY;MICELLE;MICRORNA;MITRACLIP;MITRAL VALVE REPLACEMENT;MOMETASONE FUROATE;MYCOSIS FUNGOIDES;NASAL SPRAY;NATALIZUMAB;NEGATIVE-PRESSURE WOUND THERAPY;NUCLEAR ATYPIA;OSTEOARTHRITIS;PACLITAXEL;PHENOTYPE;PRECOCIOUS PUBERTY;PROGRESSION-FREE SURVIVAL;PSEUDOMONAS AERUGINOSA;PYROSEQUENCING;RAW SCORE;REIMBURSEMENT;RESTENOSIS;REVASCULARIZATION;RHINOMANOMETRY;RNA;SEIZURE TYPES;SINUS (BOTANY);ST SEGMENT;SULFAMETHOXAZOLE;TARGETED THERAPY;TENDINOPATHY;THROMBOLYSIS;THYROID CANCER;THYROID FUNCTION;THYROIDECTOMY;TISSUE MICROARRAY;TRIMETHOPRIM;TYROSINE KINASE;VASOMOTION;WRIST PAIN","4;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LONG NON-CODING RNA;ACINETOBACTER BAUMANNII;AMPHIPHILE;BENIGN EARLY REPOLARIZATION;CD90;COLECTOMY;DNA METHYLATION;DOPAMINE TRANSPORTER;DRUG-ELUTING STENT;HYPOTHALAMIC HAMARTOMA;INTERFERON BETA-1A;KLEBSIELLA;KLEBSIELLA PNEUMONIAE;KRAS;KRUKENBERG TUMOR;MONTREAL COGNITIVE ASSESSMENT;NON-CODING RNA;NON-SMALL CELL LUNG CANCER (NSCLC);OFF-PUMP CORONARY ARTERY BYPASS;POLYCYSTIC OVARY;RIGHT CORONARY ARTERY;RIGHT HEMICOLECTOMY;RNA INTERFERENCE;SIGNET RING CELL;SPECKLE TRACKING ECHOCARDIOGRAPHY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;;ADULT;ITALY;BIOMARKERS, TUMOR;HYPOPARATHYROIDISM;SKIN NEOPLASMS;HEART FAILURE;PARKINSON DISEASE;THYROID NODULE;MITRAL VALVE INSUFFICIENCY;MYOCARDIAL INFARCTION;TREATMENT OUTCOME;ADOLESCENT;AGED, 80 AND OVER;BETA-THALASSEMIA","31;26;24;17;16;15;13;12;10;8;8;7;7;7;6;6;6;5;5;5","ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF VALVULAR HEART DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN LUNG CANCER RESEARCH;CARDIAC REHABILITATION AND CARDIOVASCULAR HEALTH INTERVENTIONS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CHRONIC RHINOSINUSITIS AND NASAL POLYPS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;CLASSIFICATION AND TREATMENT OF CUTANEOUS LYMPHOMAS;CLINICAL AND MOLECULAR CHARACTERISTICS OF GLOMUS TUMORS;COLORECTAL CANCER RESEARCH AND TREATMENT;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF OTITIS MEDIA;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NODULE (GEOLOGY);DIAGNOSTIC CRITERIA;EVEROLIMUS;HYPOPARATHYROIDISM;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;THYROID NODULES;TOLERABILITY;TREATMENT;ACINETOBACTER BAUMANNII;ACOUSTIC RHINOMETRY;ADAPTIVE IMMUNITY REGULATION;ANASTOMOTIC LEAKAGE;ANTIBIOTIC RESISTANCE;ANTIMICROBIAL SUSCEPTIBILITY TESTING;ATYPIA;ATYPICAL FIBROXANTHOMA;BARRIERS TO ADHERENCE;BENIGN EARLY REPOLARIZATION;BENIGNITY;BRAIN METASTASES","3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","ABNORMAL CELLULAR;CARDIOVERTER DEFIBRILLATOR;CELLULAR REPOLARIZATION;DEFIBRILLATOR SHOCK;HEART FAILURE;IMPLANTABLE CARDIOVERTER;MULTIPLE SCLEROSIS;NEUROMOTOR DISABILITIES;REPOLARIZATION DUE;ABERRANT EXPRESSION;ACELLULAR DERMAL;ACHILLES TENDON;ACID METABOLISM;ACID MW;ACUTE HEART;ACUTE MYOCARDIAL;ADHERENCE TREATMENT;AMPHIPHILE MICELLES;ANASTOMOSIS RESULTS;ANTIBIOTIC RESISTANCE;AORTIC VALVE;AR MOD;ARTERY BYPASS;ATRIAL MORPHOLOGY;ATYPICAL FIBROXANTHOMA;ATYPICAL MENINGIOMAS;BASELINE RISK;BENIGN THYROID;BETA FORMULATIONS;BILLING SYSTEM","2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADVERSE EVENTS;CORONARY ANGIOGRAPHY;ILIAC ARTERY;CELL PROLIFERATION;CONFIDENCE INTERVAL;EGFR TKI;HR CI;INJECTABLE IMMUNOMODULATORS;ISCHEMIC STROKE;STATISTICALLY SIGNIFICANT;ANCILLARY TECHNIQUES;CARDIAC REHABILITATION;CLINICAL PRACTICE;COMMON ILIAC;FLOW CYTOMETRY;INCLUDED PATIENTS;LINE TREATMENT;LYMPH NODAL;MAJOR ADVERSE;MOD CATHETER;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;NASAL SYMPTOMS;NODAL INVOLVEMENT;RAR MOD;RECURRENT THROMBOTIC;THROMBOTIC EVENTS;ABERRANT EXPRESSION;ACUTE HEART;ALESSANDRO WEISZ","6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2",16,0.35,2.375,24.29,9.5,52,5.75,4,8,0,0,0,1.33,1,2,0,0,0,4,1,7,3,3,3,0,0,0,1,1,1,6.5,4,8,0,0,0,0,0,0,1.67,1,3,1,1,1,0,0,0,0,0,0,1.5,1,2,1,1,1,0,0,0,0,0,0,0,0,0,81.5,48,113,81.5,48,113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2015,66,13.3787878787879,2.27272727272727,0.44,0.212121212121212,0.272727272727273,0.242424242424242,0.484848484848485,1,24,15,9,7,0.36,0.23,0.14,0.11,27.11,0.727323961936438,0.333333333333333,0.909090909090909,3.98518518518518,0.418725448232867,0.296703296703297,0.361471861471862,0.337037037037037,"GERARDO IULIANO;JEANNETTE LECHNER‐SCOTT;MARIA TROJANO;HELMUT BUTZKUEVEN;ALESSANDRA LUGARESI;PIERRE DUQUETTE;PIERRE GRAMMOND;RAYMOND HUPPERTS;RICARDO FERNÁNDEZ‐BOLAÑOS;GUILLERMO IZQUIERDO;ROBERTO BERGAMASCHI;CESARE BALDI;EDGARDO CRISTIANO;RAED ALROUGHANI;CAVIT BOZ;FRANÇOIS GRAND’MAISON;CELIA OREJA‐GUEVARA;VINCENT VAN PESCH;MARC GIRARD;FREEK VERHEUL","8;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6","CESARE BALDI;RENATO DE VECCHIS;FRANCESCO MARIA GUIDA;ANTONIO D′ANTONIO;FRANCESCO ORIO;ANNAMARIA COLAO;GIOVANNA MUSCOGIURI;GIUSEPPINA DI BIASE;ALESSANDRO WEISZ;FABIANA ZINGONE;CAROLINA CIACCI;RODOLFO CITRO;VINCENZO GIUSEPPE DI CRESCENZO;FEDERICO PISCIONE;ANGELO SILVERIO;MARIA RAVO;R ASCOLI;MARIO VITALE;GIANFRANCO DEL BUONO;ADELAIDE FUSCO","1.82;1.75;1;0.65;0.61;0.61;0.61;0.58;0.51;0.5;0.5;0.5;0.49;0.43;0.43;0.41;0.39;0.35;0.33;0.33","GERARDO IULIANO;CESARE BALDI;ALESSANDRO WEISZ;RODOLFO CITRO;FEDERICO PISCIONE;VINCENZO GIUSEPPE DI CRESCENZO;ANGELO SILVERIO;FRANCESCO ORIO;MARIO VITALE;EDUARDO BOSSONE;R ASCOLI;COSTANTINA PROTA;ANTONIO D′ANTONIO;ALESSANDRO VATRELLA;MAURIZIO GUIDA;SILVANA NOVIELLO;VINCENZO ALTIERI;ANTONIO GALDERISI;GIUSEPPE DE SIMONE;VINCENZO BELLIZZI","8;6;5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2","CESARE BALDI;FRANCESCO MARIA GUIDA;ANTONIO D′ANTONIO;FRANCESCO ORIO;ALESSANDRO WEISZ;FABIANA ZINGONE;CAROLINA CIACCI;RODOLFO CITRO;VINCENZO GIUSEPPE DI CRESCENZO;FEDERICO PISCIONE;ANGELO SILVERIO;R ASCOLI;MARIO VITALE;GIANFRANCO DEL BUONO;MAURIZIO GUIDA;ALESSIA CALEO;ANTONIO GALDERISI;GIUSEPPE PERILLO;COSTANTINA PROTA;ALESSANDRO VATRELLA","1.82;1;0.65;0.61;0.51;0.5;0.5;0.5;0.49;0.43;0.43;0.39;0.35;0.33;0.33;0.32;0.29;0.29;0.28;0.28","GERARDO IULIANO;ALESSANDRA LUGARESI;GUILLERMO IZQUIERDO;HELMUT BUTZKUEVEN;JEANNETTE LECHNER‐SCOTT;MARIA TROJANO;PIERRE DUQUETTE;PIERRE GRAMMOND;RAYMOND HUPPERTS;RICARDO FERNÁNDEZ‐BOLAÑOS;RAED ALROUGHANI;CELIA OREJA‐GUEVARA;FRANÇOIS GRAND’MAISON;FREEK VERHEUL;MARC GIRARD;VINCENT VAN PESCH;DANIELE SPITALERI;CAVIT BOZ;EDGARDO CRISTIANO;ROBERTO BERGAMASCHI","577;553;553;553;553;553;553;553;553;553;546;517;517;517;517;517;454;446;446;446","GERARDO IULIANO;RODOLFO CITRO;ALESSANDRO WEISZ;GIANGENNARO COPPOLA;EDUARDO BOSSONE;ANTONIO GALDERISI;GIUSEPPE PERILLO;GRAZIELLA CORBO;PIETRO GIUDICE;ANGELO SILVERIO;FEDERICO PISCIONE;JACOPO TROISI;MAURIZIO GUIDA;COSTANTINA PROTA;ERICA TEDONE CLEMENTE;ROSSELLA BIANCARDI;ANDREA VIGGIANO;ANNACARMELA TORO;FRANCESCA FELICIA OPERTO;GIUSEPPE FERRARIOLI","577;127;120;98;97;96;96;81;69;66;66;61;61;60;57;53;50;50;50;50","GERARDO IULIANO;CESARE BALDI;ALESSANDRO WEISZ;RODOLFO CITRO;ANGELO SILVERIO;FEDERICO PISCIONE;COSTANTINA PROTA;R ASCOLI;EDUARDO BOSSONE;MAURIZIO GUIDA;ANTONIO GALDERISI;ELISABETTA ANGRISANI;FRANCESCO ORIO;GIANGENNARO COPPOLA;GIOVANNI VITALE;GIUSEPPE PERILLO;JACOPO TROISI;VINCENZO ALTIERI;VINCENZO BELLIZZI;ADRIANO MAGLI","8;6;5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY","60;16;5;4;4;3;2;2;2;1;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;GENETICS;IMMUNOLOGY;SURGERY;CANCER RESEARCH;PATHOLOGY;PSYCHIATRY;ENDOCRINOLOGY;PEDIATRICS;RADIOLOGY;BIOCHEMISTRY;CELL BIOLOGY;INTENSIVE CARE MEDICINE;ANESTHESIA;ONCOLOGY;GASTROENTEROLOGY;OPTICS;PHYSICAL THERAPY;UROLOGY","49;14;9;8;8;7;7;7;6;6;6;5;5;5;4;4;3;3;3;3","HEART FAILURE;CANCER;DISEASE;GENE;MULTIPLE SCLEROSIS;CONFIDENCE INTERVAL;RETROSPECTIVE COHORT STUDY;BLOOD PRESSURE;COHORT;COHORT STUDY;INCIDENCE (GEOMETRY);MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;THYROID;ANEURYSM;APOPTOSIS;BIOPSY;CELL;CLINICAL TRIAL;COMPLICATION;CONCORDANCE;CORONARY ARTERY DISEASE;DIABETES MELLITUS;EPIDEMIOLOGY;ETIOLOGY;INFLAMMATION;INSULIN;KIDNEY DISEASE;LESION;LUNG;LUNG CANCER;MITRAL REGURGITATION;MITRAL VALVE;MYOCARDITIS;POPULATION;PREGNANCY;PROPENSITY SCORE MATCHING;PULMONARY EMBOLISM;RECEPTOR;REGURGITATION (CIRCULATION);RENAL FUNCTION;SIGNAL TRANSDUCTION;URINARY SYSTEM;VITAMIN D AND NEUROLOGY","9;8;8;7;6;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;ACUTE CORONARY SYNDROME;ACUTE DECOMPENSATED HEART FAILURE;BREAST CANCER;CARDIOMYOPATHY;CELL CYCLE;CLINICAL ENDPOINT;CONVENTIONAL PCI;DOWNREGULATION AND UPREGULATION;EJECTION FRACTION;EXPANDED DISABILITY STATUS SCALE;FINGOLIMOD;HAZARD RATIO;INSULIN RESISTANCE;MICRORNA;PERCUTANEOUS CORONARY INTERVENTION;THYROIDITIS;ABORTION;ACINETOBACTER;ADENOCARCINOMA;AIRWAY OBSTRUCTION;AMIKACIN;ANTAGONIST;ANTERIOR PITUITARY;ANTIBIOTIC RESISTANCE;AORTIC ANEURYSM;AORTIC DISSECTION;ASTHMA EXACERBATIONS;ASTHMA MANAGEMENT;AUTOPHAGY;BASAL (MEDICINE);BICUSPID AORTIC VALVE;BIOGENESIS;BLOOD UREA NITROGEN;CANNABINOID;CARDIAC MAGNETIC RESONANCE IMAGING;CD14;CD19;CD20;CHROMOSOME;CLOPIDOGREL;COLISTIN;COMPASSION FATIGUE;CYTOTOXIC T CELL;DEEP VEIN;DEGENERATIVE DISEASE;DEMENTIA;DIASTOLE;EMOTIONAL EXHAUSTION;ENDOMETRIAL CANCER;ENTHESIS;EXON;FINE-NEEDLE ASPIRATION;FLUID RESTRICTION;FRAMINGHAM RISK SCORE;GENE EXPRESSION;GENE ISOFORM;GENE KNOCKDOWN;GENE SILENCING;GENERAL HEALTH QUESTIONNAIRE;GLATIRAMER ACETATE;GOITER;GROWTH HORMONE;HEART RATE;HEPATORENAL SYNDROME;HYPOGONADOTROPIC HYPOGONADISM;ICTAL;IDIOPATHIC PULMONARY FIBROSIS;INDEXATION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLAMMASOME;INTERFERON BETA;IRRITABILITY;KERATOCONUS;LEPTIN;MALNUTRITION IN CHILDREN;METABOLOME;MITRACLIP;MUCOEPIDERMOID CARCINOMA;MUTATION;NATALIZUMAB;NATRIURETIC PEPTIDE;PARKINSON'S DISEASE;PATELLAR TENDON;PATENT FORAMEN OVALE;PERFORATION;PERFORMANCE STATUS;PERIPROSTHETIC;PHOSPHATASE;PI3K/AKT/MTOR PATHWAY;PLASMABLASTIC LYMPHOMA;PROGRAMMED CELL DEATH;PROSTATE CANCER;PROTEIN DIET;PROTEIN KINASE A;PROTEIN KINASE B;PSEUDOMONAS AERUGINOSA;QUARTILE;RESTENOSIS;RIGHT HEART CATHETERIZATION;RNA;ST ELEVATION;STAT3;SUDDEN HEARING LOSS;THYROID DISEASE;THYROID NODULES;TIGECYCLINE;TRACHEOESOPHAGEAL FISTULA;TYPE 2 DIABETES;VAGINAL DELIVERY;VENA CONTRACTA;VENOUS THROMBOEMBOLISM;VENOUS THROMBOSIS;VENTRICULAR ASSIST DEVICE;VITAMIN D DEFICIENCY;WARFARIN","4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","KRAS;POLYCYSTIC OVARY;ACINETOBACTER BAUMANNII;AIM2;ALTERNATIVE SPLICING;ANEUPLOIDY;AUTOPHOSPHORYLATION;BAG3;BICUSPID VALVE;CANNABINOID RECEPTOR;CASPASE;CASPASE 3;CENTRAL VENOUS PRESSURE;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;ESTROGEN RECEPTOR;FLUORESCENCE IN SITU HYBRIDIZATION;FORAMEN OVALE (HEART);GASTRIC ADENOCARCINOMA;GROWTH HORMONE DEFICIENCY;HYPERINSULINEMIA;HYPERINSULINISM;INTERFERON BETA-1A;JOINT INFECTIONS;KARYOTYPE;METASTATIC BREAST CANCER;NON-CODING RNA;PHOSPHOINOSITIDE 3-KINASE;PRODUCTS OF CONCEPTION;PROSTATE BIOPSY;PTEN;REGORAFENIB;RIGHT HEMICOLECTOMY;RNA SPLICING;SPECKLE TRACKING ECHOCARDIOGRAPHY;TERLIPRESSIN;THORACIC AORTIC ANEURYSM","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;ADULT;MIDDLE AGED;AGED;LUNG NEOPLASMS;MULTIPLE SCLEROSIS, RELAPSING-REMITTING;YOUNG ADULT;ITALY;CARCINOMA, NON-SMALL-CELL LUNG;IMMUNOSUPPRESSIVE AGENTS;MULTIPLE SCLEROSIS;ADOLESCENT;ADRENAL GLAND NEOPLASMS;BIOMARKERS;POLYCYSTIC OVARY SYNDROME;THYROID NODULE;ANTICOAGULANTS","43;32;29;22;21;21;18;12;10;10;9;8;8;8;7;7;7;7;7;6","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;ROLE OF LONG NONCODING RNAS IN CANCER AND DEVELOPMENT;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;OPTIMIZATION OF PERIOPERATIVE FLUID THERAPY;ACUTE MYELOID LEUKEMIA;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ASTHMA;ATRIAL FIBRILLATION;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS","8;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COMPETING ENDOGENOUS RNA;DIAGNOSTIC CRITERIA;LEFT VENTRICULAR FUNCTION;MICRORNAS;TRANSCATHETER AORTIC-VALVE REPLACEMENT;TREATMENT;CLINICAL ENDPOINT;CONCORDANCE;DIAGNOSIS;ETIOLOGY;MITRAL REGURGITATION;MRNA MODIFICATION;POSTINFARCTION VENTRICULAR SEPTAL DEFECT;RNA REGULATION;VITAMIN D;ACINETOBACTER BAUMANNII;ADAPTER (COMPUTING);AGING;AIM2;AIRWAY OBSTRUCTION","3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1","MULTIPLE SCLEROSIS;HEART FAILURE;LOW-PROTEIN DIET;METASTATIC COLORECTAL;MITRAL VALVE;OVARY SYNDROME;POLYCYSTIC OVARY;RANDOMIZED CONTROLLED;RETROSPECTIVE STUDY;ABORTIONS INTERPHASE;ABSTRACT DEVICE;ACID INJECTIONS;ACTIVE MULTIPLE;ACUTE CORONARY;ACUTE DECOMPENSATED;ACUTE HEART;ACUTE MALNUTRITION;ADENOCARCINOMA VEGA;ADRENAL MASS;ADRENERGIC MYOCARDITIS;AIM INFLAMMASOME-DEPENDENT;ALTERNATIVE MRNA;ANESTHESIA MONTHS;ANEURYSM PERFORATION;ANTERIOR MITRAL;ANTIMICROBIAL RESISTANCE;ANTITHROMBOTIC REGIMENS;AORTIC REGURGITATION;AORTIC VALVE;APPLICATION HELPFUL","6;5;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;DENDRITIC CELLS;PLASMACYTOID DENDRITIC;CANCEROUS PDCS;LUNG CANCER;CROTHER TR;IMMUNOL -CROSSREF;SNCRNA EXPRESSION;BSM CELLS;CANCERONCOIMMUNOLOGY -CROSSREF;HEALTHY PDCS;MOUSE MODEL;SIGMA ALDRICH;THERAPEUTIC ACTIVITY;TR SORRENTINO;ALDRICH ROME;AORTIC VALVE;IL-Α RELEASE;MONTH CONFIRMED;MULTIPLE SCLEROSIS;ROME ITALY;SUPPLEMENTAL FIGURE;TUMOR CELL;ASTHMATIC PATIENTS;CELL PROLIFERATION;FLOW CYTOMETRY;SALERNO ITALY;ANTITUMOR ACTIVITY;BICUSPID AORTIC","45;40;28;28;15;15;14;10;9;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7;6;6;6;6;5;5",28,0.42,3.05,21.05,11.054,40.234,11.43,4,34,1.67,1,3,1.2,1,2,1,1,1,1.4,1,3,2,2,2,0,0,0,1,1,1,12.14,4,36,0,0,0,0,0,0,8.14,2,29,0,0,0,0,0,0,2,1,3,3.5,1,10,5,1,16,2,2,2,0,0,0,0,0,0,104.71,33,175,104.71,33,175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2016,91,13.9010989010989,2.2967032967033,0.435406698564593,0.21978021978022,0.252747252747253,0.21978021978022,0.538461538461538,1,40,21,12,7,0.44,0.23,0.13,0.08,23.43,0.721256168631312,0.285714285714286,0.945054945054945,4.0890052356021,0.469122082981263,0.300699300699301,0.4,0.391358024691358,"TIM SPELMAN;JEANNETTE LECHNER‐SCOTT;MARIA TROJANO;CARMINE SELLERI;HELMUT BUTZKUEVEN;EUGENIO PUCCI;ALESSANDRA LUGARESI;PIERRE DUQUETTE;GERARDO IULIANO;PIERRE GRAMMOND;PIO ZEPPA;ENRICO COSCIONI;CESARE BALDI;DANA HORÁKOVÁ;RAED ALROUGHANI;FRANÇOIS GRAND’MAISON;EVA HAVRDOVÁ;VINCENT VAN PESCH;RAYMOND HUPPERTS;FREEK VERHEUL","7;7;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6","PIO ZEPPA;CESARE BALDI;RENATO DE VECCHIS;CARMELINA ARIANO;MARIA ADDESSO;CARMINE SELLERI;ENRICO COSCIONI;FABIANA ZINGONE;CAROLINA CIACCI;VINCENZO BELLIZZI;ANTONIO D′ANTONIO;GIUSEPPE BIONDI‐ZOCCAI;ARTURO GIORDANO;CARLO BALDI;MATTIA CARBONE;RODOLFO CITRO;CORRADO RUBINO;NICOLA CAMPITIELLO;LUIGI CREMONE;CRISTIANO CREMONE","1.84;1.46;1.4;1.2;0.9;0.76;0.72;0.62;0.62;0.58;0.5;0.49;0.49;0.48;0.45;0.4;0.4;0.4;0.4;0.4","CARMINE SELLERI;GERARDO IULIANO;PIO ZEPPA;ENRICO COSCIONI;CESARE BALDI;VINCENZO BELLIZZI;RODOLFO CITRO;EDUARDO BOSSONE;FEDERICO PISCIONE;PATRIZIA CALELLA;P PREDOTTI;FABIANA ZINGONE;SCIPIONE CARERJ;MARCO POETA;NICOLA CAMPITIELLO;ALESSANDRO WEISZ;ROSA MARIA DI CRESCENZO;PIETRO VAJRO;AMELIA RAVERA;CAROLINA CIACCI","7;7;7;6;6;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3","PIO ZEPPA;CESARE BALDI;CARMINE SELLERI;ENRICO COSCIONI;FABIANA ZINGONE;CAROLINA CIACCI;VINCENZO BELLIZZI;ANTONIO D′ANTONIO;CARLO BALDI;MATTIA CARBONE;RODOLFO CITRO;NICOLA CAMPITIELLO;LUIGI CREMONE;CRISTIANO CREMONE;ANTONIO D’ANTONIO;PAOLA IOVINO;CRISTINA BUCCI;ROSA MARIA DI CRESCENZO;FRANCESCO ORIO;MARIO FAENZA","1.84;1.46;0.76;0.72;0.62;0.62;0.58;0.5;0.48;0.45;0.4;0.4;0.4;0.4;0.4;0.38;0.38;0.36;0.35;0.31","ALESSANDRA LUGARESI;EUGENIO PUCCI;GERARDO IULIANO;HELMUT BUTZKUEVEN;JEANNETTE LECHNER‐SCOTT;MARIA TROJANO;PIERRE DUQUETTE;PIERRE GRAMMOND;TIM SPELMAN;FRANÇOIS GRAND’MAISON;RAYMOND HUPPERTS;DANA HORÁKOVÁ;EVA HAVRDOVÁ;FREEK VERHEUL;GUILLERMO IZQUIERDO;VINCENT VAN PESCH;DANIELE SPITALERI;FRANCO GRANELLA;MARC GIRARD;PATRIZIA SOLA","779;779;779;779;779;779;779;779;779;712;712;692;692;692;692;692;667;667;667;667","GERARDO IULIANO;ANTONELLO PANZA;ALESSANDRO WEISZ;ENRICO COSCIONI;EDUARDO BOSSONE;CESARE BALDI;ALBERTO CUOCOLO;ALESSANDRO CANNAVÒ;ANDREA ELIA;ANTONIO DE BELLIS;AURELIO CARUSO;DARIO LEOSCO;FRANCESCO BALDASCINO;GENNARO PAGANO;GIUSEPPE RENGO;GIUSEPPINA GAMBINO;GRAZIA DANIELA FEMMINELLA;LAURA PETRAGLIA;MARIA GRIMALDI;MARIA NOLANO","779;155;115;109;102;101;81;81;81;81;81;81;81;81;81;81;81;81;81;81","GERARDO IULIANO;CESARE BALDI;CARMINE SELLERI;ENRICO COSCIONI;VINCENZO BELLIZZI;EDUARDO BOSSONE;RODOLFO CITRO;FABIANA ZINGONE;ALESSANDRO WEISZ;AMELIA RAVERA;CARLO BALDI;MATTIA CARBONE;P PREDOTTI;PATRIZIA CALELLA;PIO ZEPPA;ANTONIO D′ANTONIO;ANDREA CAMPANA;CAROLINA CIACCI;CRISTIANO CREMONE;CRISTINA BUCCI","7;6;5;5;5;4;4;3;3;3;3;3;3;3;3;2.57;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;MATHEMATICS;SOCIOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE","87;20;7;5;4;3;3;3;3;3;2;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;IMMUNOLOGY;PATHOLOGY;BIOCHEMISTRY;RADIOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;PSYCHIATRY;ENVIRONMENTAL HEALTH;GENETICS;PEDIATRICS;ENDOCRINOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;CELL BIOLOGY;ONCOLOGY;OPTICS;ANATOMY;DERMATOLOGY;EMERGENCY MEDICINE;GYNECOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;NURSING;SOCIAL SCIENCE","69;24;16;15;15;11;11;9;8;8;7;7;7;6;5;5;4;4;4;3;3;3;3;3;3;3;3","DISEASE;GENE;CONFIDENCE INTERVAL;HEART FAILURE;CANCER;COHORT;MYOCARDIAL INFARCTION;MULTIPLE SCLEROSIS;POPULATION;BLOOD PRESSURE;OBESITY;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;COHORT STUDY;INCIDENCE (GEOMETRY);ANTIBODY;ANTIGEN;CLINICAL TRIAL;CORONARY ARTERY DISEASE;DIALYSIS;KIDNEY DISEASE;LOGISTIC REGRESSION;MAGNETIC RESONANCE IMAGING;ODDS RATIO;PROPORTIONAL HAZARDS MODEL;URIC ACID;VIRUS","11;10;9;9;8;8;8;7;7;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3","CLINICAL ENDPOINT;EJECTION FRACTION;HAZARD RATIO;BREAST CANCER;COLORECTAL CANCER;EXPANDED DISABILITY STATUS SCALE;GENOTYPE;HEPATITIS C VIRUS;PERCUTANEOUS CORONARY INTERVENTION;REVASCULARIZATION;ACUTE CORONARY SYNDROME;ACUTE DECOMPENSATED HEART FAILURE;ADENOCARCINOMA;ALLELE;AORTIC DISSECTION;BRAIN NATRIURETIC PEPTIDE;CD8;CYTOTOXIC T CELL;DIASTOLE;EPIDERMAL GROWTH FACTOR RECEPTOR;FATTY LIVER;HYPERURICEMIA;INSULIN RESISTANCE;MUTATION;NATRIURETIC PEPTIDE;NEUROPSYCHOLOGY;OVERWEIGHT;PHENOTYPE;QUARTILE;T CELL;VIRAL LOAD","5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RIBAVIRIN;ANTIRETROVIRAL THERAPY;POLYCYSTIC OVARY;ACUTE AORTIC SYNDROME;ALPHA (FINANCE);ANTI-NUCLEAR ANTIBODY;BAG3;BREAST CARCINOMA;BREAST TISSUE;CALPROTECTIN;CARDIAC RESYNCHRONIZATION THERAPY;CD11C;CD28;CD3;CD38;COLONOSCOPY;COMPOUND HETEROZYGOSITY;DIPPER;DOPPLER ECHOCARDIOGRAPHY;DRUG-ELUTING STENT;EXOME SEQUENCING;FLUORESCENCE IN SITU HYBRIDIZATION;GEFITINIB;HMG-COA REDUCTASE;HYDROGEN BREATH TEST;IL-2 RECEPTOR;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;LIVER STEATOSIS;LYMPH NODE METASTASIS;LYMPHOVASCULAR INVASION;MAMMOGRAPHY;MICROSATELLITE;MUTAGENESIS;PLEURAL DISEASE;PRASUGREL;PROMOTER;REGORAFENIB;SERINE PROTEASE;SIGNET RING CELL;SIGNET RING CELL CARCINOMA;SINGLE-NUCLEOTIDE POLYMORPHISM;SPECKLE TRACKING ECHOCARDIOGRAPHY;UNDERWEIGHT;VINCRISTINE","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;ADULT;ITALY;RISK FACTORS;MULTIPLE SCLEROSIS;AGED, 80 AND OVER;HEART FAILURE;TREATMENT OUTCOME;COLORECTAL NEOPLASMS;ECHOCARDIOGRAPHY;MULTIPLE SCLEROSIS, RELAPSING-REMITTING;VENTRICULAR DYSFUNCTION, RIGHT;MYOCARDIAL INFARCTION;FOLLOW-UP STUDIES;SLEEP APNEA, OBSTRUCTIVE","55;47;42;36;30;29;24;19;15;12;11;11;11;10;10;10;10;9;8;8","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EFFECTS OF KETOGENIC DIET ON HEALTH;MANAGEMENT OF VALVULAR HEART DISEASE;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;BREAST PATHOLOGY AND IMAGING TECHNIQUES;CARDIAC REHABILITATION AND CARDIOVASCULAR HEALTH INTERVENTIONS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND TREATMENT OF HEART FAILURE;HEPATITIS C INFECTION AND TREATMENT;LYMPHOID NEOPLASMS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH","7;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","CLINICAL ENDPOINT;CARDIAC IMAGING;DIAGNOSTIC CRITERIA;ECHOCARDIOGRAPHY;LEFT VENTRICULAR FUNCTION;PROSTHETIC VALVES EVALUATION;TREATMENT;AORTIC DISSECTION;BRAIN NATRIURETIC PEPTIDE;CARDIOVASCULAR EVALUATION;CARDIOVASCULAR RISK ASSESSMENT;CORONARY STENTS;DASABUVIR;DIAGNOSIS;DISCONTINUATION;GLUTEN SENSITIVITY;HEPATITIS C;HOSPITAL DISCHARGE;HOSPITAL READMISSION;HYPERTENSION","5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","HEART FAILURE;MULTIPLE SCLEROSIS;AORTIC VALVE;BAG PROTEIN;CELL CARCINOMA;CKD PROGRESSION;CLINICAL OUTCOMES;DECODE REGISTRY;FINE-NEEDLE CYTOLOGY;GUTLIVER AXIS;HEART DISEASE;HYPERTENSIVE PATIENTS;LYMPH NODE;MYOCARDIAL INFARCTION;PARKINSONS DISEASE;PATIENTS TREATED;POLYCYSTIC OVARY;RANDOMIZED CONTROLLED;REAL LIFE;SERUM URIC;SPECKLE TRACKING;TRANSCATHETER AORTIC;URIC ACID;VALVE IMPLANTATION;AATD PLOWELL;ABNORMAL HEART;ACTIVE IMMUNOMODULATORY;ACUTE AORTIC;ACUTE CORONARY;ACUTE DECOMPENSATED","6;5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","DI DIO;GIOVANNI DI;CREMONE MD;RUGGI DARAGONA;DARAGONA SALERNO;PATHOLOGIC ANATOMY;MULTIPLE SCLEROSIS;SERUM CHOLESTEROL;ADDESSO MD;ANTONIO DANTONIO;ASL SALERNO;COMPUTED TOMOGRAPHY;CONTROL SUBJECTS;DANTONIO MD;HOSPITAL TORTORA;MD UNIT;PAGANI SA;QUARANTA MD;SA ITALYSEARCH;SALERNO HOSPITAL;SALERNO ITALYSEARCH;TMT SCORE;TORTORA PAGANI;UNIT AOU;INCIDENT HF;MUSCLE MASS;NON-ERGOT DAS;PROGRESSIVE MULTIPLE;SECONDARY PROGRESSIVE;TOTAL SERUM","17;17;16;16;12;12;9;9;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;7;7;7;7;7;7",33,0.36,2.75,63.06,7.58,265.624,22.56,3,62,2,1,3,1.86,1,3,1,1,1,8.83,1,30,0,0,0,0,0,0,1,1,1,25.89,3,70,0,0,0,0,0,0,14,2,25,0,0,0,0,0,0,1.38,1,2,3.57,2,6,8.78,1,19,1.57,1,4,0.11,0,1,0,0,0,139,15,420,139.11,15,420,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2017,83,13.3493975903614,2.14457831325301,0.466292134831461,0.240963855421687,0.253012048192771,0.168674698795181,0.433734939759036,0,31,23,10,11,0.37,0.28,0.12,0.13,16.81,0.570219286283629,0.337349397590361,0.927710843373494,4.01224489795919,0.427664461947472,0.41304347826087,0.4125,0.428571428571429,"RODOLFO CITRO;FEDERICO PISCIONE;PAOLO COLONNA;CAROLINA CIACCI;EUGENIO PICAÑO;FABIANA ZINGONE;QUIRINO CIAMPI;A ZAGATINA;PIETRO GIUDICE;LAURO CORTIGIANI;MARCO PATERNI;GENNARO GALASSO;JOSÉ LUIS DE CASTRO E SILVA PRETTO;ROBERTA DE ROSA;GERARDO SARNO;CLARISSA BORGUEZAN DAROS;CLARA CARPEGGIANI;EDUARDO BOSSONE;MARIA CHIARA SCALI;MARIA VINCENZA POLITO","12;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4","CAROLINA CIACCI;GERARDO SARNO;FABIANA ZINGONE;VINCENZO CONSALVO;VINCENZO SALSANO;RODOLFO CITRO;LUIGI CINQUANTA;ANTONELLA SANTONICOLA;GENNARO GALASSO;FEDERICO PISCIONE;ROBERTA DE ROSA;PAOLA IOVINO;MARIA VINCENZA POLITO;PAOLO COLONNA;G. PARRILLI;S. GALLOTTA;MARIACONSIGLIA CALABRESE;NICOLA BIZZARO;MARIA ADDESSO;DESRÉ ETHEL FONTANA","1.21;1.08;1.04;0.92;0.92;0.82;0.73;0.71;0.64;0.64;0.58;0.53;0.48;0.41;0.38;0.37;0.37;0.33;0.33;0.33","RODOLFO CITRO;FEDERICO PISCIONE;CAROLINA CIACCI;FABIANA ZINGONE;PIETRO GIUDICE;GENNARO GALASSO;ROBERTA DE ROSA;GERARDO SARNO;EDUARDO BOSSONE;MARIA VINCENZA POLITO;ANTONELLA SANTONICOLA;ENRICO COSCIONI;ANGELO SILVERIO;PAOLA IOVINO;ANGELO MASSARI;LUIGI CINQUANTA;G. PARRILLI;ANDREA CAMPANA;CESARE BALDI;CARMINE SELLERI","12;7;7;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2","CAROLINA CIACCI;GERARDO SARNO;FABIANA ZINGONE;RODOLFO CITRO;LUIGI CINQUANTA;ANTONELLA SANTONICOLA;GENNARO GALASSO;FEDERICO PISCIONE;ROBERTA DE ROSA;PAOLA IOVINO;MARIA VINCENZA POLITO;G. PARRILLI;S. GALLOTTA;MARIACONSIGLIA CALABRESE;P. BORGHERESI;ANTONIO D′ANTONIO;PIETRO GIUDICE;RICCARDO SAVASTANO;ANGELO MASSARI;ANNA GUIDA","1.21;1.08;1.04;0.82;0.73;0.71;0.64;0.64;0.58;0.53;0.48;0.38;0.37;0.37;0.33;0.33;0.32;0.28;0.28;0.26","RODOLFO CITRO;LUIGI CINQUANTA;DESRÉ ETHEL FONTANA;NICOLA BIZZARO;EDUARDO BOSSONE;FAUSTO RIGO;PAOLO COLONNA;EUGENIO PICAÑO;JOSÉ LUIS DE CASTRO E SILVA PRETTO;MARCO PATERNI;MARIA CHIARA SCALI;QUIRINO CIAMPI;ANA DJORDJEVIC‐DIKIC;LAURO CORTIGIANI;PAOLO TRAMBAIOLO;ALBERT VARGA;CLARISSA BORGUEZAN DAROS;MAURIZIO GALDERISI;ANTONELLO D’ANDREA;CLARA CARPEGGIANI","230;209;205;205;156;152;135;133;133;133;133;133;132;132;132;123;123;123;122;122","RODOLFO CITRO;LUIGI CINQUANTA;EDUARDO BOSSONE;CAROLINA CIACCI;FRANCESCO FERRARA;FEDERICO PISCIONE;FABIANA ZINGONE;PIETRO GIUDICE;ANTONELLA TORIELLO;CARMINE SELLERI;ANGELO SILVERIO;FRANCESCO ANTONIO SALZANO;VINCENZO BELLIZZI;PAOLA IOVINO;MARICA GRASSO;GIANGENNARO COPPOLA;SIMONE PISANO;G. LOCATELLI;GIOVANNI TORELLI;GENNARO GALASSO","230;209;156;110;89;81;78;77;73;73;63;61;58;56;52;49;49;44;44;41","RODOLFO CITRO;CAROLINA CIACCI;FABIANA ZINGONE;EDUARDO BOSSONE;FEDERICO PISCIONE;PIETRO GIUDICE;ANTONELLA SANTONICOLA;GERARDO SARNO;ANDREA CAMPANA;ANGELO MASSARI;ANGELO SILVERIO;LUIGI CINQUANTA;ENRICO COSCIONI;G. PARRILLI;GENNARO GALASSO;PAOLA IOVINO;ROBERTA DE ROSA;CARMINE SELLERI;CESARE BALDI;FRANCESCO ANTONIO SALZANO","12;7;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;ART","80;16;9;6;5;5;3;3;3;3;3;2;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;GASTROENTEROLOGY;GENETICS;PHYSICAL THERAPY;RADIOLOGY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;PEDIATRICS;PSYCHIATRY;ONCOLOGY;BIOCHEMISTRY;BIOINFORMATICS;ENDOCRINOLOGY;FAMILY MEDICINE;GENERAL SURGERY;LAW;LINGUISTICS;NURSING;OBSTETRICS;OPERATING SYSTEM;OPTICS;PHYSICAL MEDICINE AND REHABILITATION","59;21;21;11;10;10;10;9;8;8;7;7;7;6;5;5;4;3;3;3;3;3;3;3;3;3","DISEASE;CANCER;HEART FAILURE;GENE;CORONARY ARTERY DISEASE;MYOCARDIAL INFARCTION;POPULATION;COMPLICATION;CONFIDENCE INTERVAL;RETROSPECTIVE COHORT STUDY;CLINICAL TRIAL;MULTIVARIATE ANALYSIS;OBESITY;PREGNANCY;TRANSPLANTATION;ADVERSE EFFECT;ANTIBODY;COHORT;HEALTH CARE;INCIDENCE (GEOMETRY);MULTIPLE SCLEROSIS;ODDS RATIO;PATHOLOGICAL;PREDICTIVE VALUE;REHABILITATION","10;9;9;8;7;7;7;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","CLINICAL ENDPOINT;BREAST CANCER;EJECTION FRACTION;UNIVARIATE ANALYSIS;CARDIOMYOPATHY;LIVER TRANSPLANTATION;STRESS ECHOCARDIOGRAPHY;WEIGHT LOSS;ACUTE CORONARY SYNDROME;AUTOANTIBODY;CHEMOTHERAPY REGIMEN;COLORECTAL CANCER;CONVENTIONAL PCI;CORONARY ANGIOGRAPHY;CORONARY FLOW RESERVE;HAZARD RATIO;MESSENGER RNA;MUTATION;PERCUTANEOUS CORONARY INTERVENTION;THYROID CANCER;THYROIDITIS","5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","TAKOTSUBO SYNDROME;FRACTIONAL FLOW RESERVE;GASTRIC BYPASS;MORBID OBESITY;PAPILLARY THYROID CANCER;ACHILLES TENDON RUPTURE;ALTERNATIVE SPLICING;ATYPICAL ANTIPSYCHOTIC;BREAST RECONSTRUCTION;CARDIAC RESYNCHRONIZATION THERAPY;CHEMILUMINESCENT IMMUNOASSAY;COLONOSCOPY;DASATINIB;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DRUG-ELUTING STENT;EOTAXIN;EPWORTH SLEEPINESS SCALE;ESTROGEN RECEPTOR;FARNESYL DIPHOSPHATE SYNTHASE;GENOMICS;GENOTYPING;HBSAG;HORMONAL THERAPY;HYPOPNEA;IDH1;KILLIP CLASS;KRAS;MALE INFERTILITY;MASTECTOMY;MEDICATION ERROR;MEVALONATE PATHWAY;MISSENSE MUTATION;ONCOGENE;OXALIPLATIN;P2Y12;PARATHYROID NEOPLASM;PAZOPANIB;PERIPARTUM CARDIOMYOPATHY;PHILADELPHIA CHROMOSOME;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RETICULOCYTE;RNA SPLICING;TERIFLUNOMIDE","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;POSTOPERATIVE COMPLICATIONS;RETROSPECTIVE STUDIES;ADOLESCENT;PROSPECTIVE STUDIES;YOUNG ADULT;AGED, 80 AND OVER;LAPAROSCOPY;RISK FACTORS;TREATMENT OUTCOME;ECHOCARDIOGRAPHY, STRESS;RECONSTRUCTIVE SURGICAL PROCEDURES;REGISTRIES","45;38;34;32;27;20;19;17;15;11;10;10;10;9;8;7;7;6;6;6","MANAGEMENT OF VALVULAR HEART DISEASE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;NUTRITIONAL GENOMICS: PERSONALIZED NUTRITION AND HEALTH;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ACCURACY OF CLINICAL CODING IN HEALTHCARE DATA;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;BIOGENESIS AND FUNCTIONS OF CIRCULAR RNAS;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CARDIAC REHABILITATION AND CARDIOVASCULAR HEALTH INTERVENTIONS;CHOLESTEROL-LOWERING TREATMENT;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES","4;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CLINICAL ENDPOINT;ECHOCARDIOGRAPHY;LEFT VENTRICULAR FUNCTION;TAKOTSUBO SYNDROME;UNIVARIATE ANALYSIS;CARDIOVASCULAR RISK ASSESSMENT;GASTRIC BYPASS;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;STRESS ECHOCARDIOGRAPHY;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CHEMOTHERAPY REGIMEN;CLINICAL SIGNIFICANCE;CORONARY FLOW RESERVE;ECHO (COMMUNICATIONS PROTOCOL);ELECTROCARDIOGRAM INTERPRETATION;EVEROLIMUS;FRACTIONAL FLOW RESERVE;INTERQUARTILE RANGE;IRRITABLE BOWEL SYNDROME","5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","STRESS ECHO;TAKOTSUBO SYNDROME;WALL MOTION;AORTIC VALVE;LIVER TRANSPLANTATION;REGIONAL WALL;ACUTE CORONARY;BOWEL SYNDROME;CARDIOVASCULAR DISEASES;CARDIOVASCULAR RISK;CLINICAL OUTCOMES;CLINICAL PRACTICE;DECODE REGISTRY;GASTRIC BYPASS;HASHIMOTOS THYROIDITIS;HEART FAILURE;INTRATHYROIDAL PAPILLARY;IRRITABLE BOWEL;MOTION ANALYSIS;NATIONAL SURVEY;PAPILLARY THYROID;PHASE II;PREDICTS OUTCOME;QUALITY CONTROL;STRESS ECHOCARDIOGRAPHY;THYROID CANCER;VALVE IMPLANTATION;ACHILLES TENDON;ACTIVITY SCALE;ACUTE CHOLECYSTITIS","5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","BASILAR ARTERY;FABRY DISEASE;CHADS-VASC SCORE;CONTROL PATIENTS;IPI LT;MUSCLE MASS;PASE SCORE;PATIENTS TREATED;RISK FACTORS;TAKOTSUBO SYNDROME;CONFIDENCE INTERVAL;CURVED LENGTH;LIVER TRANSPLANTATION;MULTIVARIATE ANALYSIS;AORTIC VALVE;CKD STAGE;CLINICAL REMISSION;CONSECUTIVE PATIENTS;INTERNAL MEDICINE;LEFT VENTRICULAR;LINEAR LENGTH;MALE PATIENTS;MEDIAN FOLLOW-UP;ADVERSE EVENTS;ANTIPLATELET THERAPY;CARDIOVASCULAR RISK;CKD PATIENTS;CORONARY ARTERY;CRT-D REPLACEMENT;DAPT OAC","12;12;6;6;6;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3",35,0.42,2.1,22.91,5.25,127.15,15.11,1,96,9,9,9,0,0,0,1,1,1,2.57,1,12,2,2,2,0,0,0,0,0,0,17.67,1,118,0,0,0,0,0,0,14.71,1,74,0,0,0,3,3,3,4,3,5,4.67,1,10,9.71,1,48,6.5,2,11,0,0,0,0,0,0,97,15,541,97,15,541,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2018,99,16.8888888888889,1.86868686868687,0.535135135135135,0.212121212121212,0.222222222222222,0.181818181818182,0.505050505050505,3,51,19,9,8,0.52,0.19,0.09,0.08,35.44,1.1617985127292,0.333333333333333,0.95959595959596,4.36363636363637,0.488552967216438,0.539019963702359,0.452012383900929,0.553571428571429,"RODOLFO CITRO;FEDERICO PISCIONE;ROBERTO MINUTOLO;VINCENZO BELLIZZI;GENNARO GALASSO;PAOLO CALABRÒ;PAOLO COLONNA;EDUARDO BOSSONE;LORETO GESUALDO;MARCELLO PERSICO;GIUSEPPE CONTE;MASSIMO PUOTI;ANGELO SILVERIO;ANTONIO CHIRIANNI;ROBERTA DE ROSA;A ZAGATINA;FRANCESCO PERTICONE;EDOARDO G. GIANNINI;D BONADIES;CESARE BALDI","20;11;10;9;9;7;7;7;6;6;5;5;5;5;4;4;4;4;4;4","RODOLFO CITRO;VINCENZO BELLIZZI;GIANFRANCO DEL BUONO;GERARDO IULIANO;MICHELE CAVALIERE;FEDERICO PISCIONE;ROBERTO MINUTOLO;GENNARO GALASSO;PATRIZIA CALELLA;ANTONIO CANERO;FORTUNA LOMBARDI;VINCENZO CONSALVO;CLEMENTINA SAVASTANO;CESARE BALDI;PAOLO COLONNA;MARCELLO PERSICO;ANGELO SILVERIO;ANTONIETTA CANNA;FABRIZIO ESPOSITO;FRANCESCO DI SALLE","1.42;1.11;1;1;1;0.79;0.66;0.65;0.55;0.5;0.5;0.5;0.5;0.5;0.43;0.42;0.36;0.35;0.35;0.35","RODOLFO CITRO;FEDERICO PISCIONE;VINCENZO BELLIZZI;GENNARO GALASSO;EDUARDO BOSSONE;MARCELLO PERSICO;ANGELO SILVERIO;ROBERTA DE ROSA;D BONADIES;CESARE BALDI;ANTONIO CANERO;VALERIA CONTI;ROSARIO FARINA;SCIPIONE CARERJ;FABRIZIO ESPOSITO;FRANCESCO DI SALLE;AMELIA FILIPPELLI;CAROLINA CIACCI;PAOLO COSTA;GAETANO GARGIULO","20;11;9;9;7;6;5;4;4;4;3;3;3;3;3;3;3;3;3;2","RODOLFO CITRO;VINCENZO BELLIZZI;GIANFRANCO DEL BUONO;GERARDO IULIANO;MICHELE CAVALIERE;FEDERICO PISCIONE;GENNARO GALASSO;ANTONIO CANERO;FORTUNA LOMBARDI;CLEMENTINA SAVASTANO;CESARE BALDI;MARCELLO PERSICO;ANGELO SILVERIO;FABRIZIO ESPOSITO;FRANCESCO DI SALLE;NICOLA CAPUANO;CARMELA RESCIGNO;ANGELO DEL BUONO;D BONADIES;VALERIA CONTI","1.42;1.11;1;1;1;0.79;0.65;0.5;0.5;0.5;0.5;0.42;0.36;0.35;0.35;0.33;0.33;0.33;0.33;0.33","RODOLFO CITRO;EDUARDO BOSSONE;ABHIRAM PRASAD;CHRISTIAN TEMPLIN;DAVID E. WINCHESTER;FILIPPO CREA;FRANK RUSCHITZKA;JELENA R. GHADRI;JEROEN J. BAX;JOHN D. HOROWITZ;LEONARDA GALIUTO;THOMAS F. LÜSCHER;VICTORIA L. CAMMANN;ABHISHEK DESHMUKH;ALEXANDER R. LYON;AMIR LERMAN;CHARANJIT S. RIHAL;DOMENICO CORRADO;ELMIR ÖMEROVIC;FEDERICO MIGLIORE","2246;2148;2131;2131;2131;2131;2131;2131;2131;2131;2131;2131;2131;1856;1856;1856;1856;1856;1856;1856","RODOLFO CITRO;EDUARDO BOSSONE;VINCENZO BELLIZZI;AMELIA RAVERA;GIUSEPPE PALLADINO;GAETANO GARGIULO;MAURIZIO TENUTA;ROSA NAPOLETANO;ALESSANDRO PUZZIELLO;DOMENICO LA SALA;MARICA GRASSO;FEDERICO PISCIONE;GENNARO GALASSO;PAOLO COSTA;ROBERTA DE ROSA;SERENA TORRACA;ANGELO SILVERIO;NICOLA MAFFULLI;CESARE BALDI;ANDREA CAMPANA","2238;2132;332;157;105;93;80;80;75;75;75;58;52;46;38;36;32;32;31;30","RODOLFO CITRO;VINCENZO BELLIZZI;MARCELLO PERSICO;EDUARDO BOSSONE;CESARE BALDI;D BONADIES;FEDERICO PISCIONE;GENNARO GALASSO;ANTONIO CANERO;ANGELO SILVERIO;FABRIZIO ESPOSITO;FRANCESCO DI SALLE;GAETANO GARGIULO;CAROLINA CIACCI;AMELIA RAVERA;CARMELA RESCIGNO;GIUSEPPE PALLADINO;MICHELE BELLINO;MICHELE ROBERTO DI MURO;NICOLA MAFFULLI","18;9;6;5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;MATHEMATICS;CHEMISTRY;ECONOMICS;ENGINEERING;PSYCHOLOGY;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;GEOGRAPHY;HISTORY;MATERIALS SCIENCE","95;11;10;10;5;5;5;5;4;3;3;2;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;INTENSIVE CARE MEDICINE;SURGERY;RADIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;GENETICS;PATHOLOGY;ENDOCRINOLOGY;PSYCHIATRY;IMMUNOLOGY;MECHANICAL ENGINEERING;PHYSICAL THERAPY;ARTIFICIAL INTELLIGENCE;COMPUTER NETWORK;NURSING;ANESTHESIA;BIOCHEMISTRY;ECONOMIC GROWTH;GENERAL SURGERY;GEOMETRY;GYNECOLOGY;LAW;MEDICAL PHYSICS;NEUROSCIENCE;OPERATING SYSTEM;PEDIATRICS;STATISTICS","76;34;17;16;12;11;10;8;8;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","HEART FAILURE;DISEASE;KIDNEY DISEASE;MYOCARDIAL INFARCTION;POPULATION;DIALYSIS;NEPHROLOGY;HEPATITIS C;CANCER;COHORT;CONFIDENCE INTERVAL;EPIDEMIOLOGY;TRANSPLANTATION;AORTIC VALVE;ATRIAL FIBRILLATION;BLOOD PRESSURE;VIRUS;CIRRHOSIS;CORONARY ARTERY DISEASE;GENE;KIDNEY;LIVER DISEASE;MITRAL REGURGITATION;OBSERVATIONAL STUDY;RENAL REPLACEMENT THERAPY;STENOSIS;STROKE (ENGINE)","18;16;11;10;10;9;9;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4","EJECTION FRACTION;ACUTE CORONARY SYNDROME;DIASTOLE;HEPATITIS C VIRUS;PERCUTANEOUS CORONARY INTERVENTION;CARDIOMYOPATHY;CHRONIC LIVER DISEASE;HAZARD RATIO;LIVER TRANSPLANTATION;MITRACLIP;AORTIC VALVE STENOSIS;BICUSPID AORTIC VALVE;BREAST CANCER;CLINICAL ENDPOINT;AORTIC VALVE REPLACEMENT;CHRONIC KIDNEY FAILURE;CLOPIDOGREL;COLORECTAL CANCER;CONVENTIONAL PCI;CUMULATIVE INCIDENCE;DEFERASIROX;END STAGE RENAL DISEASE;FABRY DISEASE;GESTATION;INTRACEREBRAL HEMORRHAGE;MUTATION;PERFORATION;PROTEINURIA;REVASCULARIZATION;THYROID CANCER;WARFARIN","11;6;5;5;5;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FUNCTIONAL MITRAL REGURGITATION;HEPACIVIRUS;RIBAVIRIN;TAKOTSUBO SYNDROME;AORTIC VALVULOPLASTY;ALPHA-GALACTOSIDASE;ANAPLASTIC THYROID CANCER;ANIMAL-ASSISTED THERAPY;ANTEROLATERAL LIGAMENT;ANTIRETROVIRAL THERAPY;BAG3;CAPECITABINE;CHA2DS2–VASC SCORE;CLASSIFICATION OF OBESITY;DIASTOLIC HEART FAILURE;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;ENDOCRINE DISRUPTOR;GENE MUTATION;GERMLINE MUTATION;HEART FAILURE WITH PRESERVED EJECTION FRACTION;HISTOCOMPATIBILITY;HISTOCOMPATIBILITY TESTING;INTERSTITIAL PREGNANCY;IRINOTECAN;MACE;METASTATIC BREAST CANCER;MYELOPROLIFERATIVE NEOPLASM;PITTSBURGH SLEEP QUALITY INDEX;PLACENTA;POINT MUTATION;PRASUGREL;PROBAND;PROSTATITIS;RUXOLITINIB;SPECKLE TRACKING ECHOCARDIOGRAPHY;SPONTANEOUS INTRACEREBRAL HEMORRHAGE;STABLE ISOTOPE LABELING BY AMINO ACIDS IN CELL CULTURE;TICAGRELOR;TRASTUZUMAB;UTERINE ARTERY;VILLOUS ATROPHY","3;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;;FEMALE;RENAL INSUFFICIENCY, CHRONIC;AGED;MIDDLE AGED;RISK FACTORS;ANTIVIRAL AGENTS;HEPACIVIRUS;ACUTE CORONARY SYNDROME;AGED, 80 AND OVER;ADULT;ITALY;TREATMENT OUTCOME;HEPATITIS C;HEART FAILURE;PROSPECTIVE STUDIES;TAKOTSUBO CARDIOMYOPATHY;HEPATITIS C, CHRONIC","58;41;40;39;29;28;25;18;17;17;16;16;15;14;14;12;11;11;11;10","MANAGEMENT OF VALVULAR HEART DISEASE;HEPATITIS C INFECTION AND TREATMENT;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;EFFECTS OF KETOGENIC DIET ON HEALTH;ACCURACY OF CLINICAL CODING IN HEALTHCARE DATA;ATRIAL FIBRILLATION;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;MANAGEMENT OF INGESTED FOREIGN BODIES AND FOOD IMPACTIONS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ROLE OF LUNG ULTRASOUND IN CRITICAL CARE;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ANORECTAL SURGICAL PROCEDURES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES","10;8;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","NEPHROLOGY;HEPATITIS C;CARDIAC IMAGING;PROSTHETIC VALVES EVALUATION;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CHRONIC LIVER DISEASE;HEPATITIS C VIRUS;LIVER DISEASE;MITRACLIP;MITRAL REGURGITATION;RENAL REPLACEMENT THERAPY;TAKOTSUBO SYNDROME;BICUSPID AORTIC VALVE;CARDIOVASCULAR RISK ASSESSMENT;CHRONIC RENAL FAILURE;CLINICAL ENDPOINT;DISCONTINUATION;ECHOCARDIOGRAPHY;ESOPHAGEAL FOREIGN BODIES;FUNCTIONAL MITRAL REGURGITATION","9;7;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","ITALIAN SOCIETY;KIDNEY DISEASE;CHRONIC KIDNEY;HEART FAILURE;AORTIC VALVE;ACUTE CORONARY;AISF ITALIAN;DISEASE POSITION;DISEASE SIMIT;INTERNAL MEDICINE;ITALIAN ASSOCIATION;JOINT COMMITTEE;LIVER AISF;MEDICINE SIMI;NEPHROLOGY SIN;POSITION STATEMENT;SIMI ITALIAN;TAKOTSUBO SYNDROME;TROPICAL DISEASE;VIRUS INFECTION;BICUSPID AORTIC;BREAST CANCER;CORONARY SYNDROME;DISEASE PATIENTS;ELDERLY PATIENTS;FAILURE PATIENTS;FUNCTIONAL MITRAL;MITRAL REGURGITATION;MULTICENTER STUDY;PRELIMINARY RESULTS","13;11;10;7;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","FOREIGN BODIES;ADVISORY COMMITTEES;ENTITYS BOARD;AORTIC VALVE;CONFIDENCE INTERVAL;HCV INFECTION;KIDNEY DISEASE;ACS PATIENTS;ACUTE CORONARY;CHRONIC KIDNEY;FOREIGN BODY;HONORARIA MEMBERSHIP;HR CI;INFLAMMATORY BOWEL;RC TEARS;SERUM Β-HCG;BAV PATIENTS;BOWEL DISEASE;BREAST CANCER;CALCIUM SCORE;CKD PATIENTS;CLINICAL PRACTICE;DISEASE PATIENTS;HAZARD RATIO;HEART FAILURE;IRON OVERLOAD;LA STIFFNESS;MEDIAN FOLLOW-UP;REFERENCE STANDARD;SPLEEN LENGTH","10;9;9;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5",45,0.45,2.35,106.05,7.8,633.230000000002,137,3,786,3.2,1,7,1.75,1,4,0,0,0,4.5,1,20,0,0,0,0,0,0,1,1,1,168,4,1006,0,0,0,1,1,1,130.67,1,743,0,0,0,6,1,11,10.67,1,27,27.22,1,112,99.27,1,525,20.62,1,77,0,0,0,0,0,0,155.25,20,691,155.25,20,691,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2019,114,17.4298245614035,2.19298245614035,0.456,0.192982456140351,0.228070175438596,0.219298245614035,0.517543859649123,0,51,16,28,7,0.45,0.14,0.25,0.06,18.1,0.74419439614576,0.368421052631579,0.956140350877193,4.86685552407932,0.461908551509551,0.502083333333333,0.501960784313725,0.528769841269841,"RODOLFO CITRO;EDUARDO BOSSONE;NICOLA MAFFULLI;FABRIZIO ESPOSITO;SARA PONTICORVO;RENZO MANARA;ENRICO COSCIONI;ANDREA G. RUSSO;CARLO DI MARIO;GENNARO GALASSO;PHILIP MACCARTHY;ANGELA CIANCIO;CHRISTIAN TEMPLIN;L. CHRISTIAN NAPP;FEDERICO PISCIONE;WOLFGANG DICHTL;GERD HASENFUß;PAOLO BARONE;HERIBERT SCHUNKERT;ANDREA ELEFANTE","21;12;10;9;8;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5","NICOLA MAFFULLI;RODOLFO CITRO;LUIGI SCHIAVO;FRANCESCO OLIVA;VINCENZO PILONE;ANTONIO FRIZZIERO;ANTONIO IANNELLI;FABRIZIO ESPOSITO;EDUARDO BOSSONE;SARA PONTICORVO;GENNARO GALASSO;GIUSEPPE IULIANO;SEVERINO IESU;FEDERICO PISCIONE;MICHELE BELLINO;RICCARDO SAVASTANO;ANDREA G. RUSSO;RENATO SAPONIERO;PAOLO BARONE;ANTONIO D′ANTONIO","2.06;1.77;1.18;1;0.89;0.71;0.68;0.65;0.59;0.54;0.54;0.52;0.5;0.48;0.48;0.46;0.45;0.44;0.43;0.42","RODOLFO CITRO;EDUARDO BOSSONE;NICOLA MAFFULLI;FABRIZIO ESPOSITO;ENRICO COSCIONI;GENNARO GALASSO;FEDERICO PISCIONE;MICHELE MANZO;CARMINE SELLERI;DAVIDE DI VECE;FRANCESCO OLIVA;RENATO SAPONIERO;MARIA TERESA PELLECCHIA;LUIGI SCHIAVO;ELISA DE MICHELE;RICCARDO SAVASTANO;MICHELE BELLINO;ANGELO SILVERIO;FRANCESCO DI SALLE;GIULIA FRAUENFELDER","21;12;10;9;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4","NICOLA MAFFULLI;RODOLFO CITRO;LUIGI SCHIAVO;FRANCESCO OLIVA;VINCENZO PILONE;FABRIZIO ESPOSITO;EDUARDO BOSSONE;GENNARO GALASSO;GIUSEPPE IULIANO;SEVERINO IESU;FEDERICO PISCIONE;MICHELE BELLINO;RICCARDO SAVASTANO;RENATO SAPONIERO;ANTONIO D′ANTONIO;MARIA TERESA PELLECCHIA;CARMINE SELLERI;MARIATERESA VITIELLO;FRANCESCO DI SALLE;GIULIA FRAUENFELDER","2.06;1.77;1.18;1;0.89;0.65;0.59;0.54;0.52;0.5;0.48;0.48;0.46;0.44;0.42;0.42;0.41;0.4;0.39;0.38","RODOLFO CITRO;EDUARDO BOSSONE;DAVIDE DI VECE;CARLO DI MARIO;ABHIRAM PRASAD;ADRIAN BANNING;ALESSANDRO CUNEO;ALEXANDRA SHILOVA;ANNAHITA SARCON;BURKERT PIESKE;CARSTEN TSCHÖPE;CHRISTIAN TEMPLIN;CHRISTIAN UKENA;CHRISTOF BURGDORF;CHRISTOPH KAISER;CLAUDIUS JACOBSHAGEN;CLÉMENT DELMAS;DAVID E. WINCHESTER;EKATERINA GILYAROVA;FABRIZIO D’ASCENZO","605;484;310;299;273;273;273;273;273;273;273;273;273;273;273;273;273;273;273;273","RODOLFO CITRO;EDUARDO BOSSONE;NICOLA MAFFULLI;GIAMPIERO VOLPE;ENRICO COSCIONI;FABRIZIO ESPOSITO;LUIGI SCHIAVO;GENNARO GALASSO;MICHELE BELLINO;SERENA LEMBO;FEDERICO PISCIONE;ANGELO SILVERIO;FRANCESCO DI SALLE;GENNARO PROVENZA;COSTANTINA PROTA;DAVIDE DI VECE;ILARIA RADANO;ELISA DE MICHELE;RICCARDO SAVASTANO;F WEIDINGER","605;210;158;153;128;114;108;98;82;80;76;72;70;69;68;68;68;66;66;64","RODOLFO CITRO;NICOLA MAFFULLI;ENRICO COSCIONI;ELISA DE MICHELE;FABRIZIO ESPOSITO;LUIGI SCHIAVO;MICHELE MANZO;RENATO SAPONIERO;EDUARDO BOSSONE;CARMINE SELLERI;GENNARO GALASSO;MARIATERESA VITIELLO;MICHELE BELLINO;RICCARDO SAVASTANO;FRANCESCO DI SALLE;GIAMPIERO VOLPE;SALVATORE TARTAGLIONE;ANGELO SILVERIO;ANTONIO D′ANTONIO;DANIELE GIUSEPPE ROMANO","21;8;6;5;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;PSYCHOLOGY;BUSINESS;ECONOMICS;MATHEMATICS;CHEMISTRY;GEOGRAPHY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;GEOLOGY;MATERIALS SCIENCE","108;19;11;9;8;7;5;5;5;4;4;4;2;2;1;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;RADIOLOGY;PATHOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;INTENSIVE CARE MEDICINE;PSYCHIATRY;MECHANICAL ENGINEERING;ENDOCRINOLOGY;GERONTOLOGY;PALEONTOLOGY;PHYSICAL THERAPY;ANATOMY;BIOCHEMISTRY;ECOLOGY;LINGUISTICS;NEUROSCIENCE;PHYSICAL MEDICINE AND REHABILITATION","80;40;30;19;18;10;8;7;7;7;7;7;6;5;5;5;5;4;4;4;4;4;4","HEART FAILURE;DISEASE;CONFIDENCE INTERVAL;COHORT;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;GENE;ATRIAL FIBRILLATION;POPULATION;ASYMPTOMATIC;CLINICAL TRIAL;BLOOD PRESSURE;CANCER;INTERQUARTILE RANGE;PROSPECTIVE COHORT STUDY;RETROSPECTIVE COHORT STUDY;STROKE (ENGINE);ADVERSE EFFECT;ALTERNATIVE MEDICINE;BONE MARROW;COGNITION;COHORT STUDY;CORONARY ARTERY DISEASE;OBESITY;OBSERVATIONAL STUDY;ODDS RATIO;PROPORTIONAL HAZARDS MODEL;STENOSIS;TENDON","22;15;12;11;10;9;8;7;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","EJECTION FRACTION;CLINICAL ENDPOINT;HAZARD RATIO;CARDIOMYOPATHY;DIASTOLE;MYELOFIBROSIS;ACUTE CORONARY SYNDROME;PARKINSON'S DISEASE;PERCUTANEOUS CORONARY INTERVENTION;WEIGHT LOSS;ACTIVE AGEING;ARBOVIRUS;ASCENDING AORTA;BETA THALASSEMIA;BICUSPID AORTIC VALVE;CARDIOGENIC SHOCK;DIFFUSION MRI;EXECUTIVE FUNCTIONS;FLUID-ATTENUATED INVERSION RECOVERY;GENE EXPRESSION;HEALTHY AGEING;HIP FRACTURE;LEFT VENTRICULAR HYPERTROPHY;MAGNETIC RESONANCE ANGIOGRAPHY;MICRONUTRIENT DEFICIENCY;NEUROPSYCHOLOGY;OSTEOARTHRITIS;PARKINSONISM;PERFUSION SCANNING;PROGRESSIVE SUPRANUCLEAR PALSY;RECOMBINANT DNA;TENDINOPATHY;THROMBOLYSIS;WARFARIN;WHITE MATTER","16;7;7;6;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CARDIAC RESYNCHRONIZATION THERAPY;TAKOTSUBO SYNDROME;DOPPLER ECHOCARDIOGRAPHY;RUXOLITINIB;FRACTIONAL ANISOTROPY;GASTRIC BYPASS;MACE;VECTOR (MOLECULAR BIOLOGY);ACHILLES TENDON RUPTURE;ANAGRELIDE;ANTERIOR CEREBRAL ARTERY;AORTIC VALVULOPLASTY;BETA ADRENERGIC RECEPTOR KINASE;CERVICAL INTRAEPITHELIAL NEOPLASIA;COGNITIVE DECLINE;CONCENTRIC HYPERTROPHY;DIABETIC CARDIOMYOPATHY;DIASTOLIC HEART FAILURE;DNA METHYLATION;DOPPLER IMAGING;GLOBUS PALLIDUS;INSULIN RECEPTOR;INTRAVENTRICULAR HEMORRHAGE;ISCHEMIC CARDIOMYOPATHY;MASTECTOMY;MICROSATELLITE;MODIFIED RANKIN SCALE;MORBIDLY OBESE;PATELLAR LIGAMENT;PHARMACOGENETICS;POSTURAL INSTABILITY;PROBAND;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;PULSELESS ELECTRICAL ACTIVITY;RIGHT CORONARY ARTERY;RIVAROXABAN;SEROPREVALENCE;SPECKLE TRACKING ECHOCARDIOGRAPHY;SUBSTANTIA NIGRA;TRANSCRIPTOME;TRANSPOSABLE ELEMENT","6;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;HEART FAILURE;ADULT;ITALY;TAKOTSUBO CARDIOMYOPATHY;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;PROSPECTIVE STUDIES;MAGNETIC RESONANCE IMAGING;TREATMENT OUTCOME;YOUNG ADULT;ATRIAL FIBRILLATION;BETA-THALASSEMIA;RISK FACTORS;ADOLESCENT","61;53;51;50;40;39;26;25;22;22;16;16;14;13;13;13;10;10;10;9","PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GLOBAL IMPACT OF ARBOVIRAL DISEASES;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT AND EPIDEMIOLOGY OF INFECTIVE ENDOCARDITIS;MANAGEMENT OF VALVULAR HEART DISEASE;SALIVARY GLAND TUMORS AND CARCINOMAS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH","9;6;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1","TAKOTSUBO SYNDROME;CLINICAL ENDPOINT;CARDIAC RESYNCHRONIZATION THERAPY;ECHOCARDIOGRAPHY;INTERQUARTILE RANGE;STROKE (ENGINE);CARDIOVASCULAR RISK ASSESSMENT;RUXOLITINIB THERAPY;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CARDIAC IMAGING;DEPRESSION (ECONOMICS);INFARCTION TREATMENT;LEFT VENTRICULAR FUNCTION;MYELOFIBROSIS;NUTRITIONAL STATUS;RUXOLITINIB;SUDDEN HEARING LOSS;TREATMENT;ACTIVE AGEING;AORTIC DISSECTION","9;7;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2","TAKOTSUBO SYNDROME;HEART FAILURE;AORTIC VALVE;BARIATRIC SURGERY;CARDIAC RESYNCHRONIZATION;ELDERLY PATIENTS;HYALURONIC ACID;MICRONUTRIENT DEFICIENCIES;MORBIDLY OBESE;SYNDROME RESULTS;ADULT PATIENTS;AGE IPSYS;CELIAC DISEASE;CEREBROVASCULAR INVOLVEMENT;COLORECTAL CANCER;COMPARATIVE STUDY;CONTROLLED TRIAL;DECODE REGISTRY;EJECTION FRACTION;HEALTHY AGEING;HEARING LOSS;INCREASED CEREBROVASCULAR;INCREASED RISK;INFECTIVE ENDOCARDITIS;INTERNATIONAL TAKOTSUBO;INTERTAK REGISTRY;ISCHEMIC STROKE;ITALIAN MULTICENTER;ITALIAN PROJECT;ITALIAN ROMEI","9;5;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ADVISORY COMMITTEES;ENTITYS BOARD;SPEAKERS BUREAU;TTS PATIENTS;COMMITTEES SPEAKERS;TAKOTSUBO SYNDROME;EJECTION FRACTION;LEFT VENTRICULAR;CONSULTANCY MEMBERSHIP;CONSULTANCY SPEAKERS;CONSULTANCY HONORARIA;HONORARIA MEMBERSHIP;IPSS RISK;MIN MAX;ADHERENCE CLASSES;HAZARD RATIO;HEART FAILURE;INT- RISK;LONG-TERM FOLLOW-UP;NOVARTIS CONSULTANCY;TOTAL SCORE;VENTRICULAR EJECTION;ADVERSE EVENTS;ALL-CAUSE MORTALITY;BAG EXPRESSION;CLINICAL TRIAL;CONFIDENCE INTERVAL;HR CI;MAGNETIC RESONANCE;SPLEEN LENGTH","44;44;28;16;14;14;13;13;11;11;10;9;9;9;8;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7",46,0.4,1.675,53.38,7,454.43,37.29,1,160,2.5,2,4,1,1,1,0,0,0,6,1,50,0,0,0,0,0,0,1,1,1,41.86,1,178,2,2,2,0,0,0,40.55,3,115,0,0,0,0,0,0,2.78,1,7,6.75,1,19,27.18,1,83,6.7,1,19,0,0,0,0,0,0,47.86,6,148,47.86,6,148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2020,172,15.7616279069767,2.51744186046512,0.397228637413395,0.267441860465116,0.331395348837209,0.244186046511628,0.645348837209302,1,60,33,21,14,0.35,0.19,0.12,0.08,16.38,0.650184640585261,0.273255813953488,0.941860465116279,5.79510022271715,0.530339284683727,0.406837606837607,0.452041963282128,0.43134138588684,"RODOLFO CITRO;ANGELO SILVERIO;GENNARO GALASSO;NICOLA MAFFULLI;MARCO CODA;ALESSANDRO CAPUTO;CARMINE VECCHIONE;LUIGI PIATTI;PAOLO BARONE;GIOVANNI TORTORELLA;CESARE BALDI;EUGENIO PICAÑO;STEFANO DE SERVI;STEFANO SAVONITTO;TIZIANA ATTISANO;COSTANTINA PROTA;ANTONIO D′ANTONIO;DANIELE GROSSETO;PIO ZEPPA;NUCCIA MORICI","23;13;13;11;10;8;8;7;7;7;7;7;7;7;7;7;7;7;7;7","MARCO CODA;RAFFAELLA TRONCONE;CAROLINA CIACCI;NICOLA MAFFULLI;RODOLFO CITRO;ALESSANDRO CAPUTO;ANTONIO D′ANTONIO;ANGELO SILVERIO;PIO ZEPPA;GENNARO GALASSO;MATTIA CARBONE;DANIELE ALIBERTI;VALERIO CICCONE;CARMINE VECCHIONE;MARIA VINCENZA POLITO;ANTONIO ROMANELLI;VALENTINA GIUDICE;SEVERINO IESU;CARMINE SELLERI;PAOLO MASIELLO","3.25;2.4;1.94;1.73;1.44;1.4;1.2;1.17;1.12;1.04;0.97;0.8;0.8;0.78;0.72;0.7;0.68;0.65;0.64;0.64","RODOLFO CITRO;ANGELO SILVERIO;GENNARO GALASSO;NICOLA MAFFULLI;MARCO CODA;ALESSANDRO CAPUTO;CARMINE VECCHIONE;PAOLO BARONE;CESARE BALDI;TIZIANA ATTISANO;COSTANTINA PROTA;ANTONIO D′ANTONIO;PIO ZEPPA;MICHELE CICCARELLI;CARMINE SELLERI;MICHELE BELLINO;EDUARDO BOSSONE;CAROLINA CIACCI;MATTIA CARBONE;ROBERTA DE ROSA","23;13;13;11;10;8;8;7;7;7;7;7;7;6;6;6;6;6;6;5","MARCO CODA;CAROLINA CIACCI;NICOLA MAFFULLI;RODOLFO CITRO;ALESSANDRO CAPUTO;ANTONIO D′ANTONIO;ANGELO SILVERIO;PIO ZEPPA;GENNARO GALASSO;MATTIA CARBONE;DANIELE ALIBERTI;VALERIO CICCONE;CARMINE VECCHIONE;MARIA VINCENZA POLITO;ANTONIO ROMANELLI;VALENTINA GIUDICE;SEVERINO IESU;CARMINE SELLERI;PAOLO MASIELLO;TIZIANA ATTISANO","3.25;1.94;1.73;1.44;1.4;1.2;1.17;1.12;1.04;0.97;0.8;0.8;0.78;0.72;0.7;0.68;0.65;0.64;0.64;0.64","CARMINE SELLERI;ATTILIO OLIVIERI;FABRIZIO PANE;FELICETTO FERRARA;MARCO LADETTO;MASSIMO GENTILE;PAOLO CORRADINI;ADRIANO VENDITTI;AGOSTINO TAFURI;ALESSANDRA ROMANO;ALESSANDRO BUSCA;ALESSANDRO CORSO;ALESSANDRO MOROTTI;ALFREDO MOLTENI;ANNA CANDONI;ANNA MARIA SCATTOLIN;ANNARITA CONCONI;ANNAROSA CUCCARO;ANTONIO CUNEO;ANTONIO PINTO","643;522;522;522;522;522;522;510;510;510;510;510;510;510;510;510;510;510;510;510","CARMINE SELLERI;RODOLFO CITRO;ANGELO SILVERIO;NICOLA MAFFULLI;ANNA BORRELLI;AMELIA FILIPPELLI;VALENTINA GIUDICE;BIANCA SERIO;BIANCA CUFFA;ALESSANDRO VATRELLA;ALFONSO MASULLO;ANGELANTONIO MAGLIO;BENEDETTO POLVERINO;CARMINE SELLITTO;CAROLINA VITALE;PASQUALE PAGLIANO;RENATO GAMMALDI;S POTO;GENNARO GALASSO;TIZIANA ATTISANO","642;306;216;178;143;125;121;120;116;115;115;115;115;115;115;115;115;115;107;88","RODOLFO CITRO;ANGELO SILVERIO;GENNARO GALASSO;NICOLA MAFFULLI;MARCO CODA;ANTONIO D′ANTONIO;PIO ZEPPA;MATTIA CARBONE;TIZIANA ATTISANO;CESARE BALDI;CARMINE SELLERI;MICHELE BELLINO;MICHELE MANZO;VALENTINA GIUDICE;CAROLINA CIACCI;ENRICO COSCIONI;ALESSANDRO CAPUTO;AMELIA RAVERA;CARMINE VECCHIONE;DANIELE GIUSEPPE ROMANO","23;12;12;11;10;7;7;7;7;7;6;6;5;5;5;5;4;4;4;4","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;ENGINEERING;ECONOMICS;CHEMISTRY;PHYSICS;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;SOCIOLOGY;MATHEMATICS;ENVIRONMENTAL SCIENCE","163;30;18;16;11;10;9;9;8;6;5;5;5;4;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;PATHOLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;GENETICS;INTENSIVE CARE MEDICINE;IMMUNOLOGY;VIROLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PSYCHIATRY;CANCER RESEARCH;GASTROENTEROLOGY;MECHANICAL ENGINEERING;NEUROSCIENCE;ONCOLOGY;ARTIFICIAL INTELLIGENCE;EMERGENCY MEDICINE;FAMILY MEDICINE;LAW;NURSING;PEDIATRICS;PHYSICAL THERAPY","129;55;39;31;28;17;15;14;13;12;11;11;10;9;8;8;8;8;7;7;7;7;7;7;7","DISEASE;MYOCARDIAL INFARCTION;HEART FAILURE;POPULATION;OUTBREAK;GENE;CANCER;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;BIOPSY;BLOOD PRESSURE;COHORT;DIABETES MELLITUS;RETROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;STENOSIS;AORTIC VALVE;ASYMPTOMATIC;HEALTH CARE;HEMODYNAMICS;RENAL FUNCTION;STROKE (ENGINE)","47;26;23;17;15;12;11;11;10;9;8;8;8;8;7;7;6;6;6;6;6;6","INFECTIOUS DISEASE (MEDICAL SPECIALTY);EJECTION FRACTION;2019-20 CORONAVIRUS OUTBREAK;PERCUTANEOUS CORONARY INTERVENTION;ACUTE CORONARY SYNDROME;HAZARD RATIO;CARDIOGENIC SHOCK;CONVENTIONAL PCI;PARKINSON'S DISEASE;STRESS ECHOCARDIOGRAPHY;CLINICAL ENDPOINT;DOBUTAMINE;GENOTYPE;MUTATION;AORTIC VALVE REPLACEMENT;ARDS;COLORECTAL CANCER;PHENOTYPE;PROSTATE;PROSTATE CANCER;REVASCULARIZATION","26;17;12;10;9;7;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);CARDIAC RESYNCHRONIZATION THERAPY;IMPELLA;COLONOSCOPY;FLUDARABINE;MISSENSE MUTATION;POLY ADP RIBOSE POLYMERASE;PROSTATE BIOPSY;SACUBITRIL;SACUBITRIL, VALSARTAN;SINGLE-NUCLEOTIDE POLYMORPHISM;STROKE VOLUME;5-HYDROXYINDOLEACETIC ACID;ACHILLES TENDON RUPTURE;ANTI-NUCLEAR ANTIBODY;ANTIBACTERIAL PEPTIDE;AORTIC VALVULOPLASTY;APNEA–HYPOPNEA INDEX;AXITINIB;BATTERY CAPACITY;BIVALIRUDIN;BUSULFAN;CARFILZOMIB;CEFTAZIDIME;CHEMILUMINESCENT IMMUNOASSAY;COGNITIVE DECLINE;COMPLEMENTATION;CORONARY ARTERY ECTASIA;DASATINIB;DNA METHYLATION;DYSKINESIA;ECULIZUMAB;ELEPHANT TRUNKS;ENDOLYMPHATIC HYDROPS;EXECUTIVE DYSFUNCTION;EXTRAMEDULLARY PLASMACYTOMA;GASTRIC BYPASS;GENOTYPING;GERMLINE MUTATION;HYPOPNEA;IDARUBICIN;IIF;IRREVERSIBLE ELECTROPORATION;ISOVOLUMETRIC CONTRACTION;KILLIP CLASS;KLEBSIELLA PNEUMONIAE;LOW CALORIE DIET;METASTATIC BREAST CANCER;MICROVESICLES;MODIFIED RANKIN SCALE;NEUROTENSIN;OVARIAN TUMOR;P2Y12;PENETRANCE;PHILADELPHIA CHROMOSOME;PLASMACYTOID DENDRITIC CELL;POLYMORPHISM (COMPUTER SCIENCE);PRASUGREL;PRAZIQUANTEL;PROBAND;QUANTITATIVE COMPUTED TOMOGRAPHY;RUXOLITINIB;SCHISTOSOMA HAEMATOBIUM;SPECKLE TRACKING ECHOCARDIOGRAPHY;SYSTOLE;TAKOTSUBO SYNDROME;TAXANE;TIMI;TOTAL BODY IRRADIATION;TRASTUZUMAB;VANCOMYCIN;VERY LOW CALORIE DIET;VILLOUS ATROPHY;WOMAC","26;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;MALE;FEMALE;ITALY;AGED;MIDDLE AGED;COVID-19;TREATMENT OUTCOME;AGED, 80 AND OVER;ADULT;RETROSPECTIVE STUDIES;ACUTE CORONARY SYNDROME;TAKOTSUBO CARDIOMYOPATHY;PERCUTANEOUS CORONARY INTERVENTION;PROSPECTIVE STUDIES;RENAL INSUFFICIENCY, CHRONIC;RISK FACTORS;CORONAVIRUS INFECTIONS;HEART FAILURE","109;62;40;38;31;30;29;23;17;16;15;15;13;12;10;10;9;9;8;8","MANAGEMENT OF VALVULAR HEART DISEASE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF HEART FAILURE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;PROSTATE CANCER RESEARCH AND TREATMENT;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EMERGENCY DEPARTMENT CROWDING","9;8;8;6;5;5;5;5;5;3;3;3;3;3;2;2;2;2;2;2","2019-20 CORONAVIRUS OUTBREAK;CARDIOVASCULAR RISK ASSESSMENT;ECHOCARDIOGRAPHY;PANDEMIC;CARDIAC IMAGING;TAKOTSUBO SYNDROME;LEFT VENTRICULAR FUNCTION;STROKE (ENGINE);TRANSCATHETER AORTIC-VALVE REPLACEMENT;CELIAC DISEASE;STRESS ECHOCARDIOGRAPHY;ANTIVIRAL TREATMENT;AORTIC ROOT REPLACEMENT;CLINICAL ENDPOINT;DIPYRIDAMOLE;DOBUTAMINE;PROSTHETIC VALVES EVALUATION;SURGICAL AORTIC-VALVE REPLACEMENT;TREATMENT;BLEEDING RISK","12;8;8;8;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;3","TAKOTSUBO SYNDROME;ACUTE CORONARY;AORTIC VALVE;CORONARY SYNDROME;ELDERLY PATIENTS;LEFT VENTRICULAR;STRESS ECHOCARDIOGRAPHY;CELIAC DISEASE;HEART FAILURE;CORONARY ARTERY;CORONARY SYNDROMES;COVID- PANDEMIC;HEALTHCARE COMPANIES;OBSERVATIONAL STUDY;ATRIAL VOLUME;CHRONIC KIDNEY;CLINICAL OUTCOME;CONSENSUS DOCUMENT;CORONARY INTERVENTION;KIDNEY DISEASE;LEFT ATRIAL;MAGNETIC RESONANCE;MULTICENTER OBSERVATIONAL;MULTIMODALITY IMAGING;MULTIPLE SYSTEM;PARKINSONS DISEASE;PERCUTANEOUS CORONARY;RISK FACTORS;SYSTEM ATROPHY;ACHILLES TENDON","9;8;6;6;6;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","AORTIC VALVE;LEFT VENTRICULAR;HR CI;TTS PATIENTS;COVID- PANDEMIC;MYOCARDIAL INFARCTION;EJECTION FRACTION;HEART FAILURE;RENAL FUNCTION;CORONAVIRUS DISEASE;DISEASE COVID-;IN-HOSPITAL MORTALITY;ACUTE CORONARY;CARDIAC DEATH;CARDIOGENIC SHOCK;CELIAC DISEASE;CORONARY ARTERY;PATIENTS TREATED;REGRESSION ANALYSIS;TAKOTSUBO SYNDROME;ACKNOWLEDGEMENT TYPE;ADVERSE EVENTS;ALL-CAUSE DEATH;ENDOLEAK TYPE;FUNDING ACKNOWLEDGEMENT;FUNDING SOURCE;HF REHOSPITALIZATION;PATIENTS UNDERWENT;CORONARY INTERVENTION;CORONARY SYNDROME","18;16;15;15;14;13;12;12;12;10;10;10;9;9;9;9;9;9;9;9;8;8;8;8;8;8;8;8;7;7",69,0.4,1.5,30.42,7,130.73,34.89,1,153,1.8,1,3,1.4,1,2,0,0,0,1.91,1,6,0,0,0,0,0,0,1,1,1,43.21,1,184,0,0,0,0,0,0,41.47,1,152,1,1,1,1,1,1,4.75,1,10,5.67,1,21,28.73,1,105,7,1,25,0,0,0,0,0,0,89.95,10,413,89.89,10,413,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2021,252,16.484126984127,2.80952380952381,0.35593220338983,0.253968253968254,0.297619047619048,0.333333333333333,0.650793650793651,0,82,42,32,45,0.33,0.17,0.13,0.18,11.02,0.714870358002137,0.273809523809524,0.932539682539683,5.9263698630137,0.519899489698791,0.416512059369202,0.509090909090909,0.487477338346874,"ANNA BORRELLI;RODOLFO CITRO;CARMINE VECCHIONE;GENNARO GALASSO;ARIANNA SCALA;EDUARDO BOSSONE;MARIA TRIASSI;TERESA ANGELA TRUNFIO;CARMINE SELLERI;ANGELO SILVERIO;MICHELE CICCARELLI;CRISTIANA GIGLIO;MICHELE BELLINO;GUIDO PARODI;DANIELE GIUSEPPE ROMANO;ILARIA LOPERTO;ENRICO COSCIONI;ANTONELLO D’ANDREA;VINCENZO RUSSO;CESARE BALDI","41;38;18;17;16;15;15;13;13;13;12;12;11;11;11;10;10;10;9;9","ANNA BORRELLI;MARIA TRIASSI;ARIANNA SCALA;RODOLFO CITRO;TERESA ANGELA TRUNFIO;DANIELE GIUSEPPE ROMANO;CRISTIANA GIGLIO;ILARIA LOPERTO;NICOLA MAFFULLI;GIUSEPPE FERRUCCI;CARMINE VECCHIONE;CLAUDIO ZULLI;ALESSANDRO CAPUTO;GENNARO GALASSO;GIOVANNI IMPROTA;ANTONIO D′ANTONIO;M. SICA;ATTILIO MAURANO;ENRICO COSCIONI;PAOLO GARGIULO","6.25;2.61;2.52;2.29;2.17;1.93;1.77;1.7;1.62;1.43;1.39;1.29;1.28;1.22;1.21;1.16;1.15;1.15;1.11;1.11","ANNA BORRELLI;RODOLFO CITRO;CARMINE VECCHIONE;GENNARO GALASSO;CARMINE SELLERI;ANGELO SILVERIO;MICHELE CICCARELLI;MICHELE BELLINO;DANIELE GIUSEPPE ROMANO;ENRICO COSCIONI;CESARE BALDI;NICOLA MAFFULLI;MARCO DI MAIO;GIUSEPPE FERRUCCI;GIANLUIGI FRANCI;VALENTINA GIUDICE;AMELIA FILIPPELLI;CLAUDIO ZULLI;ANTONIO DELLA VECCHIA;GIOVANNI BOCCIA","41;38;18;17;13;13;12;11;11;10;9;9;9;9;8;8;8;7;7;7","ANNA BORRELLI;RODOLFO CITRO;DANIELE GIUSEPPE ROMANO;NICOLA MAFFULLI;GIUSEPPE FERRUCCI;CARMINE VECCHIONE;CLAUDIO ZULLI;ALESSANDRO CAPUTO;GENNARO GALASSO;ANTONIO D′ANTONIO;M. SICA;ATTILIO MAURANO;ENRICO COSCIONI;ANDREA LOMBARDI;ANGELO SILVERIO;CARMINE SELLERI;FRANCESCO DIANA;ANTONIO DELLA VECCHIA;VALENTINA GIUDICE;CESARE BALDI","6.25;2.29;1.93;1.62;1.43;1.39;1.29;1.28;1.22;1.16;1.15;1.15;1.11;1.04;1.03;0.97;0.96;0.95;0.89;0.84","RODOLFO CITRO;ANNA BORRELLI;EDUARDO BOSSONE;GIANLUIGI FRANCI;FRANCESCO VALITUTTI;MICHELE CICCARELLI;GUIDO PARODI;PASQUALE PAGLIANO;CARMINE VECCHIONE;MARIA TRIASSI;CARMINE SELLERI;ARIANNA SCALA;ANTONELLO D’ANDREA;GIOVANNI IMPROTA;GIOVANNI BOCCIA;ALESSANDRO CAPUTO;FRANCESCO SABBATINO;ANTONIO D’ONOFRIO;MASSIMILIANO GALDIERO;JELENA R. GHADRI","467;397;285;237;221;203;202;201;193;179;176;172;171;166;161;157;143;139;139;135","RODOLFO CITRO;ANNA BORRELLI;FRANCESCO VALITUTTI;GIANLUIGI FRANCI;CARMINE SELLERI;FRANCESCO SABBATINO;AMELIA FILIPPELLI;GIOVANNI BOCCIA;PIO ZEPPA;PASQUALE PAGLIANO;ALESSANDRO CAPUTO;ANTONIO DELLA VECCHIA;ENRICO COSCIONI;ALFONSO MASULLO;MARIO CAPUNZO;BASILIO MALAMISURA;STEFANO PEPE;VALENTINA MANZO;VALERIA CONTI;CARMINE SELLITTO","467;397;221;194;176;143;126;124;124;122;110;110;109;106;102;97;96;95;95;91","ANNA BORRELLI;RODOLFO CITRO;CARMINE SELLERI;DANIELE GIUSEPPE ROMANO;ENRICO COSCIONI;GIUSEPPE FERRUCCI;CESARE BALDI;SEVERINO IESU;AMELIA FILIPPELLI;ANTONIO DELLA VECCHIA;GENNARO GALASSO;FRANCESCO DIANA;LUCIA NAZZARO;VALENTINA GIUDICE;ANDREA LOMBARDI;CLAUDIO ZULLI;FRANCESCO VALITUTTI;GIOVANNI ROSSI;NICOLA MAFFULLI;ATTILIO MAURANO","41;38;13;11;10;9;9;7;7;7;7;6;6;6;6;6;6;6;6;5","MEDICINE;BIOLOGY;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;CHEMISTRY;PSYCHOLOGY;SOCIOLOGY;PHYSICS;POLITICAL SCIENCE;PHILOSOPHY;GEOGRAPHY;BUSINESS;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE;HISTORY","246;41;32;28;18;16;14;14;10;9;9;6;4;3;3;3;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;EMERGENCY MEDICINE;ENVIRONMENTAL HEALTH;RADIOLOGY;PATHOLOGY;INTENSIVE CARE MEDICINE;MECHANICAL ENGINEERING;PEDIATRICS;VIROLOGY;PSYCHIATRY;GASTROENTEROLOGY;MEDICAL EMERGENCY;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;ARTIFICIAL INTELLIGENCE;ECONOMIC GROWTH;NURSING;ONCOLOGY;STATISTICS","183;75;66;34;33;31;30;24;23;23;23;21;20;20;19;19;17;14;14;14;14;14","DISEASE;HEART FAILURE;POPULATION;MYOCARDIAL INFARCTION;CANCER;LOGISTIC REGRESSION;OUTBREAK;BLOOD PRESSURE;COHORT;HEALTH CARE;STROKE (ENGINE);CONFIDENCE INTERVAL;GENE;RETROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;EMERGENCY DEPARTMENT;OBSERVATIONAL STUDY;UNIVERSITY HOSPITAL;ANEURYSM;INTENSIVE CARE UNIT;ISCHEMIA;TRANSPLANTATION","71;44;30;25;22;22;21;17;17;17;16;15;15;14;12;11;11;11;9;9;9;9","INFECTIOUS DISEASE (MEDICAL SPECIALTY);EJECTION FRACTION;2019-20 CORONAVIRUS OUTBREAK;CARDIOMYOPATHY;COLORECTAL CANCER;CLINICAL ENDPOINT;MIDDLE CEREBRAL ARTERY;HAZARD RATIO;CARDIOGENIC SHOCK;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;THROMBOLYSIS;ACUTE CORONARY SYNDROME;ARDS;ENDOVASCULAR TREATMENT;ISCHEMIC STROKE;MITRACLIP;BREAST CANCER;DIASTOLE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PARKINSONISM;PROGRESSIVE SUPRANUCLEAR PALSY;STAPHYLOCOCCUS AUREUS;VALSARTAN","43;29;17;9;9;8;8;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);CARDIAC RESYNCHRONIZATION THERAPY;TAKOTSUBO SYNDROME;ANTERIOR CEREBRAL ARTERY;ENTEROCOCCUS FAECALIS;SACUBITRIL;SACUBITRIL, VALSARTAN;BENTALL PROCEDURE;COLONOSCOPY;DOPPLER ECHOCARDIOGRAPHY;FUNCTIONAL MITRAL REGURGITATION;MODIFIED RANKIN SCALE;DMAIC;DNA METHYLATION;ELEPHANT TRUNKS;HERPESVIRIDAE;IMIPENEM;INTRA-AORTIC BALLOON PUMPING;LEAN SIX SIGMA;MAMMOGRAPHY;PD-L1;SPECKLE TRACKING ECHOCARDIOGRAPHY;USTEKINUMAB;VANCOMYCIN","43;7;6;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;MALE;FEMALE;AGED;COVID-19;MIDDLE AGED;ITALY;RETROSPECTIVE STUDIES;TAKOTSUBO CARDIOMYOPATHY;TREATMENT OUTCOME;HEART FAILURE;SARS-COV-2;AGED, 80 AND OVER;STROKE;ADULT;MITRAL VALVE INSUFFICIENCY;SHOCK, CARDIOGENIC;ENDOVASCULAR PROCEDURES;BRAIN ISCHEMIA","154;98;41;40;34;34;27;26;23;19;19;18;18;16;16;15;13;13;12;11","CORONAVIRUS DISEASE 2019;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;MANAGEMENT OF VALVULAR HEART DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EMERGENCY DEPARTMENT CROWDING;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ACUTE MYELOID LEUKEMIA;MECHANICAL CIRCULATORY SUPPORT SYSTEMS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT","16;16;13;8;8;7;6;5;5;5;4;4;4;3;3;3;3;3;3;3","PANDEMIC;STROKE (ENGINE);2019-20 CORONAVIRUS OUTBREAK;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CLINICAL ENDPOINT;ECHOCARDIOGRAPHY;LEFT VENTRICULAR FUNCTION;TAKOTSUBO SYNDROME;MITRAL REGURGITATION;INFARCTION TREATMENT;CLINICAL CHARACTERISTICS;EMERGENCY DEPARTMENT CROWDING;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;INTERQUARTILE RANGE;NEURORADIOLOGY;PROSTHETIC VALVES EVALUATION;RIGHT HEART ASSESSMENT;CARDIAC IMAGING;INTRACRANIAL ARTERIAL STENOSIS;MITRACLIP","22;16;14;11;9;9;9;9;8;7;6;6;6;6;6;6;6;5;5;5","HEART FAILURE;MACHINE LEARNING;TAKOTSUBO SYNDROME;HOSPITAL STAY;COHORT STUDY;COVID- PANDEMIC;MITRAL REGURGITATION;MITRAL VALVE;PATIENTS UNDERGOING;ACUTE ISCHEMIC;CARE UNIT;CLINICAL PRACTICE;COVID- PATIENTS;ISCHEMIC STROKE;ITALIAN SOCIETY;AORTIC VALVE;DI DIO;GIOVANNI DI;MYOCARDIAL INFARCTION;RUGGI DARAGONA;SAN GIOVANNI;SARS-COV- INFECTION;SOUTHERN ITALY;UNIVERSITY HOSPITAL;VALVE REPAIR;ACUTE MYELOID;ACUTE STROKE;CLINICAL CONDITIONS;CLINICAL OUTCOME;COLORECTAL CANCER","12;11;9;8;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3","PUBMED SCOPUS;HEART FAILURE;AORTIC VALVE;CROSSREF PUBMED;COVID- PATIENTS;HR CI;IN-HOSPITAL MORTALITY;LEFT VENTRICULAR;NORMAL BMI;BLEEDING COMPLICATIONS;PATIENTS UNDERGOING;BODY MASS;EJECTION FRACTION;MASS INDEX;TRANSCATHETER AORTIC;TTS PATIENTS;CORONAVIRUS DISEASE;DISEASE COVID-;LOGISTIC REGRESSION;PRIMARY ENDPOINT;PRIMARY OUTCOME;ABSTRACT AIMS;COVID- PANDEMIC;PROPENSITY SCORE;SARS-COV- INFECTION;REGRESSION ANALYSIS;HAZARD RATIO;INCREASED RISK;INTENSIVE CARE;VASCULAR COMPLICATIONS","59;33;31;31;24;24;24;24;24;23;22;21;21;21;21;19;18;18;18;17;17;16;16;16;16;15;14;14;14;14",116,0.46,2.4,41.58,7.95,224.499999999999,43.17,2,333,1.29,1,3,1,1,1,0,0,0,3.65,1,22,0,0,0,1,1,1,0,0,0,47.86,3,357,0,0,0,0,0,0,45.23,1,332,0,0,0,0,0,0,2.13,1,5,8.3,1,47,32.5,1,229,7.82,1,51,0,0,0,0,0,0,34.55,3,114,34.55,3,114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2022,273,17.992673992674,2.57875457875458,0.387784090909091,0.227106227106227,0.271062271062271,0.19047619047619,0.813186813186813,1,95,41,36,21,0.35,0.15,0.13,0.08,6.48,0.725886917487213,0.315018315018315,0.923076923076923,5.28722002635047,0.529461394652892,0.428401470906338,0.47242206235012,0.472659486329743,"GENNARO GALASSO;CARMINE SELLERI;RODOLFO CITRO;CARMINE VECCHIONE;MICHELE CICCARELLI;ANNA BORRELLI;VALENTINA GIUDICE;GIANLUIGI FRANCI;ALESSANDRO WEISZ;FRANCESCO DIANA;FRANCESCA RIZZO;GIORGIO GIURATO;BIANCA SERIO;MICHELE MANZO;GIOVANNI IMPROTA;MARIA TRIASSI;VALERIA CONTI;LEONARDO CALÒ;MASSIMILIANO GALDIERO;MICHELE BELLINO","25;23;23;23;20;18;17;11;11;11;11;11;11;10;10;10;9;9;9;9","ANNA BORRELLI;FABIO GRAZIOLI;GENNARO GALASSO;CARMINE VECCHIONE;GIOVANNI IMPROTA;MICHELE CICCARELLI;RODOLFO CITRO;CARMINE SELLERI;VALENTINA GIUDICE;MARIA TRIASSI;TERESA ANGELA TRUNFIO;NICOLA MAFFULLI;FRANCESCO DIANA;LUIGI SCHIAVO;ANTONIO ROMANELLI;GIANLUIGI FRANCI;BIANCA SERIO;ANTONIO CANERO;ROSA EMILIA;ARIANNA SCALA","2.89;2.33;2.2;2.18;2.15;1.84;1.84;1.83;1.61;1.48;1.35;1.34;1.34;1.22;1.1;1.03;1;1;1;0.98","GENNARO GALASSO;CARMINE SELLERI;RODOLFO CITRO;CARMINE VECCHIONE;MICHELE CICCARELLI;ANNA BORRELLI;VALENTINA GIUDICE;GIANLUIGI FRANCI;ALESSANDRO WEISZ;FRANCESCO DIANA;FRANCESCA RIZZO;GIORGIO GIURATO;BIANCA SERIO;MICHELE MANZO;VALERIA CONTI;MICHELE BELLINO;PASQUALE PAGLIANO;AMELIA RAVERA;AMELIA FILIPPELLI;FABIO GRAZIOLI","25;23;23;23;20;18;17;11;11;11;11;11;11;10;9;9;9;9;9;8","ANNA BORRELLI;FABIO GRAZIOLI;GENNARO GALASSO;CARMINE VECCHIONE;MICHELE CICCARELLI;RODOLFO CITRO;CARMINE SELLERI;VALENTINA GIUDICE;NICOLA MAFFULLI;FRANCESCO DIANA;LUIGI SCHIAVO;ANTONIO ROMANELLI;GIANLUIGI FRANCI;BIANCA SERIO;ANTONIO CANERO;PASQUALE PAGLIANO;VINCENZO PILONE;L SORIENTE;P CALABRESE;AMELIA FILIPPELLI","2.89;2.33;2.2;2.18;1.84;1.84;1.83;1.61;1.34;1.34;1.22;1.1;1.03;1;1;0.9;0.87;0.87;0.86;0.83","ANNA BORRELLI;GIOVANNI IMPROTA;RODOLFO CITRO;CARMINE VECCHIONE;ARIANNA SCALA;TERESA ANGELA TRUNFIO;CAROLINA CIACCI;VALENTINA GIUDICE;MARIA TRIASSI;MICHELE CICCARELLI;CARMINE SELLERI;GENNARO GALASSO;GIANLUIGI FRANCI;FRANCESCO DIANA;MASSIMILIANO GALDIERO;ALESSANDRO WEISZ;GIORGIO GIURATO;ALBINO CARRIZZO;PAOLA DI PIETRO;VALERIA CONTI","243;212;209;141;125;121;117;112;110;103;102;99;98;92;92;91;89;87;85;84","ANNA BORRELLI;RODOLFO CITRO;CAROLINA CIACCI;CARMINE SELLERI;FRANCESCO DIANA;VALENTINA GIUDICE;GIANLUIGI FRANCI;VINCENZO BELLIZZI;ALESSANDRO WEISZ;BIANCA SERIO;AMELIA FILIPPELLI;VALERIA CONTI;PAOLO VERZE;YLENIA D’AGOSTINO;MICHELE MANZO;PASQUALE PAGLIANO;CESARE BALDI;DANIELE ROMANO;ILARIA RADANO;TERESA ROCCO","243;209;117;102;92;92;83;77;72;68;62;54;51;43;42;41;39;39;39;39","CARMINE SELLERI;RODOLFO CITRO;ANNA BORRELLI;VALENTINA GIUDICE;GENNARO GALASSO;BIANCA SERIO;FRANCESCO DIANA;MICHELE MANZO;AMELIA RAVERA;ALESSANDRO WEISZ;GIANLUIGI FRANCI;AMELIA FILIPPELLI;FABIO GRAZIOLI;VALERIA CONTI;CARMINE VECCHIONE;VINCENZO BELLIZZI;LUIGI SCHIAVO;VINCENZO PILONE;FRANCESCO VIGORITO;DANIELE ROMANO","23;22;18;15;13;11;11;10;9;9;9;9;8;8;7;6;6;6;6;5","MEDICINE;BIOLOGY;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;CHEMISTRY;PHYSICS;PSYCHOLOGY;ECONOMICS;SOCIOLOGY;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;GEOLOGY","256;48;30;28;24;23;17;15;12;10;8;7;3;2;2;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PATHOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;GENETICS;BIOCHEMISTRY;MECHANICAL ENGINEERING;RADIOLOGY;INTENSIVE CARE MEDICINE;STATISTICS;EMERGENCY MEDICINE;ONCOLOGY;PEDIATRICS;VIROLOGY;PSYCHIATRY;ENDOCRINOLOGY;NURSING;CANCER RESEARCH;GASTROENTEROLOGY","208;78;77;38;35;29;26;24;22;22;20;19;18;18;18;18;17;15;15;13;13","DISEASE;HEART FAILURE;POPULATION;MYOCARDIAL INFARCTION;GENE;RETROSPECTIVE COHORT STUDY;STROKE (ENGINE);CANCER;ADVERSE EFFECT;CONFIDENCE INTERVAL;RANDOMIZED CONTROLLED TRIAL;COHORT;OUTBREAK;ATRIAL FIBRILLATION;BLOOD PRESSURE;CLINICAL TRIAL;ISCHEMIA;LOGISTIC REGRESSION;PROSPECTIVE COHORT STUDY;ANEURYSM;CHEMOTHERAPY;HEALTH CARE;MULTIVARIATE ANALYSIS;OBSERVATIONAL STUDY;OCCLUSION;ODDS RATIO;PROPORTIONAL HAZARDS MODEL","58;39;29;26;23;21;21;20;18;17;16;15;13;12;12;11;10;10;10;9;9;9;9;9;9;9;9","INFECTIOUS DISEASE (MEDICAL SPECIALTY);EJECTION FRACTION;CLINICAL ENDPOINT;2019-20 CORONAVIRUS OUTBREAK;HAZARD RATIO;THROMBOLYSIS;CARDIOGENIC SHOCK;GENE EXPRESSION;ACUTE CORONARY SYNDROME;COLORECTAL CANCER;CONVENTIONAL PCI;ISCHEMIC STROKE;TOLERABILITY;UNIVARIATE ANALYSIS;WEIGHT LOSS;ALLELE;AORTIC DISSECTION;CARDIOMYOPATHY;MIDDLE CEREBRAL ARTERY;MUTATION;PARKINSON'S DISEASE;PERCUTANEOUS CORONARY INTERVENTION;STRESS ECHOCARDIOGRAPHY;TELEMEDICINE","35;21;13;11;10;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);CARDIAC RESYNCHRONIZATION THERAPY;DNA METHYLATION;MODIFIED RANKIN SCALE;GASTRIC BYPASS;SACUBITRIL;SACUBITRIL, VALSARTAN;ANTIMICROBIAL STEWARDSHIP;COLONOSCOPY;CONNECTIVE TISSUE DISEASE;DARATUMUMAB;DASATINIB;DIFFUSE ALVEOLAR DAMAGE;LEAN SIX SIGMA;METHYLENETETRAHYDROFOLATE REDUCTASE;MONOCLONAL;PROBAND;REACTOGENICITY;RESPIRATORY DISTURBANCE INDEX;RIBAVIRIN;STROKE VOLUME;TRANSCRIPTOME","35;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;COVID-19;HEART FAILURE;FEMALE;TREATMENT OUTCOME;MALE;RETROSPECTIVE STUDIES;STROKE;AGED;ITALY;SARS-COV-2;ADULT;MIDDLE AGED;MITRAL VALVE INSUFFICIENCY;POSTOPERATIVE COMPLICATIONS;PROSPECTIVE STUDIES;THROMBECTOMY;PANDEMICS;RISK FACTORS","158;115;31;26;24;23;21;19;18;17;15;15;14;12;11;11;11;11;9;9","EPIDEMIOLOGY AND MANAGEMENT OF STROKE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;MANAGEMENT OF VALVULAR HEART DISEASE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;CORONAVIRUS DISEASE 2019;CORONAVIRUS DISEASE 2019 RESEARCH;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ACUTE MYELOID LEUKEMIA;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DUAL-ENERGY COMPUTED TOMOGRAPHY;OSTEOARTHRITIS AND CARTILAGE REPAIR","14;11;9;8;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4","STROKE (ENGINE);PANDEMIC;CLINICAL ENDPOINT;2019-20 CORONAVIRUS OUTBREAK;TRANSCATHETER AORTIC-VALVE REPLACEMENT;ECHOCARDIOGRAPHY;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;INFARCTION TREATMENT;LEFT VENTRICULAR FUNCTION;AORTIC DISSECTION;CARDIAC IMAGING;ARRHYTHMIA DETECTION;CARDIOVASCULAR RISK ASSESSMENT;HEARTBEAT CLASSIFICATION;MITRAL REGURGITATION;TAKOTSUBO SYNDROME;CARDIAC HEALTH DIAGNOSIS;CARDIAC RESYNCHRONIZATION THERAPY;DISCONTINUATION;INTERQUARTILE RANGE","21;16;14;10;10;9;8;8;8;7;7;6;6;6;6;6;5;5;5;5","HEART FAILURE;OBSERVATIONAL STUDY;COVID- PATIENTS;IMPLANTABLE DEFIBRILLATOR;BARIATRIC SURGERY;KIDNEY DISEASE;MYOCARDIAL INFARCTION;PATIENTS UNDERGOING;STRESS ECHOCARDIOGRAPHY;BICENTRIC STUDY;CAMPANIA REGION;CLINICAL OUTCOMES;COVID- PANDEMIC;FAILURE PATIENTS;MECHANICAL THROMBECTOMY;MITRAL REGURGITATION;MULTICENTER STUDY;MULTIPLE MYELOMA;MULTIPLE SCLEROSIS;MYELOID LEUKEMIA;REAL WORLD;RETROSPECTIVE STUDY;SOUTHERN ITALY;TAKOTSUBO SYNDROME;ADVERSE EVENTS;ARTERY OCCLUSION;BASILAR ARTERY;CARDIOGENIC SHOCK;CELIAC DISEASE;CHRONIC KIDNEY","16;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","HR CI;HEART FAILURE;STATISTICALLY SIGNIFICANT;EJECTION FRACTION;IN-HOSPITAL MORTALITY;KIDNEY DISEASE;AORTIC VALVE;CARDIAC SURGERY;COVID- PATIENTS;COVID- PANDEMIC;DI DIO;FUNDING SOURCES;GIOVANNI DI;MYOCARDIAL INFARCTION;REGRESSION ANALYSIS;RUGGI DARAGONA;AMBULATORY BP;MEDIAN FOLLOW-UP;LEFT VENTRICULAR;LOGISTIC REGRESSION;SARS-COV- INFECTION;SCAI STAGE;HEARTLOGIC INDEX;LINEAR REGRESSION;MD DEPARTMENT;MECHANICAL THROMBECTOMY;CHRONIC KIDNEY;FAILURE HF;FREE WALL;HEARTLOGIC ALERTS","39;34;27;23;23;23;20;20;18;17;17;17;17;17;17;17;16;16;15;15;15;15;14;14;14;14;13;13;13;13",119,0.44,1.85,30.33,9.5,221.25,29.43,2,194,1,1,1,1.2,1,2,0,0,0,3.83,1,27,0,0,0,0,0,0,0,0,0,35.6,2,242,0,0,0,0,0,0,28.45,1,193,0,0,0,0,0,0,2.2,1,5,5.48,1,28,18,1,149,5.5,1,17,0,0,0,0,0,0,18.4,1,108,18.4,1,108,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2023,219,21.3926940639269,2.44748858447489,0.408582089552239,0.205479452054795,0.246575342465753,0.168949771689498,0.748858447488584,2,87,33,31,12,0.4,0.15,0.14,0.05,3.29,0.750080801387153,0.378995433789954,0.917808219178082,5.11811926605505,0.440241491392705,0.462785114045618,0.484739956399875,0.519580805295091,"RODOLFO CITRO;CARMINE SELLERI;DANIELE ROMANO;GENNARO GALASSO;BIANCA SERIO;CARMINE VECCHIONE;VALENTINA GIUDICE;GIUSEPPE TARANTINI;ANTONIO DELLO RUSSO;AMATO SANTORO;MATTEO ZIACCHI;STACEY Q WOLFE;ENRICO COSCIONI;ROBERTO CROSA;MICHELE MANZO;JOSHUA W. OSBUN;GIANLUIGI FRANCI;ILKO MAIER;ALEJANDRO M SPIOTTA;LEONARDO CALÒ","21;14;14;13;13;12;11;10;10;10;10;9;9;9;9;9;9;9;9;9","BIANCA SERIO;CARMINE VECCHIONE;VALENTINA GIUDICE;GENNARO GALASSO;CARMINE SELLERI;RODOLFO CITRO;CLAUDIO DELLO SCHIAVO;ISABELLA ESPOSITO;ENRICO COSCIONI;NICOLA MAFFULLI;GIANLUIGI FRANCI;AMELIA FILIPPELLI;A. RAIMONDO;SERENA LEMBO;ALESSANDRO CAPUTO;MICHELE MANZO;MICHELE CICCARELLI;VALERIA CONTI;AMATO SANTORO;MATTEO ZIACCHI","1.37;1.18;1.16;1.12;1.11;1.05;1;1;0.96;0.77;0.72;0.69;0.68;0.68;0.68;0.63;0.62;0.61;0.6;0.59","RODOLFO CITRO;CARMINE SELLERI;DANIELE ROMANO;GENNARO GALASSO;BIANCA SERIO;CARMINE VECCHIONE;VALENTINA GIUDICE;ENRICO COSCIONI;MICHELE MANZO;GIANLUIGI FRANCI;MICHELE BELLINO;GIOVANNI BOCCIA;ANGELO SILVERIO;TIZIANA ATTISANO;FRANCESCO DIANA;MICHELE CICCARELLI;CESARE BALDI;NICOLA MAFFULLI;VALERIA CONTI;ALESSANDRO CAPUTO","21;14;14;13;13;12;11;9;9;9;9;7;7;7;7;6;6;6;6;6","BIANCA SERIO;CARMINE VECCHIONE;VALENTINA GIUDICE;GENNARO GALASSO;CARMINE SELLERI;RODOLFO CITRO;CLAUDIO DELLO SCHIAVO;ISABELLA ESPOSITO;ENRICO COSCIONI;NICOLA MAFFULLI;GIANLUIGI FRANCI;AMELIA FILIPPELLI;ALESSANDRO CAPUTO;MICHELE MANZO;MICHELE CICCARELLI;VALERIA CONTI;MICHELE BELLINO;GIOVANNI BOCCIA;FRANCESCA D’AURIA;GIORGIO İACONETTA","1.37;1.18;1.16;1.12;1.11;1.05;1;1;0.96;0.77;0.72;0.69;0.68;0.63;0.62;0.61;0.57;0.56;0.54;0.54","RODOLFO CITRO;FRANCESCO FERRARA;LUNA GARGANI;EDUARDO BOSSONE;MICHELE BELLINO;CIRO MAURO;ANTONELLO D’ANDREA;IACOPO FABIANI;ROSANGELA COCCHIA;ANDREINA CARBONE;DANIELE ROMANO;ALBERTO M. MARRA;ANTONIO CITTADINI;FILIPPO CADEMARTIRI;FRANCESCO BANDERA;MARCO GUAZZI;MATTEO MAZZOLA;MICHELE ARCOPINTO;MICHELE D’ALTO;PAOLA ARGIENTO","113;78;78;76;61;60;58;58;58;54;53;52;52;52;52;52;52;52;52;52","RODOLFO CITRO;FRANCESCO FERRARA;DANIELE ROMANO;CARMINE SELLERI;GIANLUIGI FRANCI;FRANCESCO DIANA;TIZIANA PASSARO;AMELIA RAVERA;CAROLINA CIACCI;NICOLA MAFFULLI;FRANCESCO CAPUANO;GERARDO IULIANO;ALESSANDRO CAPUTO;MICHELE MANZO;GIORGIO İACONETTA;ALFONSO MASULLO;FRANCESCO VALITUTTI;PAOLO BARONE;ANIELLO IOVINO;ANTONELLA TORIELLO","112;78;53;47;36;35;33;31;31;29;26;25;24;24;21;20;19;18;17;17","RODOLFO CITRO;CARMINE SELLERI;DANIELE ROMANO;BIANCA SERIO;ENRICO COSCIONI;VALENTINA GIUDICE;GENNARO GALASSO;MICHELE MANZO;CESARE BALDI;TIZIANA ATTISANO;AMELIA FILIPPELLI;FRANCESCO DIANA;GIANLUIGI FRANCI;ALESSANDRO CAPUTO;VALERIA CONTI;DANIELE GIUSEPPE ROMANO;GIOVANNI BOCCIA;GIULIA FRAUENFELDER;GERARDO IULIANO;ALFONSO MASULLO","20;14;14;11;9;9;9;9;7;7;6;6;6;6;6;5;5;5;5;4","MEDICINE;BIOLOGY;ENGINEERING;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ECONOMICS;PSYCHOLOGY;MATHEMATICS;POLITICAL SCIENCE;GEOGRAPHY;ENVIRONMENTAL SCIENCE;SOCIOLOGY;BUSINESS;ART;MATERIALS SCIENCE;PHILOSOPHY","213;36;25;18;16;16;10;9;6;5;4;3;3;2;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PATHOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;BIOCHEMISTRY;MECHANICAL ENGINEERING;GENETICS;GASTROENTEROLOGY;ONCOLOGY;PEDIATRICS;INTENSIVE CARE MEDICINE;PSYCHIATRY;PHYSICAL THERAPY;NURSING;OPTICS;VIROLOGY;EMERGENCY MEDICINE;PHARMACOLOGY","159;78;63;29;27;24;23;22;21;19;18;16;14;13;11;10;9;9;9;8;8","DISEASE;HEART FAILURE;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;POPULATION;RETROSPECTIVE COHORT STUDY;STROKE (ENGINE);GENE;CANCER;COHORT;ATRIAL FIBRILLATION;ISCHEMIA;ADVERSE EFFECT;MITRAL REGURGITATION;OCCLUSION;BLOOD PRESSURE;CLINICAL TRIAL;LOGISTIC REGRESSION;PROPORTIONAL HAZARDS MODEL;PROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL","35;31;28;21;21;21;21;20;19;18;16;13;10;10;10;9;9;9;9;9;9","HAZARD RATIO;EJECTION FRACTION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);ISCHEMIC STROKE;CLINICAL ENDPOINT;THROMBOLYSIS;GENE EXPRESSION;INTRACEREBRAL HEMORRHAGE;MIDDLE CEREBRAL ARTERY;2019-20 CORONAVIRUS OUTBREAK;ADENOCARCINOMA;AORTIC VALVE REPLACEMENT;VALVE REPLACEMENT;ACUTE CORONARY SYNDROME;BREAST CANCER;CARDIOGENIC SHOCK;HAEMATOPOIESIS;HEART RATE;PROGENITOR CELL;ANTIBIOTIC RESISTANCE;AORTIC DISSECTION;AORTIC VALVE STENOSIS;ASCENDING AORTA;BICUSPID AORTIC VALVE;CEREBRAL INFARCTION;CHARLSON COMORBIDITY INDEX;CHRONIC LYMPHOCYTIC LEUKEMIA;CYCLOPHOSPHAMIDE;EPIGENETICS;EXPANDED DISABILITY STATUS SCALE;GENOTYPE;METASTASIS;MINIMAL RESIDUAL DISEASE;MITRAL VALVE REPAIR;PERIPHERAL BLOOD MONONUCLEAR CELL;REFLUX;WEIGHT LOSS","18;15;12;11;9;8;7;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);MODIFIED RANKIN SCALE;DNA METHYLATION;VENETOCLAX;ACINIC CELL CARCINOMA;CARDIAC RESYNCHRONIZATION THERAPY;DARATUMUMAB;FLUDARABINE;GASTRIC BYPASS;GERD;HEARTBURN;IDARUBICIN;IMMUNOGLOBULIN A;RESPIRATORY DISTURBANCE INDEX;SACUBITRIL;STROKE VOLUME;ADULT STEM CELL;ANAPLASTIC LYMPHOMA KINASE;ANTERIOR CEREBRAL ARTERY;APREMILAST;AROMATASE;BICUSPID VALVE;BLINATUMOMAB;BONE MARROW FAILURE;BOOSTER DOSE;BRADYCARDIA;BROTH MICRODILUTION;CANNABINOID RECEPTOR;CARFILZOMIB;CEFTAZIDIME;CERVICAL CANCER SCREENING;CERVICAL SCREENING;CLAUDICATION;COLONOSCOPY;COMPOUND HETEROZYGOSITY;CORE BIOPSY;DASATINIB;DESMIN;DYSKINESIA;ECULIZUMAB;ELEPHANT TRUNKS;ELIMINATION DIET;ENALAPRIL;ESOPHAGITIS;FEBRILE NEUTROPENIA;FUNCTIONAL MITRAL REGURGITATION;GENOTYPING;GLUT1;HEART FAILURE WITH PRESERVED EJECTION FRACTION;HPV INFECTION;HYPOTHALAMIC–PITUITARY–GONADAL AXIS;IMIPENEM;ISCHEMIC CARDIOMYOPATHY;KARYOTYPE;KLEBSIELLA PNEUMONIAE;KRAS;LARGE CELL;LEVODOPA;LIQUID-BASED CYTOLOGY;LYMPHOVASCULAR INVASION;MEAN ARTERIAL PRESSURE;METASTATIC BREAST CANCER;MICROSATELLITE;MOLECULAR EPIDEMIOLOGY;MORBID OBESITY;MORNING STIFFNESS;OSTEOPENIA;PACHYGYRIA;PANCREATIC DUCTAL ADENOCARCINOMA;PEMBROLIZUMAB;PIPERACILLIN;PITTSBURGH SLEEP QUALITY INDEX;PKD1;POMALIDOMIDE;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;QUANTITATIVE COMPUTED TOMOGRAPHY;RIBAVIRIN;ROS1;RUNX1;SACUBITRIL, VALSARTAN;SPONTANEOUS INTRACEREBRAL HEMORRHAGE;STAPHYLOCOCCUS EPIDERMIDIS;TERIFLUNOMIDE;TRANSCRIPTOME;TRANSURETHRAL RESECTION OF THE PROSTATE;TRIPLE-NEGATIVE BREAST CANCER;VARIABLE NUMBER TANDEM REPEAT;VILLOUS ATROPHY;VINCRISTINE","12;11;6;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;HEART FAILURE;STROKE;BRAIN ISCHEMIA;FEMALE;MALE;THROMBECTOMY;ITALY;MITRAL VALVE INSUFFICIENCY;AGED;COVID-19;ENDOVASCULAR PROCEDURES;CELIAC DISEASE;ATRIAL FIBRILLATION;DEFIBRILLATORS, IMPLANTABLE;ADULT;CHILD","115;102;31;26;21;21;20;19;18;14;13;12;11;11;11;10;9;9;8;8","EPIDEMIOLOGY AND MANAGEMENT OF STROKE;MANAGEMENT OF VALVULAR HEART DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;ACUTE MYELOID LEUKEMIA;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND TREATMENT OF HEART FAILURE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;ROLE OF LUNG ULTRASOUND IN CRITICAL CARE;SALIVARY GLAND TUMORS AND CARCINOMAS;SURGICAL VENTRICULAR RECONSTRUCTION IN MYOCARDIAL INFARCTION;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANORECTAL SURGICAL PROCEDURES;ATOPIC DERMATITIS AND SKIN MICROBIOME;CANCER IMMUNOTHERAPY;CHOLESTEROL-LOWERING TREATMENT","20;12;11;7;6;6;4;4;3;3;3;3;3;3;3;2;2;2;2;2","STROKE (ENGINE);INFARCTION TREATMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CLINICAL ENDPOINT;MITRAL REGURGITATION;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;PROSTHETIC VALVES EVALUATION;ENDOVASCULAR THERAPY;ECHOCARDIOGRAPHY;PANDEMIC;SURGICAL AORTIC-VALVE REPLACEMENT;TREATMENT;CARDIAC IMAGING;DECOMPENSATION;TYPE B AORTIC DISSECTION;VALVE REPLACEMENT;VALVULAR REGURGITATION;AORTIC DISSECTION;ARRHYTHMIA DETECTION;CARDIAC HEALTH DIAGNOSIS","22;14;13;10;9;8;8;7;6;6;6;6;5;5;5;5;5;4;4;4","HEART FAILURE;MECHANICAL THROMBECTOMY;AORTIC VALVE;IMPLANTABLE DEFIBRILLATOR;MITRAL REGURGITATION;ISCHEMIC STROKE;MULTIPLE SCLEROSIS;DEFIBRILLATOR ALGORITHM;ACUTE ISCHEMIC;CELIAC DISEASE;COHORT STUDY;MULTICENTER STUDY;MULTISENSOR IMPLANTABLE;STROKE PATIENTS;VALVE REPLACEMENT;ACUTE MYELOID;ATRIAL FIBRILLATION;CELL CARCINOMA;COVID- PANDEMIC;MYELOID LEUKEMIA;RETROSPECTIVE MULTICENTER;STEM CELLS;TRANSCATHETER EDGE-TO-EDGE;ACUTE CORONARY;ALL-CAUSE MORTALITY;AORTIC STENOSIS;BARIATRIC SURGERY;BICUSPID AORTIC;BONE MARROW;CORONARY ARTERY","15;11;8;8;8;7;7;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","HEART FAILURE;AORTIC VALVE;HR CI;MEDIAN AGE;PRIMARY OUTCOME;FAILURE HF;CLINICAL OUTCOMES;EJECTION FRACTION;MEDIAN FOLLOW-UP;CORONARY ARTERY;SIGNIFICANT DIFFERENCES;COVID- PANDEMIC;HAZARD RATIO;MYOCARDIAL INFARCTION;TYPE BAV;ALL-CAUSE DEATH;COHORT STUDY;CONFIDENCE INTERVAL;MECHANICAL THROMBECTOMY;MITRAL REGURGITATION;MITRAL VALVE;ARTERY BYPASS;ATRIAL FIBRILLATION;HF PATIENTS;INCREASED RISK;NON-RL TYPE;RETROSPECTIVE STUDY;THROMBOEMBOLIC EVENTS;HEALTHY CONTROLS;HF APP","27;24;21;20;17;15;14;14;14;13;13;12;12;12;12;11;11;11;11;11;11;10;10;10;10;10;10;10;9;9",86,0.39,3.4,25.04,7.65,90.75,29.5,4,148,1.25,1,2,1,1,1,0,0,0,2.5,1,9,0,0,0,0,0,0,0,0,0,35.5,4,174,0,0,0,0,0,0,27.95,1,147,0,0,0,0,0,0,2.43,1,5,4.42,1,19,17.91,1,104,5.42,1,19,0,0,0,0,0,0,7.36,0,25,7.36,0,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANGIOVANNIDIDIO",2024,201,22.8905472636816,2.28855721393035,0.43695652173913,0.228855721393035,0.243781094527363,0.139303482587065,0.592039800995025,0,83,39,15,8,0.41,0.19,0.07,0.04,0.7,0.728799949381196,0.393034825870647,0.970149253731343,4.15929203539822,0.457121358515856,0.429065743944637,0.471710108073744,0.441954022988506,"ALEJANDRO M SPIOTTA;WALEED BRINJIKJI;ALI ALAWIEH;ISABEL FRAGATA;ROBERTO CROSA;PEDRO NAVÍA;JOSHUA W. OSBUN;ILKO MAIER;ADAM POLIFKA;READE DE LEACY;MIN S. PARK;MOHAMAD EZZELDIN;DANIELE ROMANO;ROBERT M. STARKE;OMAR TANWEER;SHAKEEL A. CHOWDHRY;PETER KAN;CHARLES MATOUK;JUSTIN MASCITELLI;MICHAEL R. LEVITT","25;25;25;25;24;24;24;24;24;23;23;23;23;23;23;22;22;22;21;21","VALENTINA GIUDICE;GIANLUIGI FRANCI;CARMINE VECCHIONE;GENNARO GALASSO;FRANCESCO CORRIVETTI;SERGIO CORVINO;MATTEO DE NOTARIS;PASQUALE PAGLIANO;BIANCA SERIO;ANTONIO ROMANELLI;RENATO GAMMALDI;NICOLA MAFFULLI;ORNELLA PIAZZA;GIOVANNI BOCCIA;VERONICA FOLLIERO;FRANCESCO LORIA;FRANCESCO DE;AMEDEO PIAZZA;CARMINE SELLERI;ALEJANDRO M SPIOTTA","1.23;1.2;1.06;1;0.98;0.98;0.98;0.93;0.89;0.78;0.78;0.77;0.76;0.76;0.74;0.71;0.68;0.67;0.65;0.64","DANIELE ROMANO;CARMINE VECCHIONE;GIANLUIGI FRANCI;VALENTINA GIUDICE;GENNARO GALASSO;BIANCA SERIO;RODOLFO CITRO;CARMINE SELLERI;GIOVANNI BOCCIA;MATTEO DE NOTARIS;PASQUALE PAGLIANO;MICHELE CICCARELLI;DANILO DE NOVELLIS;MARIO CAPUNZO;FRANCESCO DE;PIO ZEPPA;ORNELLA PIAZZA;PAOLO BARONE;VALERIA CONTI;NICOLA VIRTUOSO","23;15;14;13;13;12;11;9;8;8;8;7;7;6;6;6;6;5;5;5","VALENTINA GIUDICE;GIANLUIGI FRANCI;CARMINE VECCHIONE;GENNARO GALASSO;MATTEO DE NOTARIS;PASQUALE PAGLIANO;BIANCA SERIO;ANTONIO ROMANELLI;RENATO GAMMALDI;NICOLA MAFFULLI;ORNELLA PIAZZA;GIOVANNI BOCCIA;FRANCESCO LORIA;FRANCESCO DE;CARMINE SELLERI;MARIO CAPUNZO;GIORGIO İACONETTA;DANIELE ROMANO;PAOLO BARONE;MICHELE CICCARELLI","1.23;1.2;1.06;1;0.98;0.93;0.89;0.78;0.78;0.77;0.76;0.76;0.71;0.68;0.65;0.59;0.56;0.56;0.55;0.54","CARMINE VECCHIONE;FRANCESCO CORRIVETTI;MATTEO DE NOTARIS;SERGIO CORVINO;AMEDEO PIAZZA;GIORGIO İACONETTA;MICHELE CICCARELLI;VALERIA VISCO;NICOLA VIRTUOSO;LUIGI MARIA CAVALLO;AMIN KASSAM;TOMA SPIRIEV;CARMINE IZZO;FELICE ESPOSITO;PAOLA DI PIETRO;ALBINO CARRIZZO;ALEXANDRA STRODA;PATRICK MEYBOHM;ANTONIO DAMATO;CARMINE SECONDULFO","22;22;22;22;20;20;20;20;19;16;15;15;13;13;13;12;12;12;11;11","MATTEO DE NOTARIS;GIORGIO İACONETTA;NICOLA VIRTUOSO;CARMINE IZZO;SERENA MIGLIARINO;ALESSANDRO CAPUTO;GIANLUIGI FRANCI;AMELIA FILIPPELLI;DANIELE ROMANO;PAOLO BARONE;VALERIA CONTI;BIANCA SERIO;FRANCESCO SABBATINO;MADDALENA LANGELLA;PIO ZEPPA;STEFANO PEPE;CARMINE SELLERI;VALENTINA GIUDICE;ANIELLO ENRICO PUCA;CAROLINA CIACCI","22;20;19;11;11;10;8;7;7;7;7;6;6;6;6;6;5;5;4;4","DANIELE ROMANO;BIANCA SERIO;VALENTINA GIUDICE;CARMINE SELLERI;GIANLUIGI FRANCI;RODOLFO CITRO;GIOVANNI BOCCIA;MATTEO DE NOTARIS;DANILO DE NOVELLIS;NICOLA VIRTUOSO;ALESSANDRO WEISZ;DANIELE GIUSEPPE ROMANO;EMILIA ANNA VOZZELLA;FRANCESCO DE;GIORGIO İACONETTA;MARIA COSTANTINO;MARIO CAPUNZO;PAOLO BARONE;PIO ZEPPA;TIZIANA ATTISANO","23;12;12;10;10;9;8;8;7;5;5;5;5;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;ENGINEERING;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY;ECONOMICS;POLITICAL SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;GEOLOGY","188;44;33;20;18;10;8;7;7;6;4;3;3;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;MECHANICAL ENGINEERING;PATHOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;RADIOLOGY;GENETICS;ONCOLOGY;PSYCHIATRY;PEDIATRICS;BIOCHEMISTRY;GASTROENTEROLOGY;MICROBIOLOGY;CELL BIOLOGY;NURSING;ANATOMY;ENDOCRINOLOGY;PHYSICAL THERAPY;VIROLOGY","139;64;60;30;25;23;23;23;21;21;15;12;10;10;10;9;9;8;8;8;8","STROKE (ENGINE);ISCHEMIA;DISEASE;MYOCARDIAL INFARCTION;HEART FAILURE;GENE;OCCLUSION;CANCER;RETROSPECTIVE COHORT STUDY;COHORT;OBSERVATIONAL STUDY;ODDS RATIO;CONFIDENCE INTERVAL;LOGISTIC REGRESSION;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;ANEURYSM;ANTIBODY;IMMUNE SYSTEM;MULTIPLE MYELOMA;NEUROLOGY;POPULATION;PROPENSITY SCORE MATCHING","30;24;22;22;19;18;15;14;13;10;9;9;8;8;8;7;7;7;7;7;7;7;7","ISCHEMIC STROKE;THROMBOLYSIS;EJECTION FRACTION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MIDDLE CEREBRAL ARTERY;NEURORADIOLOGY;CEREBRAL INFARCTION;INTRACEREBRAL HEMORRHAGE;MULTICENTER STUDY;ESCHERICHIA COLI;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;2019-20 CORONAVIRUS OUTBREAK;ACUTE CORONARY SYNDROME;ACUTE STROKE;ANTIBIOTIC RESISTANCE;AORTIC VALVE REPLACEMENT;AORTIC VALVE STENOSIS;BICUSPID AORTIC VALVE;BORTEZOMIB;CARDIOMYOPATHY;EPIDERMAL GROWTH FACTOR RECEPTOR;GENE EXPRESSION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNOTHERAPY;LENALIDOMIDE;PROGENITOR CELL;STRESS ECHOCARDIOGRAPHY","21;12;8;7;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MODIFIED RANKIN SCALE;CORONAVIRUS DISEASE 2019 (COVID-19);DARATUMUMAB;FUNCTIONAL MITRAL REGURGITATION;KLEBSIELLA PNEUMONIAE;CANCER IMMUNOTHERAPY;DNA METHYLATION;ENDOVASCULAR ANEURYSM REPAIR;KRAS;PD-L1;POMALIDOMIDE;POSTERIOR CEREBRAL ARTERY;SINGLE-NUCLEOTIDE POLYMORPHISM;TAKOTSUBO SYNDROME;ACINETOBACTER BAUMANNII;ANAEROBIC GLYCOLYSIS;ANAPLASTIC THYROID CANCER;ANDROGEN RECEPTOR;ANTEROLATERAL LIGAMENT;ANTIBIOTIC STEWARDSHIP;ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY;ANTIMICROBIAL STEWARDSHIP;ASYMMETRIC CELL DIVISION;BAG3;BLINATUMOMAB;BREAST SURGERY;C DIFFICILE;CANINE PARVOVIRUS;CARDIAC RESYNCHRONIZATION THERAPY;CARFILZOMIB;CD33;CD59;CD90;CETUXIMAB;CHROMOSOME INSTABILITY;CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER;COGNITIVE DECLINE;CONNECTIVE TISSUE DISEASE;COPY-NUMBER VARIATION;CROSSOVER STUDY;CYSTECTOMY;CYTOGENETICS;DAPAGLIFLOZIN;DIASTOLIC FUNCTION;DONOR LYMPHOCYTE INFUSION;DONOR SPECIFIC ANTIBODIES;DOUBLE BLIND;EGFR INHIBITORS;ENTEROBACTER;EXOME SEQUENCING;FIBROBLAST GROWTH FACTOR 23;GEFITINIB;GENOMICS;HERPESVIRIDAE;IDIOPATHIC SHORT STATURE;INDUCED PLURIPOTENT STEM CELL;INFLAMMATORY BOWEL DISEASES;INJURY SEVERITY SCORE;LENVATINIB;MACE;MASTECTOMY;METHYLTRANSFERASE;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;NEUROTOLOGY;NIMOTUZUMAB;OCRELIZUMAB;ONCOGENE;ORAL ANTICOAGULANT;PANCREATIC DUCTAL ADENOCARCINOMA;PANEL REACTIVE ANTIBODY;PLACENTA;PLASMA CELL DYSCRASIA;PLASMA CELL NEOPLASM;PREDIABETES;PRENATAL DIAGNOSIS;PRESYNCOPE;PROBAND;PROSTATE BIOPSY;PYROPTOSIS;PYRUVATE KINASE;RNA INTERFERENCE;SEROPREVALENCE;SEROTONERGIC;SERRATIA MARCESCENS;SMALL INTERFERING RNA;STROKE VOLUME;SYNOVIAL FLUID;TELEPATHOLOGY;THORACIC AORTIC ANEURYSM;TICAGRELOR;TOLL-LIKE RECEPTOR;TRANSCRIPTOME;TROCHLEAR NERVE;ULTRASOUND ELASTOGRAPHY;VINORELBINE;WARBURG EFFECT;WHOLE GENOME SEQUENCING","12;7;4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;AGED;MIDDLE AGED;ADULT;TREATMENT OUTCOME;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;ITALY;PROSPECTIVE STUDIES;QUALITY OF LIFE;REGISTRIES;YOUNG ADULT;ANIMALS;THROMBECTOMY;ADOLESCENT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;BIOMARKERS","140;59;36;35;28;28;17;15;12;12;11;8;7;6;6;5;5;4;4;4","EPIDEMIOLOGY AND MANAGEMENT OF STROKE;MANAGEMENT OF VALVULAR HEART DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;FRAILTY IN OLDER ADULTS AND GERIATRIC CARE;APPLICATION OF 3D PRINTING IN MEDICAL ANATOMY EDUCATION;CANCER IMMUNOTHERAPY;DIAGNOSIS AND TREATMENT OF HEART FAILURE;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;ACUTE MYELOID LEUKEMIA;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK","23;13;7;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2","STROKE (ENGINE);INFARCTION TREATMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;THROMBOLYSIS;ECHOCARDIOGRAPHY;CARDIAC IMAGING;ENDOVASCULAR THERAPY;HEMATOLOGY;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;MITRAL REGURGITATION;NEURORADIOLOGY;PROSTHETIC VALVES EVALUATION;CARDIOVASCULAR EVALUATION;DARATUMUMAB;FUNCTIONAL MITRAL REGURGITATION;INTERNATIONAL MYELOMA WORKING GROUP;ISCHEMIC STROKE;REFRACTORY (PLANETARY SCIENCE);VALVULAR REGURGITATION;VENOUS THROMBOEMBOLISM","30;16;11;8;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","MECHANICAL THROMBECTOMY;STROKE PATIENTS;HEART FAILURE;ANTERIOR CIRCULATION;AORTIC VALVE;ABSTRACT TP;ISCHEMIC STROKE;MULTIPLE MYELOMA;ABSTRACT WP;ACUTE ISCHEMIC;INTENSIVE CARE;VESSEL OCCLUSION;EDGE-TO-EDGE REPAIR;MITRAL REGURGITATION;PATIENTS UNDERGOING;STROKE THROMBECTOMY;TRANSCATHETER EDGE-TO-EDGE;UNDERGOING TRANSCATHETER;BICUSPID AORTIC;CHRONIC KIDNEY;CLINICAL PRACTICE;ENDOVASCULAR THROMBECTOMY;INTRAVENOUS THROMBOLYSIS;ITALIAN MULTICENTRE;KIDNEY DISEASE;LOW ASPECTS;MEDIUM VESSEL;MULTIPLE SCLEROSIS;MYELOMA PATIENTS;OBSERVATIONAL STUDY","15;12;9;7;7;6;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","HEART FAILURE;HR CI;CLINICAL PRACTICE;DI DIO;GIOVANNI DI;NIHSS SCORE;PATIENTS TREATED;RUGGI DARAGONA;SAN GIOVANNI;SARS-COV- INFECTION;FAILURE HF;MEDIAN FOLLOW-UP;MONOCLONAL ANTIBODY;PALLIATIVE CARE;REGRESSION ANALYSIS;ADVANCED HF;ADVERSE EVENTS;AEROBIC GLYCOLYSIS;ANTIBIOTIC RESISTANCE;AOR CI;AORTIC VALVE;GROWTH RATE;HAZARD RATIO;INTENSIVE CARE;MÉNIÈRES DISEASE;PUBLIC HEALTH;STATISTICALLY SIGNIFICANT;TRAUMA PATIENTS;UNIVERSITY HOSPITAL;ACHIEVED MTICI","11;11;9;8;8;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6;5",2,0.01,20.515,40.78,40.78,40.78,23,23,23,1,1,1,1,1,1,0,0,0,4,4,4,0,0,0,0,0,0,0,0,0,28,28,28,0,0,0,0,0,0,17,17,17,0,0,0,0,0,0,0,0,0,2,2,2,12,12,12,3,3,3,0,0,0,0,0,0,3,3,3,3,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
